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1. Introduction 
 
This body of work introduces a clickable copolymer, which was used as a tri-dimensional coating for 
microarray technology and employed for the study of glycan-protein and antibodies interactions. 
To give the reader a good background to understand the results presented here, a broad 
introduction to each theme is presented. 
 
First, the introduction focuses on solid surface modifications, in particular on a polymeric coating 
that allows high performance microarray analysis, both for glycan and antibody assays.  
Once the chemical modification is discussed, a deeper illustration of the microarrays analysis 
procedure is provided. Antibody and glycan microarrays are then examined separately, because of 
their wide areas of interest. 
 
Thanks to their involvement in many biological systems, antibody microarray analysis is gaining 
increasing acceptance in the proteomic field. The need for high-sensitivity biosensors leads the 
scientific community to investigate in depth the chemical approaches that could be adopted for 
antibodies immobilization, considering the importance of orienting the antibodies immobilization1. 
Various state of the art immobilization strategies are depicted and the advantages of the strategy 
proposed are illustrated. 
 
Finally, a presentation of glycan microarrays, as a novel tool for glycomics, is reported. In particular, 
attention is focused on the interaction of glycans with legume lectins. This interaction was used to 
set up a protocol for efficient glycan immobilization onto a clickable 3D matrix. 
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1.1. Aim of the work 
 
In this thesis we introduce a method to functionalize the surface of glassy materials with alkynes 
using a polymer that produces a coating by a facile 'dip and rinse' method. The alkyne groups on 
the tri-dimensional surface can be subsequently linked to azide-containing carbohydrates using Cu-
catalyzed azide/alkyne cycloaddition (CuAAC, click chemistry). The research is aimed at developing 
a new strategy to generate a polymer coating enabling the attachment of complex sugars via click 
chemistry by a method that does not require skilled personnel and chemistry laboratories. The 
proposed approach combines the advantages of high sensitivity and superior signal-to-noise ratio 
of a Si-SiO2 substrate with the quality of a 3D coating. The Si/SiO2 surface was used as the substrate 
to take advantage from the superior optical properties of this material (see 3.1.2). A novel polymer 
named poly (DMA-PMA-MAPS), obtained from the polymerization of N,N-dimethylacrylamide 
(DMA), 3-trimethylsilanyl-prop-2-yn methacrylate (PMA) and 3(trimethoxysilyl)-propylmethacrylate 
(MAPS) (Figure 11b, paragraph 2.1.1.) was synthesized and characterized. It  consists of: 1) a 
segment of polydimethylacrylamide that interacts with the surface by weak, non covalent 
interactions such as hydrogen bonding, Van der Waals or hydrophobic forces, 2) a pending silane 
hydrolysable monomers that promote condensation of the polymer with surface silanols or 
between contiguous chains and 3) chemically active monomers whose reactivity is selected on the 
basis of the reactivity of the molecules that have to be immobilized. (see paragraph 2.1.1.). 
The polymer reported herein is similar to another polymer developed in 2004 by Pirri et al. 10 to 
form a coating on glass slides by a combination of physi- and chemi-sorption. The proposed 
approach has found widespread application in protein and DNA microarray analysis. The novelty of 
this work consists in the presence of an alkyne functional monomer that replaces the succinimide 
active ester (see Figure 11, paragraph 2.1.1.). The 3D matrix adsorbed onto the surface, was 
characterized by contact angle measurements and by dual polar interferometic analysis (DPI). This 
latter technique highlights the solution-like environment created by the polymer onto the solid 
surface and will be discussed in Chapter 5. 
Furthermore, by exploiting the presence of a stable coating that allows regio-specific and bio-
orthogonal immobilization, a glycan microarray was built and its performance was deeply 
investigated. First, a qualitative assay (fluorescence analysis) was carried out to obtain a fast 
screening of the affinity of the interaction of nine glycomimetics with Concanavlin A. Second, 
thanks to the high-sensitivity of the Si/SiO2 platform used, a study of the influence of the 
multivalency presentation of glycans during lectin interaction was made. The high-performing 
substrate used allows a dramatic decrease of glycan surface densities (from 1,96·1014 down to 
5,07·1012 molecules/cm2), offering the possibility to calculate and compare the avidity in different 
conditions by providing density dependent surface dissociation constants (KD,surf) (Chapter 6). 
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In a different application, the new poly(DMA-PMA-MAPS) copolymer coating was used to 
functionalize microarray slides with orientated antibodies taking advantage from the regio-specific 
reaction between alkyne on the surface and azido groups on the biomolecule.  
Inspired by the work of Zeglis et al.132, described in paragraph 3.2.1.1., an enzymatic procedure was 
devised to obtain site-specific modified antibodies using an unnatural UDP-6-azidogalactose and 
two commercially available enzymes: β-(1,4)-galactosidase and β-(1,4)-galactosyltransferase 
(Chapter 7). As the 6-azidogalactose is sterically less hindered, it is expected to display a higher 
reactivity in the surface immobilization process. The strategy adopted was, in part, mutated from 
the procedure reported by Bosco et al.2. 
To validate the methodology and highlight its advantages, a sandwich microray test for the 
detection of interleukin-6 (IL-6) was developed (section 7.2.).  
Cytokines, a set of proteins implicated in the onset and development of almost every major life-
threatening disease are amongst the most intensively studied biomarkers. They play a prominent 
role in cancer, neurodegenerative diseases, cardiovascular diseases, sepsis and many other 
pathologies3. Although enzyme-linked immunosorbent assay (ELISA) is the gold standard for the 
measurement of a single cytokine concentration, the key to successful identification of biomarkers 
is the simultaneous detection of multiple cytokines with high sensitivity. IL-6 was chosen as a model 
of a typical inflammatory biomarker, to demonstrate the senistivity provided  by an oriented 
immobilization of the capturing antibody in a microarray based immunoassay. 
Our site-specifically modified antibody was compared to both a randomly azido-pegylated antibody 
and a site-specifically modified antibody derivatized by a commercial Kit (Site-Click Antibody 
Labelling purchase from Life Technology), which makes use of an unnatural UDP-2-azidogalactose 
instead of UDP-6-azidogalactose, and of a mutant GalT (Y289L) instead of a commercially available 
GalT. Furthermore, through the use of the label-free sensing platform IRIS, we have correlated the 
efficiency of the Ab-antigen interaction given by the fluorescence signal with the mass of antibody 
immobilized per surface unit (ng/mm2). The fluorescence per mass unit allows to assess the 
importance the antibody orientation on  its capturing ability. In particular its was demonstrated 
that a higher amount of immobilized probe does not necessary lead to a higher antibody-antigen 
interaction. 
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2. Surface modification 
 
Recent progresses in micro fabrication techniques and microarray technology have led to the 
development of miniaturized and fully integrated solid phase analytical devices that allow to 
perform complex analysis such as the study of cellular processes, the high throughput screening 
and the parallel diagnosis of multiple analytes on a chip. They imply a scaling down of the entire 
analytical process (time, sample and reagent volumes, costs.) while maintaining very high 
sensitivity. Considering the tiny dimensions of the aforementioned devices, their surface to volume 
ratio is extremely high and the surface must be perfectly designed and controlled in order to 
maximize probe immobilization and target binding efficiency, to reduce background noise and to 
prevent non specific molecular interaction.   
When the modification of a suitable substrate must be performed to promote covalent attachment 
of oligonucleotides and proteins at specific locations, the control of surface chemical-physical 
characteristics is of remarkable importance in order to maximize probe density immobilization and 
to maintain their native and functional conformation. Besides, in order to obtain accurate analysis 
and a high of signal-to-noise ratio, the surface chemistry should minimize hydrophobic interactions, 
which are the main source of biomolecules non specific binding. 
 
Therefore, there are several requirements that must be taken into account when chemically modify 
a surface: 
 
 The chemically modified surface must be inert and resistant to non-specific adsorption; 
 The surface must contain functional groups for the facile immobilization  of molecules of 
interest; 
 Bonding between a biomolecule and a solid surface must be strong enough to retain the 
molecule on the surface, but also sufficiently non intrusive to have minimal effect on the 
delicate 3D structure; 
 The linking chemistry must allow the control of biomolecule orientation; 
 
What follows is a short, non exhaustive review on the state-of-art regarding surface derivatization 
methods. 
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2.1. Surface coating in biosensor applications  
 
Thin coatings applied to the surface of materials can improve the properties of objects dramatically 
as they allow control of the interaction of a material with its environment. This has been known 
more or less empirically to humankind for several thousand years. Lacquer generated from tree sap 
was used as a protective coating for wooden objects. Varnishes, enamels and coatings from pitch 
and balsam were used by Egyptians to render ships waterproof. Lacquers and varnishes coatings 
were applied to homes and ships for decoration and as protective measures against adverse 
environmental conditions. In modern times, the coatings industry is a multi-billion dollar business 
and, especially if the value of the protected objects is considered, a very important contribution to 
the world economy. Today, however, the application range of coatings extends much beyond the 
simple decoration and protection aspects, and functional coatings have become an enabling 
technology in a vast variety of different high-tech areas. Fields in which such high-tech coatings are 
applied range from computer chips4 and hard disk manufacturing 5 to the use of special coatings in 
biomedical and aviation applications6 . 
When considering such applications, thin organic coatings are applied to control the interactions 
between the material and its environment. Examples of interface properties which can be 
controlled by deposition of a thin organic film onto a surface include friction7, 8, adhesion, 
adsorption of molecules from the surrounding environment, or wetting with water or other liquids. 
In medical applications, coatings allow to control of the interaction of biological cells and 
biomolecules with artificial materials in order to enhance the biocompatibility of an implant, or to 
avoid the nonspecific adsorption of proteins onto the active surfaces of an analytical device9 . In 
addition, the application of functional coatings allows the coverage of a surface with groups that 
interact with other molecules in their environment through specific molecular recognition 
processes10,11 . 
 
Depending on the type of interaction between the molecules which are constituents of the coating 
and the substrate which is to be modified, two strategies for the deposition of thin organic coatings 
can be distinguished. In the first one, the molecules interact with the substrate by physical forces12, 
whereas in the second case the molecules are attached to the surfaces through chemical bonds. In 
the latter case, a monomolecular layer or a surface-attached network is strongly (“irreversibly”) 
attached to the surface. 
A number of technologically relevant coating techniques rely on physical interactions between the 
deposited molecules and the substrate, including: a) painting/droplet evaporation b) spray coating 
c) spin coating d) dip coating e) doctor blading. 
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In addition to such processes, more sophisticated coating techniques have been developed, 
including the Langmuir-Blodgett technique13, the adsorption of monomolecular layers of homo- and 
block copolymers14  from solution, and the Layer-by-Layer (LbL)15 technique in which multilayer 
stacks of oppositely charged polyelectrolytes are deposited onto a (charged) substrate.  
The films obtained by physical interactions are not very stable and can be subjected to destruction 
by: 1) desorption during solvent exposure, 2) displacement by molecules which have stronger 
interaction with the surface, 3) dewetting (for films above the glass transition temperature, Tg) and 
4) delamination (for films below Tg). 
An alternative to improve stability of coatings even in very adverse environments is to attach the 
molecules of the coating to the surface through covalent bonds. The price that must be paid for an 
enhanced stability of the system is a more complicated coating procedure and/or the requirement 
to choose the coating conditions more carefully, so that the surface reaction proceeds in high yield 
and with limited side reactions. A current, very frequently employed strategy for the preparation of 
well-controlled surface layers is the use of small molecules with a reactive head group that is 
amenable to form a covalent bond with a corresponding chemical moiety on the surface, which is 
to be modified. Such layers are commonly called self-assembled monolayer (SAM)16. Examples are 
silanes anchored on silanol groups of glass surfaces, phosphates or phosphonate on metal(oxide)s, 
and thiols or disulfides on noble metal surfaces (gold surfaces). In this way, very stable surface 
coatings can be obtained and may even have a strong degree of positional and orientational order. 
If such molecules expose a specific chemical moiety or a biochemically active group, it is possible to 
obtain a more or less strict 2D arrangement of these functionalities17. Examples are molecules 
which contain “ligands” as recognition sites in bio-affinity assays. In this way, surfaces can be 
generated (for example, on top of the transducer of a biosensor) that bind proteins very specifically 
from solution18,19. The intrinsic limitations of this strictly 2D arrangement of the functional groups 
are evident: the maximal surface density of the functional moieties is limited by the surface area 
cross-section causing a limited accessibility of functionalities. One obvious solution to the above 
problem is the extension into the third dimension, that is, the use of polymers carrying the 
functional groups along the chain, thus generating higher cross-sectional densities of these groups 
and simultaneously guaranteeing good accessibility. 
 
2.1.1. Polymeric modification of surfaces 
 
Polymeric coatings, usually referred as tri-dimensional chemistries, provide a homogenous surface 
derivatization presenting a high reactive group concentration and resulting, depending on the 
circumstances, in an increased binding capacity of targets or to its suppression. Furthermore, they 
act as linkers distributing the bound probe also in the axial position (away from the surface), thus 
11 
 
causing a faster reaction with the target involved in biomolecular recognition. Additionally, 3D 
scaffolds can be engineered to customize their properties for specific applications. 
Most approaches that aim at attaching polymers to a surface use a system where the polymer 
carries an “anchor” group, either as an end group or in a side chain. This anchor group can react 
with appropriate sites at the support surface, thus yielding surface-bound monolayers of polymer 
molecules (termed “grafting to”) (Figure 1)20,21.  
Another straightforward technique is to carry out a polymerization reaction in the presence of a 
surface onto which monomers have been attached22, 23. During the polymerization reaction, the 
surface-anchored monomers are incorporated into growing polymer chains (Figure 1).  
 
Figure 1: Schematic illustration of different processes used for the attachment of polymers to 
surfaces: (a) “grafting to”; (b) grafting via incorporation of surface-bound monomeric units; (c) 
“grafting from/surface-initiated polymerization”. 
 
Although this technique, called “grafting from” coating, enables the synthesis of polymer brushes 
with a high surface density and thickness, the synthesis requires several steps including an initial 
step of organosilanization to graft a silane initiator. 
In 2004 Pirri et al. presented a third technique that combines physisorption and chemisorption to 
simplify the coating process. The polymer used in this technique is grafted to the surface using 
pending silanols and is physisorbed to the surface (glass or Si/SiO2) thanks to H-bond interactions 
from a mostly  dimethylacrylamide (DMA) backbone10. In this way, coating can be easily achieved 
by dip and rinse procedure. Despite the simplicity of the process, the 3D matrix formed is covalently 
linked to the surface and therefore stable. Furthermore, the presence of a third functionality on the 
polymer (an active ester of succinimide, NHS) allows covalent immobilization of probes (from small 
molecules to proteins).  
 
In this thesis, the synthesis of a similar copolymer carrying a different functionality for probe 
binding, is reported. All the advantages of the previous polymeric coating are maintained in the 
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new structure, and the main difference lies in the chemistry used for the immobilization of small 
molecules or protein that have to be studied. 
 
2.2. Surface characterization: Instrumentation 
 
2.2.1. Contact angle 
 
Measure of Contact Angle is the easiest and cheapest analytic technique to characterize a surface. 
The contact angle is the angle at which a liquid/vapor interface meets a solid surface. The 
equilibrium contact angle is specific for any given system and is determined by the interactions 
across the three interfaces. Most often the concept is illustrated with a small liquid droplet resting 
on a flat horizontal solid surface. The shape of the droplet is determined by the Young-Laplace 
equation, with the contact angle playing the role of a boundary condition.  
The theoretical description of contact arises from the consideration of a thermodynamic 
equilibrium between the three phases: the liquid phase of the droplet (L), the solid phase of the 
substrate (S), and the gas/vapour phase of the ambient (G). At equilibrium, the chemical potential 
in the three phases should be equal. The relationship between contact angle and solid surfaces is 
expressed by Young equation (Equation 1): 
 
  

cos 
 SL   SG
LG  
Equation 1 
 
where γLG is the liquid/vapor interfacial energy,  γSG  is the solid–vapor interfacial energy, γSL is the 
solid–liquid interfacial energy, and θ is the equilibrium contact angle, as shown in Figure 2. 
 
 
Figure 2: Schematic representation of a drop on a surface and formation of the contact angle. 
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The Young equation assumes a perfectly flat surface, and in many cases surface roughness and 
impurities cause a deviation in the equilibrium contact angle from the contact angle predicted by 
Young's equation.  
If the molecules of a liquid are strongly attracted to the molecules of a solid (for example water on 
a strongly hydrophilic solid) then a drop of the liquid will completely spread out on the solid 
surface, corresponding to a contact angle of 0°. Less strongly hydrophilic solids will have a contact 
angle up to 90°. On many highly hydrophilic surfaces, water droplets will exhibit contact angles of 
0° to 30°(Figure 3b); if the solid surface is hydrophobic, the contact angle will be larger than 90°, 
while on highly hydrophobic surfaces the surfaces have water contact angles as high as ~120° (e.g. 
fluorinated surfaces), see Figure 3a. 
 
(a) (b) 
 
 
 
110° 30° 
Figure 3: Images of contact angle on two different surfaces. Behavior of a water-droplet on a (a) 
hydrophobic and (b) hydrophilic surface. 
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2.2.2. Dual Polarization Interferometry (DPI) 
 
Dual Polarization Interferometry is an optical surface analytical technique that provides 
multiparametric measurements of surface coatings providing information on their molecular 
dimension (layer thickness), packing (layer refractive index, density) and surface loading (mass)24. 
The instrument used in this work was the Analight Bio200 (Farfield Sensors Ltd., Salford, UK), that is 
the principal product of the Farfield Company. It uses a silicon chip which contains two channels, 
and each channel is made up of a reference waveguide and a sensing waveguide. Focused coherent 
laser light enters the two waveguides and undergoes a total internal reflection passing along the 
guide. The reference waveguide is sandwiched between two surfaces providing a constant 
refractive index and therefore the passage of light is highly consistent and the upper surface of the 
sensing waveguide is exposed. The light leaving each waveguide passes through a pin hole and 
combines, forming a 2D interference pattern in the far field (on the detector), see Figure 4. 
 
Figure 4: Dual waveguide sensor chip (viewed from the side). 
 
As molecules, or thin films, are absorbed onto the surface of the sensing waveguide, changes in the 
evanescent field of the light occur due to a change in the refractive index. Therefore the light 
exiting the top waveguide will be out of sync compared to the reference lower guide. This is seen as 
a shift in the interference pattern of the upper guide with respect to the reference (Figure 5). 
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Figure 5: sensor chip with changes occurring at the sensor surface causing a shift in the fringe 
position. 
 
The DPI technique rotates the polarization of the laser to alternately excite two polarization modes 
of the waveguides: the transverse electric (TE) and the transverse magnetic (TM) modes. Each 
polarization has a different depth of evanescent field and the TE (transverse electric) mode is more 
sensitive than the TM (transverse magnetic) mode to changes occurring in close proximity to the 
waveguide surface(Figure 6). The relative responses can be used to obtain an estimate of the layer 
structure. 
 
Figure 6: response observed to the TE and TM modes of polarization. 
 
A single TM mode measurement cannot be used to differentiate between a very thick but low 
refractive index layer (a diffuse layer) or a very thin but high refractive index layer (a dense layer), 
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as all the combinations of thickness and refractive index in the range plotted are allowable for the 
given TM polarization mode response. 
By solving Maxwell’s equations for both the TM mode and TE mode, a single point of intersection 
can be found that will give the exact layer condition (Figure 7). 
 
Figure 7: Overlaying the two calculated thickness and RI (refractive index) ranges, obtained by 
resolving the Maxwell’s equation for the TM (bold red line) and TE (dotted red line) mode, the exact 
layer condition was obtained. 
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3. Microarray Technology 
 
From the beginning of the nineties the demand of new tools to handle the enormous quantity of 
genomic information25   has considerably grown. Such a necessity led to the development of 
microarray technology, which was found to be a powerful technique for analysing thousands of 
genes of several biological systems since its very first application. This technology consists in an 
orderly arrangement of probes with known identity used to determine complementary targets in 
solutions. 
Briefly, considering DNA microarrays, microscopic drops of DNA oligonucleotides, each containing 
picomoles of a specific DNA sequence (e.g. short section of a gene, DNA segments) are deposited 
onto a surface to hybridize DNA or RNA samples26. 
The construction of microarrays involves the immobilization or in situ synthesis of DNA probes onto 
the specific test sites of the solid support or substrate material. High-density DNA microarrays 
contain hundreds of thousands of oligonucleotides immobilized onto a surface. DNA microarrays 
have attracted scientist interest because of their potential in clinical diagnostics, genotyping, 
determination of disease-relevant genes, detection of Single Nucleotide Polymorphisms (SNPs) and 
of post-translational modifications27,28,29.  
However, some difficulties occurred when analyzing, for example, mRNA transcript levels expressed 
under various conditions. In fact, mRNA expression level and the corresponding protein 
abundances (or activities) do not always correlate because of changes in translation rates and 
protein lifetimes30. Therefore analysis of mRNA is not fully representing the real conditions of a cell 
protein expression and distribution. Furthermore, analysis of mRNA transcripts does not take into 
account post-translational modifications, such as proteolysis, phosphorylation, glycosylation, or 
acetylation, although many signaling pathways are mediated by such structural alterations. As a 
consequence, the motivation to overcome such difficulties has led to the development of promising 
technology that allows large-scale analysis of proteins in a parallel and miniaturized fashion. 
Over the past decade, the combination of two-dimensional gel electrophoresis/mass spectrometry 
(MS) has been the major tool in comprehensive proteomic studies. Even though this process offers 
good resolution in the separation of protein isoforms that are modified by post-translational 
processes (for example, phosphorylation31, glycosylation32, and deamination33 it presents some 
drawbacks including: 1) lack of a good automation of the processes involved, 2) low detection limit, 
that is fundamental in the field of proteins analysis (always present in low amount), 3) low 
reproducibility, 4) time-consuming protocols, and v) difficulties in the separation of hydrophobic 
membrane proteins and basic or high-molecular-mass proteins34,35,36. Another approach widely 
used in proteomics is the combined use of liquid chromatography (LC) and mass spectrometry (MS) 
methods.  In this approach it is possible to combine ion-exchange, reversed-phase, and affinity-
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based separations to improve the resolution of each protein species. However, despite the 
theoretical proposal of these two technologies, to cover the complete proteome, parallelization 
and miniaturization, required for high-throughput screening of proteins, is still absent/lacking. 
Recently, the so-called protein microarray technique has emerged as an alternative technology 
37,38to overcome some of the limitations of the above mentioned approach. Protein microarrays 
comprise a large number of capture agents that selectively bind to the proteins of interest on solid 
surfaces. 
As in the case of nucleic acid microarrays, both multiplexing and miniaturization are achieved 
relative to traditional methods, thus dramatically increasing the amount of data that can be 
obtained per volume of biological sample. For example, when 100 μL of sample are applied to a flat 
surface with 10000 spatially and biochemically distinct features (for example, each one being 
derivatized with a different antibody), 10 000 data points can be obtain in just one experiment. By 
comparison, a conventional 96-well ELISA type assay would only produce a single data point from 
the same amount of sample39. 
A general scheme of a typical array experiment is shown in Figure 8: a large set of capture ligands 
(DNA, protein or peptide probes) is arrayed on a solid functionalized support using a robot (spotter) 
able to spot few nano-litres of a probe solution. After washing and blocking the surface unreacted 
sites, the array is probed with a sample containing (among a variety of unrelated molecules) the 
counterparts (target) of the molecular recognition event under study. If an interaction occurs, a 
signal is revealed on the surface by a variety of detection techniques. The most used one is the 
scanning of fluorescent labelled target molecules which allows detecting a large number of binding 
events in parallel. 
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Figure 8: General scheme of a typical microarray experiment. 
 
As a natural extension of the successful development of printed arrays of the above described 
biomolecules, and thanks to the wide range of carbohydrates interactions with biological targets, at 
the beginning of this century glycan microarrays were first introduced by several research 
groups40,41,42 . The principle of this technique, as for DNA and proteins microarrays, consists in the 
immobilization of glycans onto a properly modified solid surface. The advantages introduced using 
glycan microarrays in carbohydrates research is that, starting from small quantities of 
carbohydrates (picoliters), analysis of several carbohydrate molecules could be obtained, avoiding 
the waste of a material so difficult to obtain (both from synthetic and natural sources). 
 
3.1. Microarray supports 
 
The aim of microarray technology is the study of molecular interactions occurring between two 
partners: one contained in a liquid sample and one immobilized on a solid support. The chemistry 
used for the immobilization of probe molecules on the substrate plays a significant role in the 
success of any microarray experiment. This is particularly true with protein arrays. Unlike DNA, 
proteins tend to bind to surfaces in a non-specific manner and, sometimes this causes a loss of 
biological activity43. The surfaces typically used for the immobilization of DNA are rarely suitable for 
proteins due to the biophysical differences between the two classes of analytes. 
Therefore, the attributes for a substrate used to immobilize proteins are different from those for a 
DNA microarray. The key requirements of the surface hosting a protein microarray assay are:  
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(1) Provision of an optimal binding capacity of capture ligands (probes). 
(2) Retaining of biological activity of capture ligand (proteins tend to unfold when immobilized onto 
a support, in order to allow internal hydrophobic side chains to form hydrophobic bonds with the 
solid surface). 
(3) Accessibility of the ligand by the interaction partner (protein–surface interactions reduce the 
accessibility of the target, possibly leading to false negative results). This issue is particularly 
important for peptide and carbohydrates microarrays due to the small molecular mass of capture 
ligands. 
(4) Low degree of non-specific interactions (the achievement of a low degree of a-specific binding is 
extremely difficult when the sample is a complex mixture of thousands of molecules such as 
serum), resulting in a high S/N ratio. 
This is of outstanding importance because, for example, the abundance of some proteins in animal 
plasma is very low (also lower than 1 pg/ml) and their detection is very problematic. Therefore one 
of the main goals in manufacturing optimal chips is the correct choice of a solid surface and the 
development of a surface chemistry that is compatible with a diverse set of biomolecules while 
maintaining their integrity, native conformation, and biological function. 
 
3.1.1. Characteristics of the supports 
 
The final performance of a microarray biochip strongly depends on parameters related to the 
immobilization process itself. These include: 
(a) the chemical and physical properties of the surface, as they influence both specific and 
nonspecific binding of target and non-target biomolecules; 
(b) the distance between the immobilized probes and the chip surface; 
(c) the orientation of the immobilized probes, which might impair binding, especially of large 
analytes such as proteins;  
(d) the probe density on the surface, which determines chip’s sensitivity and limit of detection. 
The selection of the solid surface employed for generating microarray chip depends on the 
intended application. For example, gold surfaces are often used for the development of biosensors 
with electrochemical and SPR read-out44  because of their outstanding electrical conductivity and 
convenient functionalization by means of thiol chemisorption. In contrast, glass or silicon45  is 
typically preferred for optical sensors because of their transparency (in the case of glass) and low 
intrinsic fluorescence. In general, these surfaces are characterized by their chemical homogeneity 
and stability, their controllable surface properties (such as polarity and wettability), their reactivity 
towards a wide range of chemical functionalities, and the reproducibility of surface modification. 
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3.1.2. Planar Chip Surfaces 
 
Glass slides are the favoured surfaces for microarrays for a number of reasons such as availability, 
cost, flatness, rigidity, transparency, amenability to chemical modification and non-porosity46. 
Methodologies for functionalizing glass slides with chemical groups have been reported for the 
development of small-molecule 47  and DNA microarrays 48 , 49 . The main method for the 
functionalization of glass slides uses reactive silanol groups (Si-OH) on the glass surface that can be 
activated by a pre-treatment of the surface with, for example, piranha solution (H2O2/ H2SO4) or 
NaOH solution or oxygen plasma. Organofunctional silanes of the general structure (RO)3Si(CH2)nX 
or trichlorosilanes are then used to introduce new functional groups on the surface50. A large 
variety of silane reagents are commercially available, bearing amine, thiol, carboxy, epoxide, and 
other functional groups for subsequent modification steps. Various protocols for silanization can be 
found in the literature, employing deposition of silanes from organic solutions, aqueous solutions, 
gas phase, or by chemical vapour deposition51. Dendrimers are compounds with branched chemical 
structures that carry a range of chemically reactive groups at their periphery; they have been 
applied for surface derivatization to create a larger functional surface area. The dendritic structure 
can either be synthesized in situ by derivatization of the surface with multifunctional linkers52 or be 
generated by direct surface modification with a pre-synthesized branched structure, such as 
polyamidoamine53, phosphine54, or poly(propylene imine) dendrimers55. 
The majority of researches in the microarray community utilize glass slides as the “gold standard” 
support. To enhance fluorescence intensity, that is fundamental for microarray sensitivity, 
silicon/silicon oxide (Si/SiO2) substrates of variable thickness were recently investigated
56. These 
layered substrates are widely available, inexpensive, and compatible with established glass surface 
chemistries, have a low roughness and provide a tuneable wavelength enhancement.  A paper 
published by Cretich et al. in 200945 demonstrates using AFM analysis that the thermally grown 
silicon/silicon oxide surface has a better physical configuration (more regular, less rough) (Figure 
9a), compared to the classical glass surface (Figure 9b), validating the more ordered and 
reproducible covering of the substrate with biomolecules observed45.  
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Figure 9: Atomic Force micro-graphs and Rq values of thermal SiO2 slide (a) and of conventional 
glass slide surface (b). AFM measurements were carried out in the tapping mode with either a PSIA 
XE-150 apparatus or an NT-MTD instrument. 
 
Furthermore, the optically transparent SiO2 acts as a spacer to bring the fluorophore into the plane 
of constructive interference. By varying the thickness of the SiO2 layer, the emission wavelength of 
any fluorophore of choice can be enhanced by constructive interference. Using the dipole emission 
model57,58  to simulate fluorophore emitters near a dielectric interface on layered substrate, the 
structure can be designed and optimized for a range of wavelengths as depicted in Figure 1059. This 
concept has been proven with the development of a 100-nm SiO2 layer for broadband 
enhancement (Figure 10a and 10b) and a 320-nm SiO2 layer for the selective enhancement of Cy3 
and Cy5 fluorophore (Figure 10a)59. 
 
a)  b)  
Figure 10: a) simulated fluorescence enhancement of 100-nm and 320-nm of SiO2 and glass for 
commonly used fluorophores; b) simulation of fluorescence emission of Cy3 labelled 
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oligonucleotides placed over silicon crystals coated with silicon oxide layers of different thickness. 
The simulation curve is scaled to fit experimental data (histogram) obtained by fluorescence 
scanning of silicon slides spotted with 2.5 µM Cy3 labelled olignucleotides. 
 
Notably, the use of Si/SiO2 substrates with an optimized oxide layer of 100 nm provides a 
fluorescent enhancement up to 7 times in comparison with conventional glass thus leading to 
improved limits of detection in microarray assay45. 
A silicon/silicon oxide substrate, with a 500-nm of SiO2 layer, was also used in a label-free detection 
methodology called the interferometric reflectance imaging sensor (IRIS). This platform is a 
microarray sensing technique that utilizes a Si/SiO2 biochip for high-throughput and multiplexed 
detection. This technique utilizes optical interferometry with a buried reference plane to detect 
binding of biomolecular interaction on the surface. Binding interactions are recorded through 
sampling the reflectivity signatures of the surface with multiple wavelength sources and a camera. 
After a stack of images is acquired, the reflectivity curves for each area are mapped and fitted 
through the Fresnel reflectivity equation of the silicon chip structure60. IRIS allows a precise 
quantification of the amount of immobilized biomaterial on the silicon chips.  
 
In this thesis, Si/SiO2 biochips with a 100-nm layer of SiO2 were used for the fluorescence glycan 
microarrays experiments to get fluorescence enhancement, whereas for the antibodies 
microarrays, IRIS biochips were used to enable a correlation between the amounts of immobilized 
antibodies on the solid surface with the recorded fluorescence signal.  
 
3.1.3. Chips with 3D Matrixes 
 
Instead of spotting probes onto a two-dimensional solid surface, molecules can diffuse into a 
porous matrix formed by polymer membranes or hydrogels. These matrices show a high capacity 
for probe immobilization and can provide a more homogeneous “natural” aqueous environment 
than flat surfaces, thus preventing denaturation of biomolecules. However, they suffer from 
problems related to mass transport effects and sometimes high background signals. Traditional 
membrane materials that have been used are nitrocellulose and nylon, the latter providing greater 
physical strength and binding capacity. Probe attachment to nylon is also generally more stable 
than to nitrocellulose: nylon allows positive or negative electrostatic interactions or photocross-
linking, while nitrocellulose is believed to bind biomolecules by means of hydrophobic 
interactions61. Further improvement of mechanical stability is offered by anodically oxidized porous 
alumina. This material offers readily available surface chemistries, in particular silanization 
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methods, which can lead to higher densities of biomolecular probes, and thus to higher sensitivity 
in array applications62. 
Polymeric hydrogels represent hydrophilic matrices into which probes can diffuse, leading to an 
immobilization capacity 100 times higher than the one found for planar surfaces63. Covalent 
attachment of the gels to solid surfaces generates stable microarray chips. For example, agarose 
and acrylamide can be photopolymerized onto a surface functionalized with acrylic groups64. 
Subsequently, the polymer can be activated with hydrazine or ethylenediamine to generate amine 
groups on the surface65. Other examples of polymeric gel surfaces that can be used for the 
immobilization of biomolecules involve polysaccharides, such as chitosan or dextran. Chitosan is an 
amine-modified, natural, nontoxic polysaccharide, and it is biodegradable. Because of its pH-
responsive properties, it can simultaneously be immobilized onto glass supports and bind proteins 
through electrostatic interactions. Dextran is a complex branched polysaccharide consisting of 
glucose molecules joined into chains of varying lengths. Dextran hydroxy groups can be oxidized to 
aldehyde functionalities that can then be covalently immobilized onto amine-functionalized 
supports and unreacted aldehyde groups can be further used for probe immobilization. 
Supramolecular hydrogels composed of glycosylated amino acids have been introduced as a surface 
material for protein arrays66. Biodegradable polyesters, such as poly(l-lactic acid) and its various 
copolymers with d-lactic acid and glycolic acid, have also been studied as surfaces for biological 
applications67. 
 
3.1.4. Design Principles for Minimizing Nonspecific Adsorption 
 
In contrast to DNA microarray applications, nonspecific binding represents a major obstacle in the 
development of microarray assays for proteins and glycans. As nucleic acids are uniformly 
negatively charged, spontaneous adsorption to a given surface is much easier for proteins, which 
can adsorb through electrostatic, van der Waals, and Lewis acid–base forces as well as through 
hydrophobic interactions and conformational changes68. However, the quality of a microarray assay 
is determined not only by the desired binding events between biomolecules but also by the 
suppression of undesired binding of analytes and other components within the biological sample. 
Such nonspecific binding can give rise to background signals and thus to low signal-to-noise ratios. 
Effective reduction of non-specific adsorption has been achieved by careful selection of the surface 
material, for instance by using naturally occurring surfaces such as elastin 69, sarcosine70, agarose71, 
cellulose72  and polysaccharides73, or by using synthetic polymeric surfaces such as fluorocarbon 
polymers and molecules74, polyethylene glycol75, poly(vinyl alcohol)76, or polyelectrolytes77. One 
particularly versatile approach to suppressing non-specific adsorption is based on surfaces that 
present oligo (ethylene glycol) derivative78,79. A meticulous study by Whitesides and Prime showed 
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that crystalline helical and amorphous forms of SAMs of oligo(ethyleneglycol)-functionalized 
alkanethiolates on gold are resistant to protein adsorption80. It is hypothesized that binding of 
interfacial water by the ethylene glycol layer is important for the ability of the SAM to resist protein 
adsorption81. However, the susceptibility of ethylene glycol chains to autoxidation limits their long-
term application. Surface phospholipids also minimize nonspecific binding. Their strong hydration 
capacity, achieved by electrostatic interaction, is postulated to be responsible for this effect81. The 
zwitterionic properties of monolayers of, for example, oligophosphorylcholine SAMs result in 
suppression of kinetically irreversible nonspecific adsorption of proteins, but unfortunately, 
phosphorylcholine monolayers are not very stable. In an attempt to further rationalize the design of 
surfaces resistant to protein adsorption, Whitesides and coworkers formulated a hypothesis 
correlating the preferential exclusion of a “solute” to its ability to render surfaces resistant to the 
adsorption of proteins. When elements of known osmolytes (organic compounds affecting osmosis) 
or kosmotropes (organic compounds contributing to the stability and structure of water–water 
interactions) were incorporated into alkanethiolates such as betaine, taurine, or 
hexamethylphosphoramide, SAMs of these compounds displayed improved protein repellency82. 
Although these elaborate approaches have proven to be effective for minimizing nonspecific 
adsorption, it must be clearly stated that the old fashioned blocking of reactive surface sites by the 
addition of blocking agents such as the protein bovine serum albumin (BSA), skim milk powder, or 
other reagents and the presence of surfactants such as Tween-20 and sodium dodecyl sulfate (SDS) 
are usually indispensable to the suppression of nonspecific protein adsorption83. 
The need of minimizing the non-specific adsorption on the surface in carbohydrates microarray is 
the same as for protein assays above described. The BSA is usually employed to minimize the 
analyte non-specific interactions, whereas for probes binding, in the case of synthetic small 
molecules (like the ones studied in this thesis), it would be easier to obtain a specific interaction by 
introducing specific functional groups that will selectively react with properly functionalized surface 
(i.e. azide or alkyne). 
The same idea was translated also on biomolecules analysis, such as antibodies, and a chemical 
modification was adopted to introduce unnatural functional groups to avoid non-specific 
interaction during antibodies immobilization step. 
 
3.1.5. Polymer coating 
 
The reactivity of a chip surface is determined by the functional groups it displays. The density of the 
reactive groups is one important factor controlling the amount of protein that can be immobilized 
on a specific surface area and thus consequently influences the limit of detection attainable with 
the particular chip. For example, the direct attachment of a protein to a surface without a spacer 
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can cause steric constraint of protein’s reactivity or interaction capability, compared to the protein 
in solution. Moreover, multiple direct contacts with the surface can induce complete or partial 
denaturation and thus a decreasing in its biological activity. By introducing a spacer between the 
protein and the reactive group on the surface, these effects can be minimized. 
In general, proteins offer many functional groups, mainly in the amino acid side chains, that are 
suitable for immobilization purposes. Such functional groups can be used to covalently couple 
proteins to surfaces by a range of different reactions. 
In case of DNA, sequences can be synthetically modified at one end, so a functional group, which 
easily reacts with the derivatized surface, is exposed. 
Therefore, the development of more complex three-dimensional structure, that moves away from 
the surface and exposes the functional groups, it is one of the most important field of research in 
our laboratory. 
In an attempt to obtain a suitable polymer coating with high capacity for probes immobilization 
offering a homogeneous “natural” aqueous environment, a hydrophilic copolymer made by N,N-
dimethylacrylamide (DMA), N-acryloyloxysuccinimide (NAS), and 3-(trimethoxysilyl)propyl 
methacrylate (MAPS) (poly(DMA-NAS-MAPS)), firstly reported for the preparation of low-density 
DNA microarrays, was developed (Figure 11 a)10. 
 
  
(a) (b) 
Figure 11: structure of the two ter-polymer (a) poly(DMA-NAS-MAPS) from Pirri et al. 2004 10 and 
(b) poly(DMA-PMA-MAPS) copolymer synthesized in this thesis. 
 
The innovative aspect of this approach relies on the fact that the polymer self-adsorbs onto the 
glass surface very quickly, simply by immersing glass slides in a diluted aqueous solution of the 
polymer and without time consuming glass pre-treatments. Therefore, the coating procedure 
provides a fast and inexpensive method for producing hydrophilic functional surfaces bearing active 
esters, able to react with amino groups of modified DNA, proteins and peptides. The poly(DMA-
NAS-MAPS) slide performance was investigated in the assessment of rheumatoid factor (RF) in 
human serum samples 84   and in pathogen detection upon functionalization of 
poly(dimethylsiloxane) (PDMS) by chemisorption in DNA microarrays 85 . The results have 
demonstrated that immobilized probes maintain an active conformation and are easily accessible; 
27 
 
moreover, after the assay, the slides exhibited a very low background. The polymeric surface was 
also tested as a peptide microarray support in an epitope mapping study43,86. This study suggested 
that although the poly(DMA-NAS-MAPS) coated slides bind the capture molecule in a random 
conformation, the aqueous micro-environment created by the polymeric coating provided a good 
accessibility of the ligand.  
 
Moreover, Cretich et al. demonstrated by AFM analysis that the presence of a poly(DMA-NAS-
MAPS) ultrathin film coating did not influence the roughness of a Si/SiO2 surface (Figure 12), 
maintaining all the advantages previously described for this surface (paragraph 3.1.2.).  
  
 
Figure 12: atomic force micrographs of thermal SiO2 (a) and polymer coated SiO2 (b) surfaces. 
 
Thanks to the success of this copolymer (in terms of sensitivity, dose-response interactions, probes 
accessibility, etc.) and because of the growing interest in the use of click chemistry, due to the 
possibility of obtaining fast, simple, versatile and regiospecific reactions with high products yields87, 
one of the main goals of my thesis consisted in the synthesis of a new copolymer similar to 
poly(DMA-NAS-MAPS), in which the NAS functionality is replaced with an alkyne functionality 
(Figure 11 b). 
 
This new copolymer would allow the immobilization of small molecules, and/or any kind of probes 
carrying azide functionality, and give us the chance of study copper-mediated click reaction directly 
on the surface. 
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3.1.6. Ligands immobilization chemistry 
 
As previously described, a microarray consists of an orderly arrangement of the probes immobilized 
onto a properly functionalized solid surface. The immobilization occurs in a non-covalent or 
covalent fashion, depending on the substrate that has to be attached and on the availability of 
functional groups present both on the substrate and surface (Figure 13). 
Furthermore, the two immobilization strategies can be divided into two subclasses, which are the 
non-oriented and oriented immobilization. This topic will be discussed in depth later (paragraph 
3.2.1.), because it correlates better with proteins microarray analysis.  
Some of the interactions exploited for non-covalent immobilizations techniques include: the 
naturally strong biotin-avidin binding point (in particular streptavidin); lectin-carbohydrates pair, 
that belong to the receptor-ligand mechanism, hydrophobic binding (synthetically fluorous-tagged 
probes to fluorinated slides) and simple physisorption88,74. For antibodies it is possible also to 
employ the specific interaction of protein A, G or L with their Fc region1.  
 
 
Figure 13: (a) covalent coupling, (b) receptor-ligand non-covalent coupling, (c) adsorption, non-
covalent coupling.  
 
The use of non-covalent immobilization, during the years, was substituted with the more stable 
covalent binding that, in particular for biomolecules, takes advantage mostly from the natural 
abundance of amine groups that are very reactive toward a wide range of functional groups (i.e. 
active esters, aldehyde, etc). 
Nowadays the dominating microarray format relies on the covalent binding of probes to microarray 
slides, thanks to their higher stability during the whole analysis89,90.  
The choice of the reactive group mainly depends on the synthesis strategy of the probes that has to 
be immobilized. The coupling reaction should be fast, specific and high yielding. The group should 
not interfere during the synthesis and should not react with other groups present on the substrate. 
Fast reactions are preferable, since reactions with surfaces are significantly slower than that of the 
corresponding reactions in solution. Fast covalent immobilizations that have been exploited are 
depicted in Figure 14. Initial examples include the classical and efficient reaction between amine 
and N-hydroxysuccinimide active ester (Figure 14a)90  or epoxides (Figure 14b)91, that could be 
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applied to biomolecules without modification. However the immobilization of a compound could be 
a disadvantage: if the compound, usually present in small amount, is not completely available to 
the binding interaction it might not be recognize by the analyte in solution, which would led to a 
false negative results. To overcome this problem, special attention has been give to chemoselective 
and biorthogonal reaction for the immobilization mechanism (i.e. Staudinger ligation, 
photoactivatable immobilization and copper-mediated cycloaddition). So, later, the so called “click 
reactions” were used. They include thiols and maleimides reaction (Figure 14c)92, as well as 
cyclizations of azides and alkynes (Figure 14d) or properly substituted phosphines or photoreactive 
groups (Figure 14e)93, that are suitable for synthetically modified probes, such as glycans and 
engineered or chemically modified biomolecules (proteins, antibodies, peptides, etc).  
 
a)   
 
 
 
b)   
 
 
 
c)   
 
 
 
d)     
 
e) 
 
 
  
 
Figure 14: Surface covalent coupling chemistries 
 
In this thesis we investigated the possibility to immobilize small molecules and biomolecules 
through the well known copper-mediated 1,3-dipolar Huisgen cycloaddition. 
 
3.1.6.1. Click-chemistry 
 
The Huisgen 1,3-dipolar cycloaddition reaction of organic azides and alkynes94  has become more 
popular from 2001, when Cu(I) catalysis was introduced at the same time by Sharpless, Meldal and 
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Tornøe. Sharpless and co-worker revised the Huisgen 1,3-dipolar cycloaddition in aqueous 
condition, finding out that in water medium the reaction proceeds better than in an organic 
solvent95. Simultaneosly Tornøe and Meldal96 reported copper catalysis in a work on solid-phase 
peptidotriazoles, that led to an improvement in both rate and regioselectivity of the reaction. This 
condition allows a quantitative, very robust, insensitive and orthogonal coupling reaction, suitable 
for both biomolecular ligation97  and in vivo targeting98. The triazole formed is essentially chemical 
inert to reactive conditions, such as oxidation, reduction and hydrolysis99.  
In the set of “clickable” reaction (that include reaction such as Diels-Alder cycloaddition) the 
Huisgen 1,3-dipolar cycloaddition copper-catalyzed, thanks to the dramatically acceleration rate 
obtained with the catalyst and the beneficial effects of water used as solvent, gained all the 
attentions. 
 
 
Figure 15: Huisgen cycloaddition non catalyzed and catalyzed by Cu(I). 
 
This reaction process do not requires protecting groups on the most common functionalities of 
biomolecules, and proceeds with almost complete conversion and selectivity for the 1,4-
disubstituited 1,2,3-triazole, see Figure 15, with a surprising indifference to solvent and pH. 
Therefore it is widely applied also in the derivatisation of biomolecules and pseudo-biomolecules 
providing more challenging tasks in the field of bioconjugation. Chaikof et al. used copper-mediated 
click chemistry to immobilized both carbohydrates and proteins on a SAM modified solid surface. 
Thanks to the regioselectivity of this cycloaddition, the reduction of biomolecular activity through 
denaturation, caused by random orientation on solid surface, could be avoided incorporating a 
triazole linker obtained via click chemistry between proteins and surface carrying alkyne 
functionality. The same concept was translated to carbohydrates immobilization on solid surfaces 
derivatised with alkyne functionality (Figure 16)100.  
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Figure 16: Schematic illustration of azyde-alkyne cycloadditions of azide derivatized biomolecules 
(from carbohydrates to protein). 
 
The results obtained demonstrated that Cu(I) catalyzed click reaction is suitable for both 
carbohydrates and proteins immobilization, without the production of unwanted side products, and 
the easy procedure could be extended to the immobilization of a wide range of substances onto 
properly modified solid surfaces. 
  
However, the presence of a copper catalyst may be a problem. Some examples of in vitro copper-
induced degradation of viruses101 or oligonucleotide strands102 have been reported. In this case, 
maybe the use of thermal initiated Huisgen cycloaddition could help, but such approach is rather 
specific and cannot be extended to all the standard ligation situations. An interesting copper-free 
azide-alkyne cycloaddition strategy has been reported by Bertozzi and co-workers103  in 2007, and it 
is based on the use of strained cycloalkynes differently substituted for dynamic in vivo imaging. 
However, this strained-promoted alkyne-azide cycloaddition (SPAAC), that is gaining increasing 
acceptance in particular in the modifications of biomolecules and living system, would gave a 
slower cycloaddition kinetics if compared with copper-mediated click reaction (CuAAC). Even the 
fastest of the strained cyclooctynes react with azides >10 times more slowly than terminal alkynes 
in the presence of Cu(I)104. 
 
For these reasons, in accordance with the literature, in this thesis the CuAAC cycloaddition was 
used coupled with a protector/accelerating ligand (THPTA) for antibodies immobilization, to 
maintain all the advantages related to copper-mediated cycloaddition without damaging the 
investigated biomolecules104,105,106.  
 
32 
 
   
BTTAA TBTA THPTA 
Figure 17: Structures of three ligands reported in literature for the acceleration of click-chemistry 
reaction rate. 
 
Many studies were made on the function and utility of these ligands (Figure 17), and many 
structures were presented.   
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3.2. Protein microarrays 
 
Protein-detecting microarrays have gained increasing interest in the last few years; they mainly 
allow performing two different types of analyses. One is to determine the abundance of proteins of 
interest in complex protein mixtures using highly specific capture agents for each target protein, for 
example, by antigen-antibody interactions. The other is to find out the function of proteins of 
interest, providing information on protein–protein interaction, receptor-ligand interaction, 
enzymatic activity. Protein arrays generally fall in the following two categories107: 
 
(1) functional arrays (comprising reverse-phase arrays) 
(2) detection arrays (or analytical arrays). 
 
In functional arrays (which are generally aimed at discovering protein function in fundamental 
research) a large set of purified proteins or peptides or even an entire proteome is spotted and 
immobilized. The array is then used for parallel screening of a range of biochemical interactions. 
Protein functional arrays108  can be used to study the effect of substrates or inhibitors on enzyme 
activities109 protein-drug or hormone effector interactions110 or in epitope mapping studies43. In 
reverse phase microarrays111, tissues, cell lysates or serum samples are spotted on a surface and 
probed with one antibody per analyte for a multiplex readout. The reverse-phase microarrays fall, 
generally, in the category of functional microarray. 
In protein detection microarrays, an array of well-characterized affinity reagents (antigens or 
antibodies) rather than the native proteins themselves, is immobilized on a support and used to 
determine protein abundances in a complex matrix such as serum. Analytical arrays can be used to 
assay antibodies (for diagnosis of allergy112) or autoimmunity diseases or to monitor protein 
expression on a large scale).  
 
 
Figure 18: Examples of analytical (or detection) proteins microarrays: (a) is the useful sandwich 
microarray test, while (b) is a representation of the so-called reverse phase microarrays.  
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The microarray assay format is ideally suited to the panel of tests that are emerging from the 
proteomic and genomic initiatives because this method of highly parallel testing is more rapid than 
serial assays. Examples of clinical assays that are suited to a protein microarray format are tests for 
autoimmune diseases, detection of cytokines and assessing of allergic responses. A commercially 
available protein microarray for allergy diagnosis is, for instance, one of the first examples of a 
protein microarray that really entered into routine clinical analysis113. 
 
Antibody microarrays belong to the family of protein microarrays. Thanks to the specificity of 
antibody-antigen binding, they have great potential in many fields, such as clinical diagnostics, 
assessment of environmental pollution and quality control in the food industry, or simply as 
comprehensive research tools114. Proteome profiling is the most exciting application of antibody 
microarrays for systems biology, very similar to the gene expression microarray. Many studies using 
antibodies microarrays have recently been reported, and also the list of commercial antibody 
microarrays is expanding rapidly. In theory, with antibodies microarrays, using one specific antibody 
for each human protein, one would be able to profile, in a few hours, all the human proteome115.  
 
3.2.1. The critical role of protein orientation 
 
The study of protein structure and function is certainly of significant importance for fundamental 
scientific research, but also critical for the development of biomedical and biotechnological 
applications because of their implication in many biological systems.  
Thanks to its high-throughput character, protein microarray analysis is gaining increasing 
acceptance in proteomics. Compared to its counterpart in genomics, i.e. DNA microarrays, there 
are two principal difficulties associated with protein immobilization:  surface background and the 
conformation and orientation of proteins once immobilized116. 
The background has to be minimized as much as possible by suppressing the non-specific 
adsorption of proteins onto the chip solid surface in order to keep a high signal-to-noise ratio 
during fluorescence analysis and avoiding false negative results.  
On the other hand, the conformation and orientation of immobilized proteins has to be taking into 
account. Proteins have complex structures and activities, and their printed quantities are very low, 
so the immobilization chemistry has to preserve proteins native state providing an optimal 
orientation to increase the exposure of the protein functional domain to better interact with the 
target in solution1,116.  
The most common methods of protein immobilization in microarrays are based on non-specific 
random adsorption and covalent bond formation between natural available functional groups on 
protein molecules (e.g. -NH2) and complementary coupling groups (e.g., aldehyde or epoxide) on 
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the surface . However, non covalent binding by hydrophobic interaction may causes protein 
denaturation, leading to a loss of functional activity; while the use of covalent binding enhances the 
stability of immobilized proteins, sometimes proteins denaturation cannot be prevented. In fact, if 
the most abundant functional groups on protein (-NH2) is used to covalently attach molecules onto 
the surface, a loss of activity could be observed because no control is achievable on protein 
orientation. 
Various substrates, as well as various functional groups on the same substrate, were tested and 
compared1,117. Since the most crucial disadvantages of non-oriented immobilization are insufficient 
exposure of functional domains, spacer arms (e.g. N-hydroxysuccinimide) 118and polymeric matrix10 
have been used to separate proteins from substrate to enhance ligands accessibility. In spite of 
these precautions, protein orientation after immobilization on surface cannot be predicted; this 
would results in binding of fraction of proteins with improper orientation that cannot bind to their 
ligands1. 
 
Given this background, the importance of oriented immobilization of protein molecules has been 
extensively investigated1. Strategies were demonstrated including the use of fusion proteins119, 
immobilized protein A or G (which binds selectively the Fc portion of antibodies)1, m-RNA protein 
hybrids1 and chemical modifications based on biotin-streptavidin interaction or Staudinger ligation 
reaction120. Although proteins or antibodies with uniform controlled orientation have shown higher 
activity than those of random orientation120, chemical modifications and recombinant methodology 
still have limited applicability due to their laborious achievement. 
 
In the field of proteins, antibodies (Abs) represent a class of glycoproteins with a well-defined 
structure (as it will be briefly described in Section 3.2.1.1.). Since Abs posses only two binding sites 
on the top of the Y-shape, it can be highly advantageous to orient these molecules to improve 
biosensor performance, with improvement factors as high as 200 being reported upon 
orientation121,122. 
Immobilized IgG can adopt four exemplary molecular orientations: side-on (one Fc and one Fab 
attached to the surface), tail-on (Fc attached to the surface), head-on (both Fabs attached to the 
surface) or flat-on (all three fragments attached to the surface) (Figure 19).  
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Figure 19: Schematic representation of a random and oriented Abs immobilization onto a solid 
surface. The oriented immobilization improves the avaibality of Abs toward the antibody-antigen 
interaction, increasing the sensitivity of the biosensor.  
 
For the highest analyte binding, Abs should assume tail-on orientation, displaying free antigen-
binding regions after immobilization. As a consequence, controlling Abs orientation will lead to 
better analyte binding, resulting in improved biosensor sensitivity.  
To reveal the presence and study the binding function of immobilized Abs, many techniques have 
been used, such as: Fourier transform infrared reflection (FTIR) spectroscopy, used to characterize 
the presence of specific chemical groups; various fluorescence microscopies to visualize efficient 
binding of analyte to Ab-functionalized surfaces123  and Surface Plasmon Resonance (SPR), used to 
calculate Ab coverage and affinity. In particular with SPR the obtained data on the relationship 
between the adsorbed amount and molecular orientation on the surface has been used to 
distinguish between tail/head-on and side/flat-on orientation 124 . Nonetheless, using these 
techniques only minimal direct information about Abs orientation could be deduced.  
To better understand their immobilization mode, more sophisticate techniques have been 
reported, such as: Atomic Force Microscopy (AFM), used to deduce Abs orientation by determining 
the dimensions of the Abs; High-resolution Time-of-Flight Secondary Ion Mass Spectrometry (ToF-
SIMS), that determined surface structure providing biophysical information about the molecular 
structure; Dual Polarization Interferometry (DPI), used to determine Abs orientation combining the 
known dimensions of the molecules with the information obtained from the instrument (layer 
thickness, density, or layer refractive index, and mass). These and other techniques are examined in 
depth in a minireview published last year on Analyst by Trilling et al.122. 
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3.2.1.1. Antibody immobilization: carbohydrate moieties 
 
Antibody Structure: brief overview 
 
Antibodies play key roles in humoral adaptive immune response. Thanks to their unique structure 
they are able to control immunity by binding specific antigens and linking them to the innate 
immune system. Their structure has been successfully exploited in development of therapeutic 
treatments for many disease types, such as cancers, autoimmune diseases, and inflammatory 
disorders125,126. 
Human immunoglobulins can be categorized into five classes (IgG, IgA, IgD, IgE and IgM) referencing 
the heavy chain. IgG and IgA are further separated into four (IgG1-4) and two subclasses (IgA1-2). 
Our attention will be focused on IgG, which are the most abundant class in serum, with the longest 
half-life (75% of antibodies in circulation).  
 
Figure 20: (a) IgG structure. (b) Composition of complex-type N-linked glycans. The enzymes, 
glycosyltransferases (left arrow) and glycosidases (right arrow), responsible for the addition or 
removal of the specific sugar, are placed directly underneath of the sugar linkage. 
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IgG proteins (~150 kDa, 143 x 77 x 40 Å
3) are constituted by two heavy chains (Figure 20 A, black 
outline) and two light chains (Figure 20 A, blue outline), linked by disulfide bonds to form the 
characteristic Y-shape structure. Each IgG heavy chain includes a variable region (VH) and a 
constant region containing three domains (Cγ1-3). On the second heavy chain constant region 
(Cγ2), IgGs contains carbohydrate moieties (Figure 20 B). The line between Cγ1 and Cγ2 represents 
the hinge region, while the red dot represents N-linked glycans of complex-type. As for the heavy 
chains also the light chains has a variable (VL) and constant region (CL). The IgGs structure could be 
divided into antigen-binding fragment, Fab (Figure 20 A, empty ovals), and fragment crystallizable 
region, Fc (Figure 20 A, pink ovals). The variable domain bears three hypervariable regions, known 
as complementary-determining regions (CDRs), which are responsible for the specific antibody-
antigen interaction. The diversity in this area justifies the presence of an almost infinite number of 
types of Abs with different specificity and binding strength (affinity)122. The complex-type N-linked 
glycans is composed by a biantennary heptasaccharide core (Figure 20 B, gray block) and a variable 
extension (Figure 20 B, dash line out of the gray block). 
The majorities of human IgG Fc glycans are highly fucosylated (<92%) and can be separated into 
three subsets as determined by the number of terminal galactose, IgG; G0F (~35%), G1F (~35%), and 
G2F (~16%) for the fucosylated glycans terminating in zero, one or two galactose, respectively. A 
small portion of these IgG Fc glycans contains a bisecting GlcNAc (>11%). Only 5-10% of IgG Fc 
glycoforms are mono-sialylated. Furthermore, <1% of IgG Fc glycoforms have two syalic acids125,127. 
 
Keeping in mind the above described Abs structure, it is quite clear that, to preserve the biological 
recognition activity of the immobilized Ab, an ideal immobilization method should enable the 
binding at solely single point with a proper orientation, to promote antigen binding under mild 
conditions (aqueous buffer solutions). To improve antibodies orientation, many immobilization 
strategies were adopted exploiting the presence of carbohydrate moieties on a unique position on 
the stem region (Fc, Figure 20 B). 
 
Most of the reaction investigated to chemically modify the glycoside chain of the Abs, consist in the 
oxidation of the sugar chain presents on the Fc region, by different chemical or enzymatic 
approaches. 
Starting from the high-specific non-covalent biotin-streptavidin interaction (Figure 21a), Peluso et 
al. used periodate to selectively oxidize the conserved N-linked glycosylation site on the Fc portion 
of the Ab. The obtained aldehyde were subsequently biotinylated using the biotin-aminooxy 
compound ARP, and the biotinilated Abs were immobilized on a streptavidin coated surface128. 
Turkova et al. exploited enzymatic oxidation pathway using galactose oxidase. Once obtained, the 
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aldehyde functionality was used to selective react with hydrazide groups present on the solid 
surface (Figure 21b)129. 
As for non-covalent immobilization mechanism, in addition to the previously cited streptavidin-
biotin interaction, in the field of carbohydrates lectin interaction has to be taking into account. As it 
would be later examined in depth (paragraph 3.3.), carbohydrates-lectin is a high-specific and 
strong interaction, that could be used to selective immobilize the Fc portion of antibodies. 
Pyrohova et al. used this strong affinity to increase the density of immobilized Abs in an oriented 
manner130. 
 
 
Figure 21: scheme of some of the immobilization chemistry cited above: (a) biotinylated Ab sugar 
portion to obtain an oriented immobilization through the strongest non-covalent interaction 
(biotin-avidin) toward a streptavidin coated surface, (b) oxidation of galactose lead to the formation 
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of an aldehyde functionality, that selective reacts with coated hydrazide solid surface, (c) a 
photoactive boronic acid surface that is reactive toward glycans Ab portion using a UV photo-cross-
linking approach 131 and (d) copper-mediated 1,3-dipolar Huisgen cycloaddition. 
 
Furthermore Adak et al.131 recently presented a UV photo-cross-linking approach, that utilizes a 
photoactive boronic acid probe in which boronic acid provided good affinity and specificity for the 
recognition of glycan chains on the Fc region of the antibody (Figure 21c), enabling covalent binding 
to the antibody upon exposure to UV light. In this way they achieved an oriented immobilization of 
different antibodies on a surface, retaining their antigen-binding activity. 
Moreover, considering the growing application of click chemistry from the beginning of this 
century, Zeglis et al.132 exploited the possibility to enzimatically modify the galactose moieties 
present on the Fc antibody portion using a system based on an unnatural UDP-galactose substrate 
azido-modified and a substrate permissive mutant of β-1,4-galactosyltransferase, GalT(Y289L), first 
designed, engineered, and expressed by Ramakrishnan and Qasba 133 . Differently from the 
previously discussed methodology, this system has been used in a number of different settings, and 
in particular Zeglis et al. proposed this approach for the site-specific radio-labeling of antibodies, 
combining both enzyme-mediated GalNAz incorporation and bio-orthogonal, strain-promoted, 
copper-free azide/alkyne cycloaddition click chemistry132. 
 
Given the themes discussed above and motivated by the great potential of antibody microarrays as 
a rapid and effective diagnostic tool, we focused our attention on antibody site-specific enzymatic 
modifications to optimize antibody microarrays, using a covalent, regio-specific and oriented, 
copper-mediated, click chemistry immobilization (Figure 21d) coupled to the previously introduced 
polymeric matrix (paragraph 3.1.5.). 
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3.3. Glycan Microarrays 
 
In recent years, carbohydrate research has gained increase interest as the function of cells and 
organisms cannot be explained by proteins and nucleic acids alone134. 
 
Most oligo and polysaccharides are cell surface carbohydrates or part of the extracellular matrix, 
while only few polysaccharides are found inside cells135. Cell surface sugars are either part of the 
protective layer that shields cells from harmful physical forces or regulate interactions of cells with 
the environment. Thus, carbohydrates are involved in most cell–cell interactions, cell motility and 
cell adhesion processes and in general all the processes that involved cell interactions with their 
environment, including differentiation, inflammation, fertilization, apoptosis and cell growth134,136. 
Carbohydrates act in a variety of ways to transmit signals. Some sugars are classical ligands or co-
receptors that facilitate cell attachment or mediate signaling. 
Unnatural expression of carbohydrates is associated with many diseases including cancer and thus, 
they are also important drugs and drug targets137,138.  
Many studies are dedicated to exploiting the cell specific expression of carbohydrates for cell 
targeting. Carbohydrates or carbohydrate binding proteins are also present on the cell surface of 
pathogens and can mediate their cellular absorption. Unique carbohydrate structures on pathogens 
are exploited to generate carbohydrate-based vaccines139. Some viruses and bacteria use cell 
surface sugars to gain entry into host cells140. For example, blocking carbohydrate-processing 
enzymes with inhibitors, such as Tamiflu141, at an early stage can terminate influenza virus 
infections. 
 
Carbohydrate complexity is a major challenge for studies focusing on interactions with other 
biomolecules142. 
The assessment of the biological function of a particular carbohydrate remains challenging. Knock-
out techniques yield insights into sugar function and interactions143, but they are time-consuming. 
Biochemical studies of carbohydrates are complicated by the fact that the interactions are often 
weak. Efficient binding relies on multivalent interactions144  that are experimentally difficult to 
measure. Carbohydrate heterogeneity and the cross-reactivity of sugar binding proteins require 
large numbers of carbohydrate ligands to be screened. To overcome or circumvent these 
challenges, novel tools for glycomics have been developed145, including carbohydrate microarrays 
that specifically are focused on the needs of studying carbohydrate interactions. 
 
Glycan microarrays were first introduced in 2002 with publications by several independent groups 
aiming to systematically array this class of biological molecules. Two reports demonstrated 
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robotically printed arrays of diverse glycan libraries40, and many other laboratories demonstrated 
various approaches for immobilization of glycans in printed slide or multi-well plate formats41,42. 
These achievements were a natural extension of the successful development of printed arrays of 
other classes of biomolecules, including DNA arrays in 1995146, and recombinant protein arrays a 
few years later147. 
In the years following the first reports of large-scale glycan microarrays, there has been an 
explosion of interest for developing glycan libraries, efficient methods of immobilization of glycans 
on array surfaces, and applications for analysis of glycan binding protein specificity. 
 
 
Figure 22: Figurative glycan microarray experiment. 
 
The principle of the technique is similar to DNA and protein microarrays and consists on the 
immobilization of the desired glycans onto a properly modified solid surface through a covalent or 
non-covalent binding. The array is obtained through the printing of micromolar carbohydrate 
solution by means of a robot.  
The advantage, in the use of a microarray format, is that only few picoliters of glycans are required, 
allowing high-throughput analysis of several carbohydrate molecules and minimal amount of 
carbohydrate needed for each binding experiment, making most out of the precious material.  
After the immobilization, the target proteins are incubated on the microarray to allow them to bind 
the exposed glycans before unbound proteins are washed from the surface. If necessary, 
fluorescent tag binding proteins are incubated subsequently in a similar fashion (Figure 23). 
Following the incubation, the slides are dried and scanned with a microarray confocal scanner laser. 
The fluorescence intensities represent the amount of ligand bound to the chip (the avidity-affinity 
between the ligand and the target). Varying the tag used to label the target protein, or its 
complementary, one could also detect the interaction through chemiluminescence or colorimetry. 
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Figure 23: Exemplified microarray experiment for protein binding. Binding of the protein to the 
arrayed sugars, binding of the fluorescently labelled detection protein, read out by a fluorescence 
scanner and analysis.  
 
A large number of different immobilization strategies have been used for sugar arrays, exploiting 
different reactive functionality, as previously described in 3.1.6., such as amine toward active ester 
or epoxy groups and various “click reactions” such as maleimide-thiols, azide-alkyne, etc. 
 
Generally, the carbohydrates can be either isolated from natural sources or chemically synthesized. 
 
A number of groups have been examining strategies for producing “natural glycan arrays”. The 
basic approach involves: a) isolating mixtures of glycans from natural sources such as cells, tissues, 
pathogens, milk, or urine, b) derivatizing the glycans with a linker/tag (if necessary) to facilitate 
purification and allow immobilization on array surface, and then c) separating the mixture into 
individual components or sub-fractions. 
This approach offers a number of advantages: the organism synthesizes the glycans, in principle 
one can access the entire glycome, and one can focus studies on the glycans found in a particular 
target cell, tissue, or sample.  
On the other hand, to be effective, this approach needs efficient and reliable methods to derivatize 
the glycans, powerful separation and purification techniques (impurities could interfere with the 
carbohydrates analysis not being ruled out148), and methods to identify and characterize the 
unknown glycan structures.  
In addition, each of these steps must be amenable to very small scale, since many individual glycans 
are only present in minute amounts. 
 
On the other side chemical, chemo-enzymatic or enzymatic carbohydrates synthesis is also 
available as an alternative to isolating glycans from natural sources. The primary advantages are the 
control of the target structure being synthesized, the ability to produce larger quantities, if 
compared with the isolated ones, of homogeneous material and the possibility to increase sugars 
structural diversity134,148. The chemical synthesis relies on the sequential coupling of appropriately 
protected carbohydrate building blocks139. Following oligo-saccharide assembly, all protective 
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groups are removed and the linker is either installed or liberated, if it was present in protected 
form during the synthesis.  
In chemical synthesis, the similar reactivity of the hydroxyl groups on the sugar ring requires 
complex blocking strategies with different protecting groups on the glycosyl acceptor, and a 
suitable leaving group at the anomeric position of the glycosyl donor. Although enzymatic synthesis 
provides an alternative, relying on the specificity of the enzymes to form the desired glycosidic 
linkage, the limited availability of glycosyltransferases continues to impede the generality of this 
approach149. Nevertheless the needing of libraries containing diverse carbohydrate structures 
stimulate the development of sophisticated techniques to chemically, enzymatically, and chemo-
enzymatically rapid synthetize glycan libraries. Solid-phase synthesis, carried out by Seeberger et 
al.150, and OptiMer-based one-pot solution-phase method, presented by Wong and collegues151, are 
examples of these techniques. 
Among the synthetic carbohydrates, glycomimetics have been developed to antagonize the action 
of specific lectins in natural settings. They are designed mostly by trial and error processes, 
supported by molecular modeling of ligands and/or of ligand-lectin complexes152,153,154,155156. Such 
molecules find application as tools to interrogate the glycobiology of human lectins, which is still 
largely unknown in its molecular details, and can also be used as leads in drug discovery programs 
in fields ranging from antibacterial, antiviral and anti-inflammatory drugs. Drug discovery programs 
based on glycomimetics are greatly facilitated by the availability of glycomimetic arrays, which can 
be interrogated with individual lectins to identify specific leads. 
 
Although the principle of carbohydrates microarray is the same of DNA and proteins, glycan arrays 
have revealed some specific aspects of sugar-protein interactions (i.e. multivalency). Biochemical 
studies of carbohydrates are complicated by the fact that the interactions are often weak144, but 
thanks to the microarray format a surface higher concentration could be reach, mimic sugar 
presentation on cell surfaces157.  
 
3.3.1. Multivalency and carbohydrates presentation 
 
In all the interactions occurring in a natural environment, multivalency is one of the key principle 
for achieving strong and yet reversible interactions. The burr and its man-made analogous material 
(Figure 24), velcro, are good examples from daily life. The large amount of anchoring/coupling 
points, present on a side of the velcro allows, despite the weakness of the single interaction, a 
stronger final binding; therefore, the greater the surface, the stronger the binding. 
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a.  b.  
Figure 24: The principle behind the burr and nature-inspired velcro can be transposed to the 
molecular level. 
 
On the molecular level, one can compare the hooks seen in the macroscopic example from nature 
with specialized molecular binding units (ligands) and the corresponding loops with the binding 
pockets in a complex molecule (receptor). Biologically speaking, such multivalent interactions 
between cells or with other organisms, such as bacteria and viruses, wherein the extensive 
interaction between a large number of individual  binding partners plays a major role, are medically 
very important. 
In contrast to weak monovalent binding, multivalent interactions offer the advantage of a multiple, 
and thus dramatically enhanced, binding on a molecular scale158. In the case of glycans, since the 
individual protein–carbohydrate interactions are weak, it often takes a multitude of simultaneous 
interactions, i.e. multivalency, to produce a biological effect159. Since blocking the carbohydrate 
binding proteins or lectins may be beneficial for treating certain diseases, the aspect of 
multivalency cannot be ignored. For this reason, the incorporation of multivalency into the design 
of inhibitors may be necessary to achieve sufficient inhibitory potency, and the development of a 
high-sensitivity analytical platform, that could monitors the behaviour of glycans moving from 
multi- to mono-valent conditions, could be an important breakthrough in carbohydrate research157. 
 
Mono- and oligosaccharides immobilized on a solid surface are likely to behave like cell-surface 
carbohydrates and bind biomolecules of interest in a specific manner, allowing the study of 
multiple interactions simultaneously. The high local concentration on the array slide mimics the 
multivalent presentation of glycans on proteins or cell surfaces, and allows for the detection of 
carbohydrate-protein interactions, which are typically intrinsically weak in a monovalent format as 
explained before160,161.  
 
Together with the multivalency aspect, presentation still remains the major bottle-neck for 
carbohydrate recognition in a microarray format134,148,162. It has been observed that the type of 
linker used to immobilize the glycan on the surface may affect the ability of a glycan to be 
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recognized by its binding protein 163 , 164 .  Linker-dependent false-negative binding has been 
attributed to the influence of the spacer on the presentation of the glycan relative to the support 
surface. Ideally, the linker would present the glycan in the same way as it is found in natural 
conditions, but this is impossible with non natural linkers and surface.   
As a consequence, the ability to immobilize a variety of different carbohydrates on the same 
surface, with proper spacing and orientation148,149, 165 plays a crucial role in the study of sugar-lectin 
interactions, that is translated in the success of any experiment, since the final performance of a 
microarray biochip strongly depends on parameters related to the immobilization process itself. 
Polymeric coatings, yielding 3D matrixes rather than flat surfaces may significantly alleviate many of 
the presentation problems observed in glycoarrays166. However, to the best of our knowledge, no 
3D matrixes have ever been employed in the construction of glycoarrays. As a part of this thesis, a 
glycan array was built on a 3D polymeric matrix using our clickable polymer for ligand 
immobilization. The results of this work are discussed in Chapter 7 of this thesis.  
 
3.3.2. Glycan microarrays: tools for research and diagnostics 
 
Soon after the first proof-of-principle glycan arrays had been constructed and used, the focus 
turned to applications addressing glycomics research (Figure 25).  
 
 
Figure 25: Different applications of carbohydrate microarrays. 
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Potential binders are added to the sugars on the microarray surface and the binding intensities are 
measured by a fluorescence reporter. Sugar binding preferences can be determined by comparing 
the spot fluorescence intensities. Protein–sugar interactions have been thoroughly established and 
provided valuable information regarding carbohydrate action in vivo.  
Screening for inhibitors of carbohydrate-mediated interactions and determination of IC50 values 
can be performed by co-incubation of the binding molecule with an inhibitor41.  
In addition, kinetic constants can be calculated using carbohydrate microarrays 167 . Binding 
intensities at various dilutions are measured and kinetic constants can be determined. 
Since whole cells168  and viruses bind90 to carbohydrates on microarrays, sugar interactions of an 
entire organism can also be determined without purifying the carbohydrate-binding proteins. 
Carbohydrate binding bacteria can be detected in crude mixtures and isolated for detailed 
examination. 
 
In an early, ground-breaking experiment, ten different proteins were tested against 200 arrayed 
sugars, using fluorescence detection90. Several new interactions were identified due to the large 
number of sugars on the array. A detailed binding pattern for each protein was established, 
including fine differences in specificity. These experiments proved that carbohydrate microarrays 
are suitable for the high throughput investigation of most carbohydrates. 
The new carbohydrate microarray system was exploited to analyze glycan dependent interactions 
of two HIV-1 envelope proteins, gp120 and gp4189. 
Carbohydrate microarrays were also used to investigate the action principle of different enzymes, 
such as glycosyl-, fucosyl-, galactosyl- and sialyl-transferases134. 
 
Microarrays also offer an attractive platform for diagnostic applications since many binding events 
can be screened in parallel. Bacterial adhesion to carbohydrate microarrays was investigated for E. 
coli, as the sugar based attachment to the urinary tract renders these bacteria into harmful 
pathogens168. It was demonstrated that E. coli bacteria bearing a receptor protein (Fim H) that 
interacts with mannose, bind specifically to mannose on carbohydrate microarrays while bacteria 
lacking Fim H do not bind.  
 
With the constant increase of carbohydrates research, also the analytical application has 
considerably grown. The official archive that collects more or less all the data obtained in the 
glycomics field is the “Consortium of Functional Glycomics”.  
 
This project was born in the USA in 2001, promoted by the increasing quantities of research groups 
that focused their attention on carbohydrate interactions study, with funding coming from an 
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NIGMS Large-Scale Collaborative Project Award, also known as a 'glue grant’. At the beginning of 
the project, the program had the aim to define examples where protein-carbohydrate interactions 
mediate cell communication.  To achieve these goals they initially focused their studies on:  
1. the three major classes of mammalian glycan-binding proteins (GBPs): C-type lectins, 
galectin and SIGLEC;  
2. immune receptors that bind carbohydrates: CD1, T cell receptor, and anti-carbohydrate 
antibodies;  
3. GBPs of microorganism that bind to host cell glycans as receptors. 
 
The Consortium of Functional Glycomics (CFG) comprises eight core facilities and more than 
500 participating investigators, that work together to develop resources and services, and make 
them available to the scientific community free of charge. Its goal is to provide a networking forum 
and glycomics resources which enable investigators to reveal functions of glycans and glycan-
binding proteins that impact human health and disease. The data generated by these resources are 
collected in databases accessible through the Functional Glycomics Gateway.  
 
Furthermore, the CFG offers glycan microarrays screening services, a reagent bank, and free access 
to its extensive data repositories and molecule databases. 
The Consortium also developed molecule databases for glycan-binding proteins, glycan structures, 
and glycosyltransferases, which integrate CFG-generated data and information from other publicly 
available databases. The available datasets, together with the molecule databases, are highly 
interconnected, representing an important step towards an integrated systems biology approach to 
glycobiology169. 
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4. Lectins: Glycan Binding Proteins 
 
Lectins (from lectus, the past participle of legere, to select or choose) 170  are defined as 
carbohydrate binding proteins, other than enzymes or antibodies, and exist in most living 
organisms, ranging from viruses and bacteria to plants and animals. Thanks to their involvement in 
diverse biological processes in many species, such as clearance of glycoproteins from the circulatory 
system171, adhesion of infectious agents to host cells, recruitment of leukocytes to inflammatory 
sites172,173 , cell interactions in the immune system, in malignancy and metastasis, their study is of 
upmost interest. 
The first pure lectin, concanavalin A (Con A, from jack beans), was isolated in 1919 by Sumner174, 
and its sugar specificity was then demonstrated175. 
Lectins interact with carbohydrates non-covalently, in a manner that is usually reversible and highly 
specific176. Classical lectins contain two or more carbohydrate-binding sites; therefore, their 
interaction with sugars on the surface of erythrocytes results in the cross-linking of several blood 
cells and their subsequent precipitation. This phenomenon, known as cell agglutination, is a major 
attribute of the activity of lectins and has been used classically and routinely for their detection and 
characterisation (however it is now recognised that cell agglutination is not a defining feature of 
lectins177). Both the agglutination and precipitation processes are inhibited by the carbohydrate for 
which the lectin is specific.  
 
According to the monosaccharide ligand toward which they exhibit the highest affinity, lectins were 
first classified into five groups: mannose, galactose/N-acetylgalactosamine, N-acetylglucosamine, 
fucose and N-acetylneuraminic acid178. However this classification, that ignores certain important 
monosaccharides such as mannose-6-phosphate and N-acetylgalactose-4-sulfate, is becoming 
obsolete.  
Supported by marked differences in the fine specificities of lectins within a single category, and by 
the discovery of an increasing number of lectins, lacking of a high affinity toward simple 
saccharides, a new lectins classification was made; it is based on the lectins grouping, considering 
their similar sequences and structual organization. Furthermore, sequence similarity with known 
lectins provides a valuable guideline for the identification of new ones. 
Most lectins belong to three classes: (1) simple, (2) mosaic (or multidomain) and (3) 
macromolecular assemblies.  
(1) Simple lectins consist of a small number of subunits, not necessarily identical, each of 
molecular weight usually below 40 kDa. Each monomeric unit contains a carbohydrate-binding 
site. This class comprises practically all known plant lectins179  and most members of the 
galectin family (formerly known as S- lectins), a group of -galactoside specific animal lectins180. 
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(2) Mosaic lectins (or multidomain) are composite molecules consisting of several kinds of protein 
domains, only one of which possesses a carbohydrate-binding site. This class includes diverse 
proteins from different sources: viral hemagglutinins181 and animal lectins of C-, P- and I-
types182. 
(3)  Macromolecular assemblies are common in bacteria. They are filamentous organelles 
consisting of helically arranged subunits (pilins) assembled in a well-defined order183. 
 
A particular emphasis was addressed on legume lectins. Their abundance in plant seeds, their 
solubilities and their wide range of saccharide specificities make them good model systems, tools 
for elucidating protein-carbohydrate interactions as well as for biomedical and biotechnological 
applications. 
 
4.1. Legume lectins 
 
Legume lectins represent the largest and most thoroughly studied family of simple lectins. 
Concanavalin A (Con A), the lectin from the jack bean, is the prototype member of the family. The 
relative abundance of this protein in jack bean, the ease of its preparation and the large number of 
saccharides with which it can interact, have led to numerous studies on Con A, markedly 
accelerated by the discovery in 1969 that cells transformed by DNA tumour viruses or carcinogens 
were agglutinated by the lectin more readily than normal cells184.  
 
4.1.1. Structural features 
 
Typically, legume lectins consist of two or four identical or near-identical subunits (protomers) of 
25–30 kDa each, which are commonly single polypeptide chains of about 250 amino acids 
presenting one or two N-linked oligosaccharides. Each protomer typically contains a carbohydrate-
combining site, a tightly bound Ca2+ and a transition metal ion, usually Mn2+. Approximately 20% of 
the amino acid residues are invariant in all legume lectins and another 20% are similar. The 
conserved amino acids include several of those involved in the interaction with the saccharide and 
almost all the residues that coordinate the metal ions. The resolution of 3D-structures of about ten 
legume lectins has shown that each subunit is constituted largely (~ 60%) of -strands mutually 
connected by loops. The tertiary structure is made up of two anti-parallel -sheets, a six-stranded 
flat “back” and a seven-stranded curved “front”, connected by a five-stranded -sheets, giving the 
well known “jellyroll” motif, also referred to as the “lectin fold”185 (Figure 26 a). 
The subunit structures of different legume lectins can be nearly superimposed, without considering 
proteins’ specificity. Despite their similarities at the primary, secondary and tertiary structural 
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monomeric level, legume lectins exhibit considerable variation in their quaternary structure: the 
monomers’ association modes is affected by small differences in the amino acid sequences at the 
monomer-monomer interfaces and the presence/absence of glycosylation. In the case of lectins 
with “canonical” quaternary structure, such as Con A, PEA lectin, Favin and L. Ochrus, dimerisation 
involves anti-parallel side-by-side alignment of the flat six-stranded -sheets of the two monomers, 
resulting in the formation of a continuous 12-stranded sheet that extends across the dimer 
interface. 
 
Figure 26: (a) representative tertiary structure of a legume lectine monomer; (b) dimeric structure 
of ConA.  
Further association of two dimers gives the tetrameric assembly of, for example, Con A, observed in 
physiological conditions186. As with most plant lectins, the quaternary structure, such as the one of 
ConA and PNA, depends on the pH (see paragraph on Concanavalin A). The lectin is a tetramer at 
physiological pH187, and dissociates reversibly into dimers at acidic pH, where the exact value 
depends on the considered lectin (i.e for ConA is under 5.8, while for PNA is below 3.4188). 
 
4.1.2. Carbohydrate-binding site 
 
During the past 25 years there has been significant progress in explaining the features of lectins 
involved in carbohydrate binding. X-ray crystallography of the proteins complexed with their 
ligands, site-directed mutagenesis experiments and molecular modelling have allowed the 
identification of the chemical groups belonging to both interacting species involved in the binding 
and of the types of bond formed. Studies of lectin-oligosaccharide complexes are especially 
interesting, providing the basis for the understanding of the proteins’ interaction with natural 
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ligands. Generally, lectins show very good specificity for di-, tri- and tetrasaccharides, with 
association constants significantly higher than those for the corresponding monosaccharides. 
Carbohydrate-binding sites are often superficial depressions on the surface of the protein. In all 
cases the combining site appears to be preformed189, since few conformational changes occur upon 
binding. In all legume lectins, independently from their specificity, four invariant amino acid 
residues participate in the ligand binding, with an exception for ConA190.  
However, despite the conservation of key amino acids involved in the binding of the carbohydrate, 
different legume lectins can show different specificity. For instance, while Con A binds mannose 
and glucose, PNA, and SBA, for example, bind galactose. Therefore, while the multiplicity 
constellation of highly conserved amino acids provides the framework required for binding, 
specificity apparently arises from the variability of amino acid residues in other regions of the 
combining pocket191. 
The Ca2+ and Mn2+ (or other transition metal) are situated around 4 Å apart and in close proximity 
to the sugar-combining pocket. Although not always directly involved in the carbohydrate binding, 
the cations help the positioning of the amino acid residues interacting with the glycoside.  
Lectins bind carbohydrates through a network of hydrogen bonds and hydrophobic interactions. 
Van der Waals forces, although rather weak (usually a fraction of 4.2 kJ mol−1 for each pair of 
atoms), are frequently numerous, contributing significantly to the overall binding178. The steric 
disposition of hydroxyl groups in carbohydrates creates hydrophobic patches192  on the sugar 
surface that can interact with hydrophobic regions of the protein193. Furthermore, tightly bound 
water molecules can in effect be considered as structural, i.e. an extension of the protein surface, 
playing a significant role in carbohydrate recognition, imparting in some cases exquisite specificity. 
In general, water molecules in the carbohydrate-binding region mimic the ligand to a substantial 
extent not only at the primary site, but also in the regions adjacent to it. 
 
4.1.3. Physiological functions 
 
Despite their long history, the true physiological role of legume lectins is still not well understood. 
Many hypotheses have been formulated in the course of the years but, at present, no physiological 
function for any legume lectin has been established with certainty. The difficulty to fully understand 
their precise role arises from several of their features. The defining characteristic of all lectins is 
their carbohydrate-binding ability. This activity has been preserved during evolution, suggesting 
that it is essential for the exploitation of their function.  
In general, a single legume plant can contain a variety of lectins that may have evolved by gene 
duplication and become specialised for different roles in the plant194. Furthermore, despite being 
concentrated in plant seeds, lectins are also present in different tissues, where their function 
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probably requires lower concentrations. One of the most validated theories on legume lectins’ 
physiological role considers them as defence agents against predators195. An essential feature of 
any active defence agent is the ability to recognise specifically the pathogen. Based on their 
carbohydrate-binding specificity and also considering their abundance in plant seeds and bark, 
lectins seem to possess all the necessary characteristics to exploit this function. Early investigators 
noted the similarities of lectins to antibodies and hypothesised that lectins might function as plant 
antibodies. 
Furthermore, based on their carbohydrate-binding ability, lectins have also been thought to be 
involved in the establishment of symbiosis between nitrogen-fixing bacteria and plants196. Legumes 
are able to associate specifically and form symbioses with soil bacteria of the rhizobia family, a 
phenomenon that makes them independent from soil nitrogen supplies. The nitrogen-fixing 
symbiosis is a multistep process that requires the formation of the root nodule, followed by the 
adhesion of the bacteria to the roots and, finally, the internalisation of the bacteria into the 
nodule 197 . However, despite the fact that molecular genetics experiments support this 
hypothesised role of lectins as receptors for oligosaccharides produced during the symbiosis 
processes, several inconsistencies can be pointed out. First there is no proof of the presence of 
lectins and of the respective ligands on the two interacting species, and second, the correlation 
between the sugar specificity of legume lectins and their ability to recognise bacteria appears not 
to be particularly strong198.  
In other world, even if all the hypotesys born around the physiological functionality of legume 
lectins were considered, their exact biological role still remains unknown, but their specific 
saccharide-binding properties make them an ideal object for the study of protein–saccharide 
interactions199.   
 
4.2. Concanavalin A 
 
As a part of this work I examined legume lectin Con A interacting with eight different 
glycomimetics, synthesized in the laboratory of Professor Anna Bernardi at University of Milan, 
through microarray analysis on a polymer-coated chip.  
Concanavalin A, as briefly described before, belongs to the legume lectins family. It was the first 
pure lectin isolated in 1919 by Sumner174 from the jack bean. This lectin generally binds to 
saccharides containing -D-mannose or -D-glucose residues but it could also recognize 
oligosaccharide sequences lacking these units. Con A has specific biological activities which depend 
on its binding to cell surface receptors. It preferentially agglutinates certain cells transformed by 
oncogenic viruses more than their untransformed counterparts, inhibits growth of malignant cells 
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in animals, and exhibits mitogenic activity. It has also been used in studies on the number and 
mobility of cell-surface receptors associated with cell–cell interactions199. 
The monomer of Con A is composed of 237 amino acid-residues that form 2 anti-parallels -sheets. 
A curved ‘front’ -sheet of 7-strands aligns with a flat ‘back’ -sheet of 6-strands, these two are 
connected by another 5-strands ‘roof’ -sheet from the front to the back. Two Con A monomers lay 
in an adjacent, anti-parallel and back-to-back manner, form a dimer. Two dimers form a tetramer in 
the same way (Fig. A)200,201. Each monomer has the saccharide-binding site on the outer surface of 
the tetramer (spaced ca. 72 Å from each other159), and the amino acids that participate in the 
interaction of Con A with the substrate are Tyr-12, Pro-13, Asn-14, Thr-15, Asp-16, Leu-99, Asp-208 
and Arg-228. The structural organization of ConA is pH dependent: at phisiological pH exists as a 
tetramer, otherwise, at pH lower than 5.8, as a dimer202. 
 
 
Figure 27: Molecular structures of Concanavalin A (ConA). (A) The primary and secondary structures 
of ConA, binding Mn2+ at S1 and Ca2+ at S2; (B) The crystal three-dimensional structure of ConA; (C) 
The quaternary structure of ConA. 
 
Concanavalin A (ConA) is a Ca2+/Mn2+ dependent. Each monomer contains a tightly bound 
manganese and calcium ion in the vicinity of the saccharide binding site. Each of the metal ions is 
coordinated by four amino acid side chains and two water ligands. In all four subunits the 
coordination of the manganese ion is octahedral, whereas the calcium ion has pseudo-octahedral 
geometry, with Asp10 binding in a bidentate manner capping the sixth vertex of the octahedron. In 
the case of the calcium ion, one of the water ligands forms a bridge between the metal and the 
main carbonyl chain of Asp208, thus stabilizing the unusual Ala207–Asp208 cis-peptide bond that is 
conserved in all known legume lectin crystal structures199. 
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Concanavalin A has generated a rising attention for its anti-proliferative and anti-tumour activities 
towards various types of cancer cells. Con A has been reported to kill tumour cells targeting 
apoptosis, autophagy, anti-angiogenesis as well as immunomodulatory. These findings shed light on 
new perspectives of Con A as a potential anti-neoplastic agent for cancer therapeutics. However, 
the exact biological role of Con A remains unknown, but its specific saccharide-binding properties 
make it an ideal object for the study of protein–saccharide interactions199. 
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5. High-performing microarray platform: solid support and polymeric 
matrix 
  
5.1. Click-chemistry for surface modification: introduction of an alkyne 
functionality 
 
The majority of reports present in the literature, that discuss the immobilization of probes onto a 
solid surface through “clickable” procedures, require multi-step approaches to introduce click 
functionalities (i.e. alkyne).  
For example, Chaikof et al. in 2006100 set up a procedure to introduce alkyne functionality onto a 
solid surface creating a self-assembled monolayer (SAM) through a short bi-functional PEG linker 
carrying alkyne and cyclodiene groups at opposite chain termini. The Diels-Alder reaction would 
allow the coupling of the short PEG with the maleimide functionalized glass slide commercially 
available, exposing in this way the alkyne functionality for copper-mediated bioconjugation (see 
Figure 16, paragraph 3.1.6.1.). The first coupling needs 12 hours of reaction time at room 
temperature, and the blocking of unreacted maleimide groups requires a further reaction with 
cysteine before “clicking” azido-probes. Pioneers in the area of clickable SAMs are Collman and 
Chidsey, who reported several important examples of SAMs functionalized by triazole linkages203. 
Their work primarily focused on gold surfaces, but was extended by other groups to different types 
of substrates such as silicon wafers or glass slides204.  
Zhang et al. in 2006205 presented SAMs of carbohydrates on gold surface for surface plasmon 
resonance. They functionalized gold surface with a N,N’-(dithiodidecane-10,1-diyl)bispropiolamide 
(NDDA) that, besides a quite laborious synthesis, needs anhydrous ethanol solution in an overnight 
incubation step at 4°C to coat the surface.  
Some years later Miura et al.206 published a work reporting on the functionalization of silicon, glass 
and quartz surfaces with a self-assembled monolayer of saccharides via click chemistry (Figure 28), 
through a silanization step for immobilizing the alkyne moieties onto the surface through a reaction 
with silanols.  
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Figure 28: Schematic illustration of surface functionalization through the formation of carbohydrate 
self-assembled monolayers (SAMs) using click-chemistry as reported by Miura et al.206. 
As most of the silanization processes reported in the literature, the SAMs formation needs at least 4 
hours to be completed and the coating produced do not have the same antifouling character of a 
polymeric coating. 
A number of works reported in the literature describe also the synthesis and characterization of 
polymeric coatings, that introduce functionalities promoting the regio-specific Huisgen 
cycloaddition207,208,209,210,211,212. An example is given by the work recently published by Russel and 
co-worker in 2013 (Figure 29). They reported the synthesis of a novel alkyne-functionalized diblock 
copolymer (di-BCP), poly(methyl methacrylate-random-propargyl methacrylate)-block-poly(4-
bromostyrene), synthesized by atom transfer radical polymerization (ATRP), and its use for the 
development of functionalized nanostructured materials via alkyne/azide click chemistry213.  
 
 
Figure 29: structure of the novel diblock copolymer (di-BCP) reported by Russel and co-worker213. 
 
However, in spite of the intense activity in the field of 'clickable' polymer coating, for the best of 
our knowledge, there are no examples in the literature of polymeric coatings obtained with 
processes as fast and robust like the one presented by this thesis. 
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5.1.1. Design of poly(DMA-PMA-MAPS): structure and characterization  
 
In this work, a novel copolymer named poly(DMA-PMA-MAPS), obtained from the polymerization 
of N,N-dimethylacrylamide (DMA), 3-trimethylsilanyl-prop-2-yn methacrylate (PMA) and 
3(trimethoxysilyl)-propylmethacrylate (MAPS) was introduced (Figure 30).  
 
 
Figure 30: structure of poly(DMA-PMA-MAPS) The molar fraction of the monomers MAPS, PMA, 
and DMA monomers is 1, 2, and 97 respectively. 
5.1.1.1. Synthesis of poly(DMA-PMA-MAPS)  
 
The acryloyloxy-alkyne monomer was synthesized starting from commercially available 
trimethylsilylpropyn-1-ol reacting with metacryloyl-chloride in the presence of triethylamine (TEA) 
as the base (Figure 31), following a procedure reported by Ladmiral et al. (see materials and 
methods, paragraph)214. 
 
 
Figure 31: reaction scheme of the synthesis of protected alkyne monomer (PMA). 
 
Poly(DMA-PMA-MAPS) was synthesized10 in THF via random free radical polymerization, thermally 
initiated by AIBN (azoisobutyronitrile) from the three monomers in different concentration (Figure 
32), as described in materials and methods, and it was characterized through 13C-NMR.  
The alkyne-monomer protected with TMS (compound (3), Figure 31) was used in the free radical 
polymerization due to the instability of the triple-bond under radical condition. After the 
polymerization, to provide available alkyne functionality for probes immobilization, a deprotection 
step was carried out in an aqueous solution of K2CO3 (pH≈9) as described in materials and method 
(paragraph 9.2.1.). 
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Figure 32: Synthesis of the poly(DMA-PMA-MAPS) copolymer. In brackets the molar fractions of the 
monomers (w/v). 
5.1.1.2. Characterization of poly(DMA-PMA-MAPS) 
 
13C-NMR poly(DMA-PMA-MAPS) analysis 
 
13C-NMR analysis was made before and after the deprotection step, to highlight the presence and 
the absence of trimethylsilyl protecting group on alkyne moiety (Figure 33).  
 
 
Figure 33: poly(DMA-PMA-MAPS) before and after the deprotection. 
 
Furthermore two different solvents, DMSO (d6) and CDCl3, were used to resolve overlapping 
resonances of the signals of interest with the solvent signals. NMR samples were obtained by 
dissolving 50 mg of compound in 2.5 ml of solvent; 13C decoupled spectra were acquired at 100.62 
MHz at room temperature and 64K point over 210 ppm were employed. 
 
Polymer analysis before deprotection: 
13C-NMR (400 MHz, CDCl3), δ (ppm): 0.00 (Si(CH3)3); 36.65 (all CH2); 45,62 (OCH2C) 50.94 
(Si(OCH3)3); 53.32 (OCH2CH2) 174.95 (all CO).  
13C-NMR (400 MHz, DMSO), δ (ppm): -0.31 (Si(CH3)3); 36.08 (all CH2); 44.78 (OCH2C) 50.10 
(Si(OCH3)3); 52.76 (OCH2CH2) 173.89 (all CO). 
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Polymer analysis after deprotection: 
13C-NMR (400 MHz, CDCl3), δ (ppm): 36.65 (all CH2); 45,62 (OCH2C); 52.40 (OCH2CH2); 75.92 (CH); 
174.95 (all CO).  
13C-NMR (400 MHz, DMSO), δ (ppm): 36.08 (all CH2); 44.79 (OCH2C); 52.02 (OCH2CH2); 77.63 
(CH); 78.31 (CCH); 174.96 (all CO). 
 
Decoupled 13C NMR spectra, run in CDCl3, of protected (Figure 34, bottom) and deprotected (Figure 
34, top) polymers are shown in Figure 34. The deprotection step was confirmed by the 
disappearance of the peaks at 50 and 0 ppm, which correspond to the methoxy and trimethylsilyl 
(TMS) groups respectively. Furthermore, the integration of the two signals at 45.31 ppm and 52.08 
ppm (belonging to the methylene signals of the PMA and MAPS moieties respectively) in the 
deprotected sample (Figure 34, top) show a ratio of 2:1, confirming the molar fraction ratio of the 
monomers in the copolymer to be as desired. The resulting PMA peak is very close to 2% (1.75%) of 
the total methylene signal at about 36 ppm. The presence of alkyne moieties was also confirmed to 
be in the desired ratio through a 13C decoupled NMR spectrum run in DMSO. The two peaks of the 
methyne moiety appear around 76 and 78 ppm, exactly under the CDCl3 peak (data/spectra not 
shown). 
 
 
Figure 34: 13C decoupled NMR spectra of protected (bottom) and unprotected (top) polymer, run in 
CDCl3. 
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Gel Permeation Chromatography 
 
The polymer was analysed by Gel Permeation Chromatography in tandem with an UV-detector 
(λ=214nm). The polymer molecular weight was obtained by using a calibration curve (made of 
polyacrylamide standards). Poly(DMA-PMA-MAPS) sample was diluted using the GPC mobile phase 
(GPC buffer: 100 mM NaCl, 50 mM NaH2PO4, pH 3, 10% v/v Acetonitrile) to a concentration of 2.66 
mg/ml and the sample (V=20 μl) was run three times through the GPC-UV system to test for 
reproducibility (v=0.3 ml/min). The GPC-MALLS analysis of poly(DMA-PMA-MAPS) reveals a 
polymer molecular weight (Mw) of 4.2 × 104 g/mol (≈ 40 kDa), and its polydispersity is about 2.6. 
Both values  are in the same range of the previous synthesized poly(DMA-NAS-MAPS). 
 
Poly(DMA-PMA-MAPS) is similar in composition and in behaviour to its predecessor poly(DMA-NAS-
MAPS). In fact, the difference stands only in 2 % of the total monomers. It was demonstrated by the 
work of this thesis that the replacement of NAS with PMA does not change the ability of the 
copolymer to form a coating on a silicon oxide surface as demonstrated by a detailed 
characterization of the coating carried out by Dual Polarization Interferometry (DPI) and Contact 
Angle (CA) analysis discussed in Section 5.1.2..  
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5.1.2. Poly(DMA-PMA-MAPS) coating: characteristics and advantages 
 
This new polymer, as previously described, is similar to a ter-polymer introduced by our group in 
2004 to allow the formation of a hydrophilic 3D coating on a solid surface by a simple “dip and 
rinse” procedure10. Due to its self adsorbing properties, the coating was obtained by simply 
immersing the slide in an aqueous solution of the copolymer (10mg/ml) at room temperature, and 
after 30 minutes an ultrathin polymer film was generated. To remove the polymer excess the slides 
were rinsed in D.I. water and dried under nitrogen flow. The coated substrates were then cured at 
80°C for 15 min to fix the polymer through formation of siloxane bridges (Figure 35).  
 
 
Figure 35: Schematic representation of the chemical structure of the copolymer poly(DMA-PMA-
MAPS) coating on a SiO2 surface. The drawing illustrates the binding mechanism of the polymer to 
the SiO2 surface. Dimethylacrylamide (DMA) residues form hydrogen bonds whereas silanol (MAPS) 
groups react with silanols on the surface and stabilize the coating by covalent attachment via 
formation of siloxane bridges. The alkyne functionality provided by the PMA group promotes the 
covalent attachment by reacting with azide groups on probe molecules. 
 
The polymer introduced by this work provides a number of advantages in the coating formation 
over commonly used approaches. Similarly to poly(DMA-NAS-MAPS), also this polymer physisorbs 
on the surface through formation of H-bond between its backbone and surface silanols. Following 
adsorption, 3(trimethoxysilyl)-propylmethacrylate (MAPS) binds covalently to the solid surface 
through formation of siloxane bridges, stabilizing the coating. The thin layer of hydrophilic polymer 
provides a solution-like environment that is of fundamental importance to obtain a high-
performance in microarray analysis.  
The novelty of this polymer relies on the presence of a different functionality, compared to 
poly(DMA-NAS-MAPS), for the covalent binding of probes. Instead of the succinimide (NHS) active 
esters provided by the NAS monomer, an alkyne moiety was introduced, using the 3-
trimethylsilanyl-prop-2-yn methacrylate (PMA) monomer in the random radical polymerization.  
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The presence of the alkyne functionality allows the binding of azide-modified probes (from small 
molecules, such as glycomimetics, to peptides and antibodies) by the well-known Cu(I) catalyzed 
1,3-dipolar azide-alkyne Huisgen cycloaddition. Therefore, the regio-specific and bio-orthogonal 
reaction in microarray analysis could be investigated in depth. The proposed coating approach is 
advantageous as it provides  a fast, simple and versatile method to obtain an alkyne functionalized 
solid surface in a solution-like environment. 
  
Surface characterization: Contact Angle measurements (CA) 
 
Contact angle is measured using a contact angle goniometer, in this case using water as liquid and 
following the so called sessile drop method. A high resolution camera captures the profile of a 
water drop on a solid substrate and a software is empolyed to analyze the contact angle value. 
In case of microarray analysis an hydrophilic surface exhibiting a contact angle of about 30°-40° is to 
be preferred as it ensures probe spots not to spread out on the surface or to merge and, at the 
same time, it guarantees a proper probe tethering. 
 
In the case of poly(DMA-PMA-MAPS) Si/SiO2 coated surface, the contact angle was measured both 
before and immediately after the coating deposition onto silicon/silicon oxide surface, to monitor 
and quantify changes of the surface hydrophilicity resulting from the presence of a surface polymer 
layer. The water contact angle could not be measured on an uncoated silicon chip after 10 minutes 
of oxygen plasma treatment because of its extremely high hydrophilicity (i.e. complete wetting). 
Thanks to this characteristic, the formation of a polymer coating was clearly detectable because the 
water droplet contact angles increased on the coated surface from 0° to 33° ± 0.78 ° (the obtained 
contact angle value is the average of five measurements each on five different coated chips). 
The surface hydrophilicity of poly(DMA-PMA-MAPS) was found to be similar to that of poly(DMA-
NAS-MAPS): the contact angle value on a poly(DMA-PMA-MAPS) coated surface showed an 
hydrophilic feature with a 33° ± 0.78 angle, while poly(DMA-NAS-MAPS) coated surface showed a 
contact angle value of 31° ± 0.48 (Figure 36). 
 
 
Figure 36: image of a water-drop on a poly(DMA-PMA-MAPS) coated Si/SiO2 surface. 
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Surface characterization: Dual Polarization Interferometry (DPI) 
 
The coating was also characterized using dual polarization interferometry (DPI), which is an optical 
surface analytical technique that provides multiparametric measurements of surface  coatings 
providing  information on their molecular dimension (layer thickness), packing (layer refractive 
index, density) and surface loading (mass)24. 
 
From the DPI analysis it was possible to characterize the polymeric coating by obtaining information 
in its thickness, mass and density as shown in Table 1. 
The obtained thickness values revealed the swelling capability of poly(DMA-PMA-MAPS) and 
confirmed its straight similiraty with poly(DMA-NAS-MAPS). 
 
 Thickness (nm) Mass (ng/mm2) Density (g/cm3) 
Poly-(DMA-PMA-MAPS) 15.31 ± 3.21 1.98 ± 0.14 0.14 ± 0.04 
Poly-(DMA-NAS-MAPS) 13.6 ± 3.8 1.4 ± 0.01 0.105 ± 0.03 
Table 1: Thickness, mass and density of the poly(DMA-PMA-MAPS) and poly(DMA-NAS-MAPS) 
coating obtained from DPI analysis. 
 
The similarity between the two polymers, poly(DMA-NAS-MAPS) and poly(DMA-PMA-MAPS), is 
expected as only a 2% of the total monomers has been changed from one polymer to the other. 
Furthermore the monomer in question is not involved in the covalent interaction with the 
substrate. 
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Polymer binding capacity: wash-off experiments. Density of the immobilized probes as a function of 
the spotting concentration 
 
In order to assess the density of molecules bound to the polymer coated slide, a simple experiment 
was carried out based on the measurement of fluorescence after spotting, immobilization and 
washing of the azido-modified dye, Cyanine-3 (Figure 37).  
 
 
Figure 37: Cy3-N3 chemical structure. 
 
From the attachment density of the dye, estimated through a fluorescence calibration curve it was 
possible to evaluate the distance between the bound molecules, which is representative of the 
distance between immobilized glycans. This parameter is a very important characteristic of glycan 
arrays, because, as mentioned above, carbohydrate-protein interactions depend critically on 
multivalent presentation. Indeed,  when a glyco-chip is challenged with a multivalent target, such as 
most lectins, depending on the probe density of the chip different mechanisms can contribute to 
the affinity measured. If the distance between the immobilized molecules is larger than the 
distance of two binding sites on the protein, the multivalency of the chip works through statistical 
rebinding of the target, which reduces the off rate. When the distance between probes decreases 
below a critical threshold reaching the distance between two binding sites on the protein, two 
probes on the chip can simultaneously engage two binding sites (chelation) and this normally 
results in a measurable decrease of the dissociation constants (Kd,surf), i.e. in an increase of the 
apparent affinity of the protein. 167 
Following an approach described in the literature by Wong and coworkers for a glycan monolayer 
array on glass167, Cyanine 3 carrying an azido linker, was printed at concentrations ranging from 1 
pM to 1 mM on poly(DMA-PMA-MAPS) coated Si/SiO2 slides in 14 replicates using the optimized 
“click-protocol” described below. The slide was immediately imaged at 543 nm with a confocal 
scanner laser. After 12 hours of incubation in a dark humid chamber, the slides were washed with 
dimethylformamide (DMF) for 10 minutes to remove unbound molecules, dried under a nitrogen 
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flow and imaged again to assess the binding efficiency. At a fixed laser power and photomultiplier 
gain (60% and 70% respectively) not all the spots could be visualized: the lowest detectable 
spotting concentration was 0.5 μM. Since the concentration (C) and the volume (V) of the Cy3 dye 
spotted are known, the number of molecules covalently bound to the surface (Np or Nmolecules) is 
the product of the number of Cy3 printed and the ratio of the prequench (Qpre) to postquench 
(Qpost) spot fluorescence intensities, where NA is Avogadro’s number (Equation 2). Spot diameters 
vary from 55 to 280 µm, depending on the concentration the printed dye (Figure 37, Cy3-N3).  
 
 
 
 
 
 
The distance between molecules on the surface can be estimated as the distance d between  
the center of two tangential circumferences, with radius d/2 and an area Np/spot area,  obtained as 
the fraction of the total area (spot area, Figure 38a) occupied by a single immobilized molecule. 
This estimate results from an approximation of the 3D matrix to a 2D arrangement. The thickness (≈ 
15 nm) of the polymer layer is indeed negligible, considering the size of the spot area (in the range 
of 61,5·103 - 2,4·103 µm2). Clearly, when the concentration of immobilized probes on the surface 
decreases the distance between two molecules in the same spot increases. 
 
Figure 38: (a) corresponds to the spot total area, while (b) is the area occupied by each single 
molecule, which was calculated dividing the total area (a) by the total number of immobilized 
molecules (or Np). The distance between the centers of two tangential circumferences (d) 
corresponds to the distance of two near molecules inside the spot, and it is equal to the diameter 
of the area occupied by each molecule.  
Np = 
C∙V∙NA∙Qpost 
Qpre 
Equation 2: equation for the calculation of the effective number of molecules (Np) covalently 
bound to the surface. 
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As shown in Figure 39, at spotting concentrations  >600 μM the binding sites on the surface appear 
to be saturated and the maximum binding capacity (or maximum binding density) of the polymer is 
≈2,2·1014 molecules/cm2, corresponding to an average distance between two probes of 8 Å. At 
lower spotting concentrations, the number of molecules immobilized on the surface (Np) is 
proportional to the spotting concentration. At the lowest detectable concentration (0.5µM) the 
probe density is 5.07·1012 molecules/cm2 and the average distance between two molecules inside a 
spot can be estimated to be 50 Å (Table 2). 
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Figure 39: number of the azide modified Cyanine-3 immobilized onto the Si/SiO2 surface, as 
measured by the “wash-off experiments”. 
 
Cy3 printing 
conc. (μM) 
Density 
(Np/cm2) 
Distance 
(Å) 
0.5 5.07·1012 50 
1 6.84·1012 43 
5 1.22·1013 32 
10 1.50·1013 29 
50 2.98·1013 21  
100 4.12·1013 18  
500 1.96·1014 8 
600 2.19·1014 8 
Table 2: Probe density and average distance between Cyanine3 molecules on the surface as a 
function of their printing concentration. 
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The maximum density (≈ 2·1014 molecules/cm2) obtained on the poly(DMA-PMA-MAPS) 3D matrix is 
higher than value described for standards in the glycan array field.  For instance, in the seminal 
paper by Wong et al. cited above167, the binding capacity of the system was reported to be ≈ 1·1014 
molecules/cm2),  two times lower than on this polymeric format.  The higher density of immobilized 
probes onto the 3D matrix results in a higher sensitivity of the platform at lower spotting 
concentration of the probe (see 6.1.1). 
 
5.2. High-performing support selection  
 
Commercially available Si/SiO2 slides were chosen as support to maximize the intensity of the 
fluorescence detected on the surface. As previously shown (in paragraph 3.1.2), the optical 
interference phenomenon induced by layers of different refractive index  of well-defined thickness 
(100 nm) maximizes photo-absorption of the dye molecules in the vicinity of the surface and 
enhances the light emitted towards the detector45,56. To demonstrate the advantage of using this 
substrate, a comparison of fluorescence intensity on glass and Si/SiO2 slides was made. 
Both glass and Si/SiO2 slides were coated with poly(DMA-PMA-MAPS) and a 50μM solution of Cy3-
azide (Figure 37), in DMF:H2O (1:1), was printed by means of a piezoelectric spotter (SciFlexArrayer 
S5, Scienion, Berlin Germany) and the click reaction performed under the conditions previously 
optimized (section 7.1.). After overnight incubation in a humid chamber, both slides were washed 
10 minutes in dry DMF under nitrogen flow and imaged with a fluorescence scanner. Each image 
was taken with the scanner set at the same laser power (70%) and photomultiplier gain (60%).  
The spots on Si/SiO2 (Figure 40b) showed more intense fluorescence signals relative to the glass 
slide (Figure 40a). The fluorescence detected for the same amount of dye was higher by a factor of 
4 (Figure 40c) on the silicon slide as a result of constructive interference between the radiations 
reflected at the silicon/silicon oxide interface and that reflected from the surface of the slide.  The 
optimal enhancement is obtained with a silicon oxide thickness of 100 nm on the silicon surface, as 
reported in the literature45.  
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Figure 40: Fluorescence signals of Cy3-azide 50μM on poly-(DMA-PMA-MAPS) coated glass slides 
(a) and silicon oxide chip (b); (c) mean fluorescence of the above Cy3-azide spots and relative 
standard deviation. 
70 
 
6. Glycan microarrays 
 
6.1. Fluorescence bioassay: a qualitative analysis of carbohydrates-lectin 
interaction 
 
 
Figure 41: scheme of glycans immobilization on the clickable polymeric matrix, adsorbed on Si/SiO2 
surface, here presented for the construction of a high-performance microarray analysis. 
 
The novel substrate was first tested in glycan microarray analysis (Figure 41). In collaboration with 
the group of Prof. Anna Bernardi, at the University of Milan, we set up a procedure for the 
screening of a small library of glycomimetics. Eight α-mannose derivatives, interacting with the 
legume lectin Concanavalin A (Con-A) were spotted on polymer coated slides. Con-A was chosen for 
its high affinity toward α-mannose derivatives215,216. 
At first, to prove the successful immobilization and accessibility of the selected glycomimetics onto 
the polymeric matrix, we compared the behaviour of amino-modified α-mannose derivatives (Table 
3, compounds 2a and 10a) on both, epoxysilane (Figure 42a) and poly(DMA-NAS-MAPS) (Figure 
42b) coated Si/SiO2 slides. The probes were attached through a reaction between  the free amino 
terminal group at 1 mM concentration and the epoxy or succinimidyl ester on the surface.  
 
a  b  
Figure 42: (a) epoxysilane and (b) poly(DMA-NAS-MAPS) structures. 
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The solvent used to obtain a good immobilization of the sugars onto the two modified surfaces was 
phosphate buffer saline (PBS, pH 7.4). A synthetic β-galactose with an amino linker (11a, Table 3) 
was employed as the negative control to confirm the specificity of the binding with the target in 
solution. After spotting, the slides were incubated overnight in a humid chamber and the free 
reactive groups (active ester and epoxide) were blocked with ethanolamine (1 hour at room 
temperature). The slides were incubated with biotinylated-ConA (0.1mg/ml) and after an 
incubation step with streptavidin labelled with fluorophore Cy3, they were scanned by means of a 
confocal scanner laser. The results are shown in Figure 43.  
 
 
Figure 43: Fluorescence of the spots of  α-mannose derivative 10a (Table 3) on (a) epoxysilane 
monolayer and (b) poly(DMA-NAS-MAPS) Si/SiO2 coated surfaces.  (c) β-galactose (11a, Table 3) 
negative control on poly(DMA-NAS-MAPS).  
 
As shown in Figure 43, poly-(DMA-NAS-MAPS) coating, due to its higher binding capacity and 
antifouling properties, provided better results in terms of spot fluorescent intensity, and signal-to-
noise ratio if compared to the epoxysilane monolayer coating. Therefore, these results confirmed 
that this polymeric coating provides major technical advantages in glycan microarray technology 
and allows good accessibility to the immobilized small glycan molecules. These observations 
prompted us to develop the new alkyne functionalized ter-polymer coating. 
 
With the synthesis and characterization of poly(DMA-PMA-MAPS) and its use in the coating 
formation, a new surface with the desired alkyne functionality was ready to be tested in the 
screening of the affinity of different α-mannose derivatives (Table 3, 2-9) immobilized through a 
copper-catalyzed cycloaddition, for the  legume lectin Con A.  
All the glycomimetics shown in Table 3 share a common azide linker of the same lenght on the 
anomeric position. They were synthesized in the laboratory of Prof. Bernardi. A positive (10b) and 
negative (11) control were also introduced, while the azido-modified dye (1) was used as a 
positional reference. 
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1 2 3 4 
 
 
  
5 6 7 8 
   
 
9 
10 
(α-mannose) 
11 
(β-galactose) 
 
 
  
 
Table 3: Chemical formula of: azide cyanine dye (1), α-mannose derivatives (2-9) positive (10, α-
mannose) and negative (11, β-galactose) controls. 
 
After careful optimization of the relative concentration of glycans and CuSO4/ascorbic acid in the 
spotting solution (kept at constant 1:5 ratio) on the new polymeric surface, an intense fluorescence 
signal was obtained upon interaction of immobilized glycans with biotinylated lectin detected 
through interaction with strepatvidin labelled with cyanine 3 (Figure 44). The conditions were 
optimized using mannose derivative (2b) in four different concentrations (from 0.05 mM up to 0.5 
mM) and incubating the array with the same concentration of biotinylated-Con A (0.75µg/ml) that 
was optimized in a separate experiment. Con A concentration was screened starting from 100µg/ml 
to 10ng/ml, and 0.75µg/ml was selected as the most suitable concentration for a first qualitative 
screening. The results showed that decreasing the concentration of the immobilized probe down to 
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0.05 mM, improved spot morphology and provided high signal to noise ratio in the hybridization 
with Con A. (Figure 44).  
 
 
Figure 44: (a) Microarray spotting scheme. (b) Fluorescent image of the microarray spots labelled 
with Cy3 (c) Plot of relative fluorescence intensities. The bars are the average of the intensity of the 
18 spots of each subarray. 
 
The glycans were spotted onto the coated surface by means of a piezoelectric spotter. The 
optimized printing solution was composed of 0.05 mM glycan, 2.5 mM CuSO4 and 12.5 mM sodium 
ascorbate. After overnight incubation in a humid chamber, the slides were incubated with solutions 
of protein (0.1µg/ml) in Lectin Binding Buffer (50mM HEPES, 5 mM MnCl2∙6H2O, 5 mM CaCl2∙2H2O, 
pH 7.4). The biotinylated Concanavalin A was visualized after an incubation step with Streptavidin-
Cy3, 2µg/ml in PBS (Phosphate Buffer Saline, pH 7.4) by means of a confocal laser scanner. The 
quantification of the spot fluorescence intensity provided a rough estimate of the affinity between 
the lectin and each glycan. The lectin concentration was decreased (from 0.75 to 0.1 µg/ml) to 
highlight the differences between sugar-lectin affinities. In fact, in order to be significant, a 
microarray analysis must be run using a lectin concentration below saturation level, that on these 
arrays  is reached using a 0.5µg/ml Con A concentration. 
After optimization of the experimental conditions, the eight compounds (shown in Table 3), 
together with the negative (β-galactose, 11b) and the positive (α-mannose, 10b) control were 
spotted and screened. The positive control is needed as an internal quality control of the Con A-
glycan interaction, while the negative control (β-galactose, 11b) is needed to confirm the specificity 
of the lectin recognition. The spots of Cy3 dye (1, Table 3) were used as to guide the image 
processing (Figure 45).  
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Figure 45: Mean fluorescence intensity of the glycomimetics of Table 3 (11 replicates per line, 50 
µM) incubated with 0.1µg/ml of biotinylated Con A (0.943 nM) and revealed with Cy3 labelled 
streptavidin, (a) image of the glycomimetic microarray; (b) histogram of spot fluorescence intensity 
of 11 spot replicates. 
 
The surface-immobilized glycans, incubated with 100 ng/ml (0.943 nM) of biotinylated ConA and 
detected with Cy3-labelled streptavidin, show a variable degree of fluorescent intensity (Figure 45, 
b) depending on their affinity for Con A. The interaction between α-mannose derivatives and Con A 
was specific as confirmed by the lack of fluorescence on the spots of β-galactose (11), the negative 
control. The plot (Figure 45, b) reports the fluorescence intensity observed for different glycan 
spots. Except for ligand 5 (Table 3), all the mannosides of this study, as well as the control 10 (Table 
3), have similar affinities for Con A, as expected from their strong structural similarities.  On the 
contrary, ligand 5 does not seem to interact, possibly due to steric hindrance from the large, 
lipophilic amide groups. This analysis provided only a qualitative estimation of the affinity between 
the α-mannose derivatives immobilized onto the surface and the selected lectin, but showed that 
the technology can be applied to these small molecules with good results and sensitivity. The next 
step, we evaluated equilibrium constant for the surface interactions, following an approach 
described by Wong et al. in 2007167. 
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6.1.1. Determination of the surface equilibrium constant (KD,surf): quantitative 
estimation of carbohydrates-lectin affinity 
 
As reported in the literature, in all the interactions occurring in a natural environment, multivalency 
is one of the key principle for achieving strong and yet reversible interaction. In contrast to weak 
monovalent binding, multivalent interactions offer the advantage of a multiple, and thus 
dramatically enhanced, binding on a molecular scale158. In the case of glycans, since the individual 
protein-carbohydrate interactions are weak, it often takes a multitude of simultaneous interactions, 
i.e. multivalency, to produce a biological effect159.  
Thanks to the high local concentration of surface-immobilized glycans on microarray format, it is 
possible to reproduce the mechanism and the behavior of cell-surface glycoconjugates217,218 during 
lectin’s binding that occurs through multiple, simultaneous interactions. The observed 
discrepancies between the values of KD obtained in solution and on surface for sugar protein pairs 
could be ascribed to the high local concentrations of the carbohydrates present in a single spot, 
which may generate a multivalent interaction with the lectin. This effect has been reported by 
others in different experimental conditions219. 
 
6.1.1.1. Microarray experiment: KD,surf and glycans multivalent presentation 
 
The influence of the multivalence presentation of carbohydrates on this new platform, which 
combines the higher sensitivity provided by the Si/SiO2 surface with a good surface quality, was 
investigated. The surface chemistry proposed by this work allows an easy immobilization of probes 
in an oriented manner thanks to the regio-selectivity of the click chemistry reaction in a solution-
like environment thanks to the use of the poly(DMA-PMA-MAPS) coating. The impact of these 
features on the interaction with Con A was investigated at different glycan immobilization densities. 
By carrying out a series of hybridization experiments at different concentration of Con-A, a 
quantitative characterization of the glycomimetic affinities were obtained, allowing the 
measurement of the surface dissociation constant (KD,surf). In particular, the high-sensitivity of the 
platform proposed allows the study of carbohydrates-lectin interactions at both high (50 µM) and 
low (0.5 µM) glycan surface density, in conditions where most of the conventional solid phase 
assays fail to provide a detectable signal. 
A fundamental example in the literature, obtained on a glass-immobilized hydrogel matrix 167, 
reports that the maximum binding capacity towards ConA was reached at carbohydrate printing 
concentrations around 100-10 µM. In these conditions, multivalency is responsible for the high-
affinity (KD,surf in the scale of nano-molar) recorded. At these printing concentrations the ligands are 
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displayed at a distance lower than the distance between two lectin’s binding sites (≈72 Å for Con 
A159). A significantly weaker affinity was found in a more diluted (< 10 µM) presentation.  
Therefore, in this work, each glycomimetic was first analyzed at 50 µM and 10 µM, obtaining KD,surf 
values in high-density conditions. The results confirmed the considerations reported in literature167 
on the high-affinity obtained thanks to a multivalent effect. The experiment was performed in 
parallel : nine  slides were spotted with 50 μM and 10 μM aqueous solutions of the glycomimetics 
2-11 (11 replicates) (Table 3), in the optimized condition previously reported (CuSO4 : Ascorbic acid 
= 2.5 mM : 12.5 mM). The chips were incubated with Con A solutions of increasing concentration, 
from 47.2 pM up to 469.3 nM. By scanning the surface, a mean fluorescence value was obtained for 
each of the glycomimetic spot replicates. For each glycan, average values of fluorescence were 
plotted against Con A concentrations (logarithmic scale) and the curve was fitted as a 
sigmoidal/growth function. Typical curves of high (3) and low affinity (5) glycomimetics spotted at 
50 μM concentration are shown in the graphs below (Figure 46).  
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Figure 46: Fluorescence vs log([ConA]) in a sigmoidal/growth graph. Both the glycomimetics (3 and 
5) were spotted at 50 μM printing concentration. The bars represent the standard deviation of each 
fluorescence mean value. (a) Trend of a glycan with higher affinity for ConA (0.34 nM) (b) trend of a 
glycan with a lower affinity with the lectin (5.33 nM). 
 
From these curves it was possible to extrapolate a value of EC50 (the half maximal Effective 
Concentration) for each molecule. EC50 refers to the Con A concentration at which half of the 
probes on the surface are occupied by the target. The values of EC50 reported in Table 4 represent 
the surface equilibrium constant KD,surf, and provide a quantitative estimation of the affinity 
between the glycomimetics and the considered lectin, when the interaction occurs on a surface at a 
given ligand density.  
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Glycomimetic 
50 μMa 
*KD,surf  (nM) 
10 μMb *KD,surf  
(nM) 
2 0.26 1.01 
3 0.34 0.79 
4 0.67 1.71 
5 5.33 N/A 
6 0.88 1.77 
7 0.40 0.98 
8 0.34 0.85 
9 0.43 0.75 
10 0.90 1.33 
   a. probe density  ≈3·1013, distance 21 Å; b. probe density  ≈1,5·1013, distance 29 Å 
Table 4: KD,surf values obtained for each glycomimetic printed at 50 μM and 10 μM concentration.   
To obtain KD,surf reported in Table 4 ,all the data obtained were fitted with OriginPro8 using a 
growth/sigmoidal function fixing the parameter p=1 and the parameter A1=0. 
The experimentally found KD,surf values are considerably lower than KD reported in the literature for 
interactions taking place in solution220 and, although they are in the same range of the values 
determined by other authors based on surface interactions221, they are substantially lower. A 
possible reason for the observed difference could be a better multivalent presentation of 
immobilized glycans provided by the polymeric matrix. The tri-dimensional coating creates, during 
lectin incubation, a solution-like environment, improving the accessibility of the probes, with an 
oriented immobilization fashion, by the analyte in solution. Furthermore, between 50 µM and 10 
µM glycans concentration a high-multivalent presentation is available (the ligand’s distance is lower 
than the distance between two ConA binding sites, ≈72 Å) so, no significant difference in affinity 
could be notice (KD,surf are of the same order).  
 
6.1.1.2. Microarray experiment: KD,surf at lower glycans’ surface density 
 
Thanks to the high sensitivity of the platform presented in this thesis and motivated by the results 
previously shown, we have investigated the close dependence of the KD on the glycans density in 
the interaction with ConA.  
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Figure 47: The four curves represent dose response curves obtained changing the glycans density 
immobilized on the surface. In particular, these graphs represent the behaviour of glycomimetic 
10b (Table 3) at different priting concentrations interacting with increasing concentrations of Con A 
(from 0.450 nM up to 13.4 μM). The bars represent the standard deviation of each mean 
fluorescence. A) 10b printed at 0.5μM B) 10b printed at 1μM C) 10b printed at 2.5μM and D) 10b 
printed at 5μM. (For the probe density and distances expected at these printing concentrations, see 
Table 2) 
 
The behaviour of α-mannose (10) and the α-mannose derivative (9) has been investigated more in 
depth. Both glycans were printed on a poly(DMA-PMA-MAPS) coated Si/SiO2 surface at four 
different concentrations (from 5 μM to 0.5 μM), and incubated with a wide range of Con A 
solutions (from 0.450 nM up to 13.4 μM). In Figure 47, typical dose response curves of fluorescence 
versus Con A concentrations at various glycan surface densities are depicted for 10. Similar curves 
were obtained for 9.  
By extrapolating KD,surf from these curves, it is clear that as the glycan surface density decreases, the 
affinity also decreases (Table 5), thus supporting the hypothesis that the surface affinity between 
the analyzed carbohydrates and the lectin is dominated by multivalency effects. It is worth noting 
that, due to the high immobilization density achieved on the 3D matrix, the probe distance is 
expected to remain lower than  the distance between two binding sites of ConA (≈72 Å) at all the 
printing concentration (between 21 Å,  when the glycans are spotted at 50μM concentration and 50 
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Å when they are spotted at 0.5 µM concentration). Thus chelation should be allowed under all the 
examined situations. However, in a clear illustration of the importance of multivalency in 
determining the strength of sugar-protein interactions, the increased local density of the probes is 
still producing a measurable effect (over one order of magnitude), presumably via statistical 
rebinding mechanisms.  159  
 
Carbohydrate 
Printing 
conc. (µM) 
molecular 
distance (Å) 
*KD,surf 
(nM) 
10 0.5 50 756 
10 1 43 146 
10 2.5 36 77 
10 5 32 47 
9 0.5 50 171 
9 1 43 93  
9 2.5 36 6.7 
9 5 32 1.5 
Table 5: Dependence of KD,surf values of α-mannose derivatives 9 and 10 on printing concentration. 
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6.2. Conclusion: poly(DMA-PMA-MAPS)-Si/SiO2 platform in glycan arrays 
 
In this work we introduce a new polymer obtained from the polymerization of N,N-
dimethylacrylamide (DMA), 3-trimethylsilanyl-prop-2-yn methacrylate (PMA) and 3(trimethoxysilyl)-
propylmethacrylate (MAPS), poly(DMA-PMA-MAPS) and describe its use in the formation of a 
functional coating for microarray. The backbone of the polymer bears alkyne moieties that allow 
binding azide-modified glycans to the surface by "click" chemistry. This attachment mode offers a 
number of advantages in the immobilization of glycans, such as high grafting efficiency, oriented 
immobilization and insensitivity to functionalities present in natural glycans (bio-orthogonality). The 
solution-like environment provides by a swelling of the dimethylacrylamide backbone (≈15 nm) 
when in contact with a buffer solution, as well-demonstrated by the DPI measurements, 
dramatically increases the availability of the probes immobilized onto the surface and their 
accessibility to the target in solution, that could better interacts. This is clearly noticeable in the 
very low values of KD,surf observed using this novel platform if compared with the ones reported in 
literature167. Furthermore, the higher sensitivity to the fluorescence signal provided by the novel 
Si/SiO2 microarray substrate offers significant advantages over conventional glass slides allowing 
analysis at lower glycan priting concentration. 
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7. Antibody microarrays 
 
7.1. Oriented antibody microarrays: high-performing biosensor 
 
In the last decade, a wide variety of different biosensors emerged. Sensor specificity relies strongly 
on the properties of the immobilized detection element, which has stimulated the use of antibodies 
(Abs) or fragments thereof. In 1971 Abs were used for the first time in an enzyme-linked 
immunosorbent assay (ELISA) to quantitatively detect analytes222. Abs with better affinities and 
higher stabilities have been selected to improve biosensor performance. Further sensor 
optimization was directed towards surface preparation of biosensors aiming to promote specific 
binding and suppress non-specific binding. For this purpose site-specific coupling and 
immobilization of antibodies, and proteins in general, are of great interest223. 
 
Antibodies are a class of glycoproteins with a well-defined Y-shape structure as depicted in section 
3.2.1.1. (Figure 20). Since only two binding sites on the top of the Y-shape are present, it can be 
highly advantageous to orient these molecules to improve performance of a bio-sensor. 
To preserve the biological recognition activity of the immobilized antibody an ideal immobilization 
method, under mild conditions (aqueous buffer solution), should enable the binding at a solely 
single point providing a tail-on orientation, which promotes antigen binding. Many immobilization 
strategies adopt this tail-on orientation to improve the functionality of the antibodies by exploiting 
the presence of carbohydrate moieties on a precise position on the stem (Fc) region127,128,129,130,131. 
Since the azido functionality is not present in nature, inspired by the work of Zeglis et al., we set up 
a procedure that allows a site-specific modification of the constant region (Fc) of any desired 
antibody (IgG) through an enzymatic pathway, which exploits the presence of a terminal galactose 
on the side chain (see Figure 20, paragraph 3.2.1.1). This modification would allow an exclusively 
tail-on orientation, leaving the two binding sites free for the interaction. This feature is extremely 
important to construct high-performing biosensors122,224. 
As it will be discussed below, the modification procedure proposed in this work, although time-
consuming, is still more convenient than other procedures used for providing tail-on orientation 
that require the use of the recombinant proteins A, G or L. These proteins specifically interact with 
the Fc portion, but the wide range of interactive immunoglobulins (IgGs) increases the possibility of 
non specific interactions, which could lead in a high-background. Furthermore, the few binding sites 
available on the protein for the Fc binding will provide a biosensor with a low binding efficiency225.  
On the contrary, the oriented immobilization obtain on the antifouling polymeric coating proposed 
by this thesis provides excellent signal-to-noise ratio in a solution-like environment with a good 
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binding efficiency, offering improved accessibility of the antibody’s binding site by the target in 
solution.  
The enzymatic modification process was inspired by a work published in 2013 by Zeglis et al.132 and 
described in depth in the Introduction (paragraph 3.2.1.1). The authors report on an enzymatic 
modification of the galactose moiety present on the Fc antibody portion using a system based on 
an unnatural UDP-galactose substrate azido-modified and a substrate-permissive mutant of β-1,4-
galactosyltransferase, GalT(Y289L), first designed, engineered, and expressed by Ramakrishnan and 
Qasba 133. They proposed this approach for the site-specific radio-labeling of antibodies, combining 
both enzyme-mediated GalNAz incorporation and bio-orthogonal, strain-promoted, copper-free 
azide/alkyne cycloaddition click chemistry132. 
 
Motivated by the great potential of antibody microarrays as a rapid and effective diagnostic tool, 
we focused our attention on this antibody site-specific enzymatic modification to optimize antibody 
microarrays, using a covalent, regio-specific and oriented, copper-mediated, “click” chemistry 
immobilization. In this thesis the procedure proposed by Zeglis132 (now available as a SiteClick 
Antibody Labelling Kit sold by Life Technologies) was reproduced using commercially available 
enzyme, β(1-4)-galactosyl-transferase, and replacing the UDP-2-azidogalactose used by Zeglis with 
the UDP-6-azidogalactose, that is synthetically simpler and expected to display a better reactivity in 
surface immobilization procedures because it is less sterically hindered.  
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7.1.1. Syntesis of UDP-GalNAz 
 
Part of the strategy adopted for the synthesis of UDP-6-azidogalactose came from the procedure 
reported by Bosco et al.2. They developed a new strategy to tag glycoproteins carrying terminal 
GlcNAc using commercially available bovine β(1,4)-galactosyltransferase (GalT) and UDP-6-
azidogalactose.  
The azide functionality was introduced at the C-6 position of the galactose ring because it was 
demonstrated by Bosco and co-workers that a modification, such as azide or even biotin, appended 
to the C-6 position of UDP-galactose could maintain the sugar as a substrate for human GalT, 
without the need for a mutant enzyme2. Mainly two strategies for the chemical synthesis 
pyrophosphate UDP-azidogalactose can be exploited. The first one, essentially developed by 
Hindsgaul’s group226, is based on the reaction between an activated galactose moiety with an 
uridine diphosphate. Through this methodology the desired product could be obtain rapidly but in 
anomeric mixtures and in low yield. The second methodology, here partially adopted, was first 
developed by Moffatt and Khorana227  and improved by Wittmann and Wong228 . They purposed, 
together with the use of nucleoside-5’-phosphoromorpholidates in the synthesis of pyrophosphate 
derivatives (i.e. UDP-GalNAz), the use of 1-H tetrazole as catalyst in phosphomorpholidate coupling 
reactions, reporting an efficient synthesis of GDP-Fucose, GDP-Mannose, and UDP-Galactose. 
First, as reported in Scheme 1, the 6-azido-6-deoxygalactose (3) was prepared from commercially 
available (1) passing through the tosylate (2) using NaN3 in large molar excess (9 eq.). 
 
 
Scheme 1: two reaction schemes: (a) the one-pot Mitsunobu reaction with the three different 
solvents studied under microwave condition, and (b) the classical nucleophilic substitution passing 
through the formation of tosil derivative (2). 
 
Also the Mitsunobu reaction of (1) with TMSN3 
229 was tested, under microwave condition, testing 
toluene, dioxane and dimethylformamide as the solvent (Scheme 1), but it was discarded for scale-
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up because of the high amount of by-products formed and the cost of the reagents. Once the azido 
functionality was introduced, the diisopropylidene azido-galactose was fully deprotected and the 
sugar was re-protected using acetates as protecting group (Scheme 1, 4), which is more stable 
compared to the trimethysilylether protection used by Hindsgaul’s group226. The anomeric position 
was deprotected within a 2 hours reaction (Scheme 2b) using hydrazine-acetate, prepared in situ by 
dissolving hydrazine-monohydrate in dry methanol, in the presence of 1 eq. of acetic acid, under 
nitrogen atmosphere for 30 minutes, and added drop-wise to a DMF solution of (4) cooled to 0°C. 
The purified product (5) was obtained in a 65% yield. This is to compare with the procedure 
described by Bosco et al. with AcONH4 (Scheme 2a), which, although the high yield (80%), requires 
2 days and lead to a 80 % yield to reach the completion. 
 
 
Scheme 2: two reaction conditions for achieve the anomeric deprotection. (a) procedure reported 
by Bosco et al.2, (b) our procedure230. 
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Once the anomeric position was deprotected it could be activated as the H-phosphonate (7) 
(Scheme 3). 
As reported in the literature231,232, depeding on the phosphorylating agent used it is possible to 
favor the β- or α-anomer. In particular, using 2-chloro-4H-benzodioxaphosphorin-4-one (8, Scheme 
3)231 the configuration of the anomeric centre could be controlled and almost only α-anomer of (7) 
was isolated.  
The authors reported the phosphite formation using a mixture of THF/Dioxane in the presence of 
triethylamine and 2-chloro-4H-benzodioxaphosphorin-4-one (8) (also called salycilchlorophosphite), 
Scheme 3a. In our hands, the reaction worked better under conditions optimized by L. Morelli 230, 
in which a 82% yield of (7) could be reached in 4 hours, in dry pyridine using a mixture of (8) and 
H3PO3 (Scheme 3b). The reaction mechanism porposed for our strategy is reported in Scheme 4. 
 
 
Scheme 3: reaction scheme for the synthesis of phosphite derivative. (a) is the protocol presented 
in the article Bosco et al., while (b) is the protocol we followed, condition from L. Morelli230. 
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Scheme 4: mechanism of salycil-chlorophosphite (8) in the formation of the phosphate-salt (9). 
 
After the phosphite derivative (7) oxidation to the phosphate (9) was obtained under the conditions 
reported by Bosco et al., in the presence of tBuOOH and I2 in catalytic amount (Scheme 5). For the 
formation of phosphodiester bridge, uridine-5’-phosphoromorpholidate was used to yield, after 
purification and deprotection in mild condition, the Gal-T substrate compound (10) in only its α-
anomeric conformation. 
 
 
Scheme 5: scheme of the last steps for the synthesis of the UDP-6-azidogalactose (12) in its α-
conformation. 
The use of 1-H-tetrazole as catalyst in phosphomorpholidate coupling reactions was well-explained 
in the work published by Wittmann and Wong228. 1H-Tetrazole (pKa 4.9) is commonly used for the 
87 
 
activation of phosphoramidites233  and accelerates coupling during oligonucleotide synthesis by the 
phosphotriester method234. It turned out that this heterocycle is also an efficient catalyst for the 
phosphoramidate coupling. When used to activate phosphoramidites, tetrazole is known to act as 
both an acid and nucleophilic catalyst, and tetrazolophosphane derivatives (13, Scheme 6) have 
been identified as reactive intermediat235. Compared with the activation of phosphomorpholidates 
by acetic acid (p Ka 4.75), tetrazole (pKa 4.9) activation of phosphomorpholidates accelerates the 
reaction much more than the acid, suggesting a nucleophilic catalysis mechanism in addition to the 
simple acid catalysis. 
 
 
Scheme 6: reaction scheme of sugar nucleotide derivative formation via phosphoramidate coupling 
catalyzed by 1-H-tetrazole. (a) sugar phosphate derivative, (b) sugar nucleotide derivative and (13) 
phosphotetrazolide intermediate. 
 
The activation mechanism proposed by Wittmann et al. 228(that carried out the coupling reaction 
with different additives and followed the course of the reaction by 31P-NMR spectroscopy), is that 
the tetrazole activates uridine-5’-phosphoromorpholidate (10) (Scheme 6) by protonation of the 
leaving group nitrogen and presumably by nucleophilic catalysis via the highly reactive 
phosphotetrazolide (13) (Scheme 6), which reacts with sugar phosphate (Scheme 6, a) to give the 
sugar nucleotide derivative (Scheme 6, b) (i.e. UDP-Gal). 
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The main difficulty of the whole reaction process consisted in the purification of the phosphite and 
phosphate derivatives (from compound (7) to compound (12)) with the C-18 reverse phase column 
using only water as eluent, as reported by Bosco et al.2. The purification of (7) phosphite derivative 
and (8) phosphate derivative was carried out using C-18 biotage column with water as eluent in the 
presence of TEA (1%) to stabilize the product as a salt, but the purification yield (≈ 30%) were low, 
probably due to its instability and its possible interaction with silica. So, to avoid loss of precious 
products (in particular 11 and 12 di-phosphate derivatives), the acetilated UDP-6-azidogalactose 
(11) and the final product (12) were purified by means of  HPLC chromatography using a semi-
preparative C-18 column. The eluent used was a NH4HCO3 50 mM buffer (pH 7.4). The introduction 
of the HPLC chromatography enhanced dramatically the final purification yield affording compound 
11 in 63% yield from 10, and 12 in 65% yield from 11 (higher than the 46 and 53% yield respectively 
reported by Bosco et al.). 
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7.1.2. Antibody site-specific modification 
 
An UDP-azido galactose was synthetized (as described in the experimental section 9.2.2) by 
introducing the azido functionality on C-6 instead of C-2; the enzymes used for the antibody 
modification were the commercial available β-(1,4)-galactosidase and β-(1,4)-galactosyltransferase. 
The original galactose, which was cleaved in acidic condition in the presence of β-(1,4)-
galactosidase (Figure 48, step 1), was replaced with the unnatural UDP-6-azido-galactose (Figure 
48, step 2) using β-(1,4)-galactosyltransferase to catalyze the conjugation. In the first step (Figure 
48, step 1), the enzyme β-(1,4)-galactosidase works in acidic condition (sodium acetate, 10 mM, pH 
5), whereas in the second step the enzyme β-(1,4)-galactosyltransferase requires the use of a 
slightly alkaline buffer (TRIS·HCl, 50 mM, pH 7.4) and the presence of MnCl2 (20mM) and Alkaline 
phosphatase (2U) (Figure 48, step 2). The nucleoside diphosphatases generated during the reaction 
are potent glycosyltransferase inhibitors, therefore the presence of alkaline phosphatase would 
prevent product inhibition by hydrolyzing the UDP moiety. 
 
 
Figure 48: Scheme of the enzymatic site-specific modification of the antibody. (1) Cleavage of the 
GlcNAc-Gal bond through β(1,4)-galactosidase in sodium acetate buffer (10 mM, pH 5). The 
reaction was left overnight (≈12 hours) at 30°C. (2) Attachment of the unnatural UDP-6-
azidogalactose using UDP-6-azido-galactose and β(1,4)-galactosyltransferase in TRIS·HCl buffer (50 
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mM, pH 7.4), in the presence of Alkaline phosphatase (2 U) and MnCl2·4H2O (20 mM). The reaction 
was left at 37°C overnight. 
 
7.1.3. Antibody immobilization 
 
7.1.3.1. Copper-mediated click-chemistry and its biocompatibility 
 
Instead of using strain-promoted click reaction, we decided to use copper catalyzed cycloaddition 
to exploit its higher reactivity over copper-free azide/alkyne cycloaddition click chemistry. In fact, 
strain-promoted cycloaddition still remains 10-times slower than copper catalyzed terminal alkyne 
cycloaddition104. 
The main drawback of using a transition metal as catalyst to modify a protein is its toxicity caused 
by the Cu(I)-mediated generation of reactive oxygen species (ROS) from O2, that would damage 
biomolecules and cells236.  
To overcome this problem, additives known to improve the biocompatibility of the reaction such as 
THPTA, BTTA and bis-L-histidine are currently used. These molecules are water-soluble ligands for 
Cu(I) that offer the advantages of both, accelerating the cycloaddition reaction and acting as 
reductants, helping the protection of biomolecules from ROS106. Inspired by the work of Hong et 
al.106, we focused on the use of THPTA catalyst, a water-soluble member of the 
tris(triazolylmethyl)amine family. The performance of this system was found to be sensitive to the 
nature of the solvent and to the overall copper concentration. The copper-catalyzed bioconjugation 
reaction was carefully optimized. The key factors to achieve a fast reaction are the following106: 
 
a) Ascorbic acid is the preferred reducing agent, due to its convenience and effectiveness in 
generating the catalytically active Cu(I) oxidation state. 
b) Copper concentrations should generally be between 50 and 100 µM (use used 100 µM). The 
lower limit is necessary to achieve a sufficient concentration of the proper catalytic complex 
which incorporates more than one metal center, while more than 100 µM is not necessary 
to achieve high rates. 
c) At least 4 equivalents of THPTA relative to CuSO4 should be employed
104,106. The purpose is 
to intercept and quickly reduce reactive oxygen species generated by the ascorbate-driven 
reduction of dissolved O2 without compromising the CuAAC reaction rate. 
d) Compatible buffers include phosphate, carbonate, or HEPES in the pH 6.5-8.0 range, while 
Tris buffer should be avoided as the tris(hydroxymethyl)aminoethane molecule is a 
competitive and inhibitory ligand for Cu. 
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e) Ascorbic acid should not be added to copper-containing solutions in the absence of the 
ligand (THPTA). So, it would be better first mix CuSO4 with the THPTA ligand, add this 
mixture to a solution of the azide and alkyne substrates, and then initiate the CuAAC 
reaction by the addition of ascorbic acid to the desired concentration. 
 
7.1.3.2. Optimization study using IgG from porcine serum(p-IgG) 
 
Once a modification protocol was devised, the activity was focused on the optimization of the 
immobilization conditions. To this purpose we have used, as a model protein, an anti-rabbit 
immunoglobulin from porcine serum (hereafter reported as p-IgG). 
 
 
Figure 49: Scheme of the sandwich assay of the anti-rabbit immunoglobulin from porcine serum (p-
IgG), where r-IgG is the antigen (anti-pig immunoglobulin from rabbit) and g-IgG is the biotinylated 
secondary antibody from goat (anti-rabbit). The last step (d) is the incubation with strepavidin 
labelled Cy3, to allow the fluorescence detection by a confocal scanner laser. 
 
Starting from the consideration that the density of triple bonds on the surface, accessible for the 
interaction with the azide-probe, is not known, and considering that the amount of copper catalyst 
to be used strictly depend on this parameter, it was not possible to set up a protocol with an exact 
amount of catalyst calculated in theory. 
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Therefore, it was decided to start from the condition employed previously for glycans 
immobilization (paragraph 6.1) and to optimize this recipe: a solution containing antibody (0.6 
mg/ml), CuSO4 (2.5 mM) and ascorbic acid (12.5 mM) in TRIS HCl 50 mM buffer (pH 7.4) was 
arrayed on a poly(DMA-PMA-MAPS) coated Si/SiO2 surface. In parallel, an experiment on 
poly(DMA-NAS-MAPS) coated surface was run, printing the same antibody (0.6 mg/ml) without 
modification, leading to a random immobilization via amine. After an overnight incubation of both 
chips in a humid chamber, the slides were washed and.  A blocking-step with ethanol-amine was 
needed to block the unreacted active esters only for poly(DMA-NAS-MAPS) coated slides. Then, as 
depicted in Figure 49b, the chips were incubated with a solution (100ng/ml) of antigen (r-IgG), for 2 
hours in dynamic conditions at room temperature. After a washing step an incubation with the 
secondary biotinylated antibody (g-IgG) was carried out (1µg/ml in PBS, 1 hour at rt in static 
condition) (Figure 49c), to allow fluorescence detection of the spots through the incubation with a 
streptavidin-Cy3 labelled (2µg/ml in PBS, 1 hour at room temperature in static condition) Figure 
49d . 
After the first washing step (10 min., PBS buffer) for the poly(DMA-PMA-MAPS) slide, and a 
blocking step of 1 hour with ethanolamine for the poly(DMA-NAS-MAPS) slide, the  mass of p-IgG-
N3 and p-IgG immobilized on the corresponding chip were quantified through label-free IRIS 
analysis. This technique, as described in section 3.1.2., is a microarrays sensing technique that 
utilizes optical interferometry with a buried reference plane to detect binding of biomolecules on a 
Si/SiO2 biochip with a 500 nm layer of silicon oxide
56.  
 
 
Figure 50: quantification of mass immobilized onto poly(DMA-PMA-MAPS) surface, p-IgG-N3, and 
poly(DMA-NAS-MAPS), p-IgG, respectively. 
The mass determined, expressed as ng of antibody per mm2, in each immobilization strategy is 
reported in Figure 50. The immobilization of azido p-IgG resulted in a lower amount (5.6 ± 0.6 
ng/mm2) of antibody compared to the random immobilization via amine p-IgG (7.34±0.64 ng/mm2). 
In the following steps the chips were incubated with the antigen (r-IgG immunoglobulin from 
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rabbit) and with a biotinylated secondary antibody (g-IgG, biotinylated immunoglobulin from goat). 
The amount of captured antigen (r-IgG) was detected thanks to a final incubation with streptavidin-
Cy3 allowing fluorescence detection using a confocal scanner laser. The mean fluorescence 
reported in Figure 51a confirms the presence of a lower amount of the p-IgG-N3 (8000 ± 826) 
compared to the unmodified p-IgG (12000 ± 1332), each immobilized on a surface modified by the 
specifically reactive polymer. The fluorescence signals normalized by the mass of the immobilized 
p-IgG demonstrate that there is no signal gain using the oriented antibody (Figure 51b). So, in spite 
of the oriented immobilization, an apparently similar interaction affinity was observed. 
 
(a)  
(b)  
Figure 51: (a) mean fluorescence data for the two immobilized antibodies following a site-speific (p-
IgG-N3), via azide/alkyne cycloaddition, immobilization and a randomly (p-IgG), via amine, 
immobilization. (b) binding-efficiency obtain relating the immobilized amount with the recorded 
mean fluorescence signal. 
Optimization of click condition using IgG-pegylated-N3 (from porcine serum) 
 
In the procedure described in paragraph 7.1.3.2., no precautions were taken toward oxidation and 
the antibody was used without THPTA protecting ligand, appropriate buffer and optimal  reaction 
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time, etc. These conditions led to a low apparent affinity of the antibody under investigation. 
Therefore the entire procedure was revised. A new immobilization protocol implying random 
modification of the antibody, using a bifunctional polyethylene glycol (Azido-PEG8-NHS ester) as the 
linker, was developed. The use a bifunctional reagent with an azide moiety on one side and an 
active ester at the other end, allows introducing a larger number of azide groups by exploiting the 
numerous lysine amino-acids, present on the antibody. 
A 5 mg/ml solution of p-IgG (from porcine serum) in PBS buffer (pH 7.4), reacted at room 
temperature for 2 hours in the presence of 4 equivalents of NHS-PEG8-N3 linker. Once the reaction 
was completed, the unreacted PEG was removed on centrifugal filter (Amicon Ultra 0.5 ml, Ultracel-
30K) and the buffer was changed to sodium phosphate buffer (50 mM, pH 7.4) to facilitate the 
following click-reaction. 
We compared the p-IgG-PEG8-N3 with the unmodified p-IgG on Si/SiO2 surfaces coated with 
poly(DMA-PMA-MAPS) and poly(DMA-NAS-MAPS) respectively. 
 
At the same antibody printing concentration (0.6 mg/ml), the following conditions were tested for 
the azido-modified p-IgG in sodium phosphate buffer (50 mM, pH 7.4): 
 
1. CuSO4 2.5 mM, ascorbic acid 12.5 mM ([Cu]:[AAc]=1:5); 
2. CuSO4 2.5 mM, THPTA 10 mM, ascorbic acid 12.5 mM ([Cu]:[THPTA]:[AAc]=1:4:5); 
3. CuSO4 100 µM, THPTA 400 µM, ascorbic acid 6.25 mM ([Cu]:[THPTA]:[AAc]=1:4:62). 
 
Te unmodified p-IgG was spotted, at the same concentration (0.6mg/ml), in sodium phosphate 
buffer (50 mM, pH 7.4) on poly(DMA-NAS-MAPS) coated Si/SiO2 surface. 
 
After the spotting, the slides were left in a humid chamber for the immobilization step. Two 
different reaction times (1 hour, 12 hours) were initially tested to check if the introduction of the 
ligand protector, THPTA, could accelerate the immobilization rate also on a solid surface. 
After the reaction was completed, the chips were washed 10 minutes with PBS, incubated with the 
antigen (r-IgG) and with the biotinylated-secondary antibody (g-IgG). The final incubation with 
streptavidine-Cy3 in PBS, allowed fluorescence detection, using a confocal scanner laser, and 
quantification of the captured antigen (r-IgG). 
The same exact conditions were used for the immobilization of the unmodified p-IgG on poly(DMA-
NAS-MAPS). On this surface a blocking-step was carried out before the incubation with the antigen. 
This was necessary to block all the remaining active esters that could be still reactive thus avoiding 
any secondary/aspecific interaction with the surface10. In the graph below (Figure 52) a comparison 
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of the fluorescence obtained at the end of the assay in experiments run at different reaction times 
(1 and 12 hours) is depicted. 
  
 
Figure 52: The three reaction conditions for the immobilization of the randomly modified p-IgG-
PEG8-N3 are signed as (a) CuSO4 2.5 mM, ascorbic acid 12.5 mM ([Cu]:[AAc]=1:5), (b) CuSO4 2.5 mM, 
THPTA 10 mM, ascorbic acid 12.5 mM ([Cu]:[THPTA]:[AAc]=1:4:5) and (c) CuSO4 100 µM, THPTA 400 
µM, ascorbic acid 6.25 mM ([Cu]:[THPTA]:[AAc]=1:4:62). Both p-IgG-PEG8-N3 and p-IgG were left 
react 1 hour (blue bars) and 12 hours (pink bars), in a humid chamber before starting the 
experimental protocol.  
 
From the results it was evident that the presence of the ligand THPTA was essential to protect the 
antibody from possible damage. The experiment also provided information on the correct amount 
of reagents to be used. In the presence of THPTA the reaction time must be shorter, therefore a 
higher amount of the reducing agent (ascorbic acid) was required (≈62 equivalents)104,106. 
Furthermore, an unnecessary long-time of reaction leads to an increase of the toxic effect of the 
copper catalyst. As described by others, an increased exposure to O2 also enhances the production 
of reactive oxygen species (ROS) that are known to be prejudicial for biomolecules and cells104.  
 
For these reasons, similar experiments were performed to investigate reaction immobilization time 
in a humid chamber in two different reaction conditions. The same p-IgG-PEG8-N3 amount (0.6 
mg/ml) in sodium phosphate buffer (50 mM, pH 7.4) was reacted in the presence of copper, THPTA 
and ascorbic acid at different concentrations but maintaining an “excess” of the reducing agent 
(ascorbic acid), as reported: 
1. CuSO4 2.5 mM, THPTA 10 mM and ascorbic acid 125 mM ([Cu]:[THPTA]:[AAc]=1:4:50); 
2. CuSO4 100 µM, THPTA 400 µM and ascorbic acid 6.25 mM ([Cu]:[THPTA]:[AAc]=1:4:62). 
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Six poly(DMA-PMA-MAPS) coated Si/SiO2 surfaces were arrayed with p-IgG-PEG8-N3 in the two 
different reaction condition, and six poly(DMA-NAS-MAPS) coated Si/SiO2 surfaces were arrayed 
with the unmodified p-IgG. In order to study the influence of the different reaction times, two chips 
for each coating were incubated for 5, 10, 20, 30, 60 minutes whereas the classical 12 hours 
protocol was used to compare the classical condition of immobilization on the active ester coated 
surface. 
 
 
Figure 53: mean fluorescence intensities obtained from the different immobilization conditions of 
p-IgG-PEG8-N3 (blue: CuSO4 2.5 mM, THPTA 10 mM and ascorbic acid 120mM; red: CuSO4 100 µM, 
THPTA 400 µM and ascorbic acid 6.25 mM) on poly(DMA-NAS-MAPS), of unmodified p-IgG, green, 
on poly(DMA-NAS-MAPS), depending on the immobilization time. 
 
As it can be observed from the above histogram (Figure 53), the best results among the p-IgG-PEG8-
N3 conditions were obtained using copper catalyst at 100 µM concentration. A higher catalyst 
amount is therefore not necessary, confirming the data reported by Hong et al.106. Considering the 
immobilization via 1,3-dipolar Huisgen cycloadditon, a higher immobilization yield was obtained in 
30 minutes, whereas, extending the reaction time (from 1 to 12 hours), was not advisable probably 
due to antibody stability problem. On the other hand, the random immobilization via amine active 
ester reaction on a poly(DMA-NAS-MAPS) coated surface, has the drawback of requiring a longer 
immobilization time. However it still remains competitive when random immobilization conditions 
are used. The real advantage of the “click” approach lies in its site-specific immobilization. If the 
azide functionalities are randomly introduced there are no reasons to use of the more sophisticated 
click approach. 
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7.2. Interleukin-6 bioassay: the advantage of orientation 
 
In order to evaluate the advantages provide by the oriented immobilization, we deeply explored 
the advantages of a site-specific modification on the Fc region of an antibody, coupled with the use 
of a quickly and regio-specific immobilization onto a polymeric coated surface, that features a 
solution-like environment (paragraph 5.1.2.). 
To validate the methodology and highlight its advantages, a sandwich microarray test for the 
detection of interleukin-6 (IL-6) was developed237. Among the most intensively studied protein 
biomarkers, cytokines are implicated in the initiation and development of almost every major life-
threatening disease. They play a prominent role in cancer, neurodegenerative diseases, 
cardiovascular diseases, sepsis and many other pathologies 238 . Although enzyme-linked 
immunosorbent assay (ELISA) is the gold standard for the measurement of individual cytokine 
concentration, the key to successful identification of biomarkers is the simultaneous detection of 
multiple cytokines with high sensitivity. IL-6 was chosen as a model of a typical inflammatory 
biomarker to be detected with high sensitivity, thus demonstrating the advantages provided by an 
oriented immobilization of the capturing antibody in a microarray based immunoassay. 
  
 
Figure 54: Scheme of the IL-6 test. (a) First the immobilization of the capturing antibody occurred 
via oriented copper mediated 1,3-dipolar Huisgen cycloaddition; then (b) the interaction with the 
target in solution (IL-6) occurs and (c) the detection-Ab was used to allow a final fluorescence 
detection through (d) streptavidin-Cy3. 
98 
 
The IL-6 capturing antibody was modified both site-specifically, using the procedure described 
above and detailed in “materials and method” (chapter 9), and randomly, using 4 equivalents of the 
azido-PEG linker (NHS-PEG8-N3), exploiting the abundance of lysine (-NH2 terminal) on the antibody 
structure.  
Furthermore, to validate the enzymatic procedure here proposed to modify antibodies with an 
azide moieties, the enzymatic path developed in this thesis was compared with the one proposed 
by the commercial kit, named Site-Click Antibody Labelling from Life Technologies. With the 
commercial kit a 2-azidogalactose was introduced on Fc region of the antibody using a mutant 
enzyme, GalT(Y289L)133 . 
With both enzymatic pathways, the advantage of surface oriented immobilization was 
demonstrated. This immobilization strategy leaves the two binding-sites available for the 
interaction with the antigen (IL-6) in solution (comparison with the pegylated antibody). In addition, 
the higher binding-efficiency obtained by introducing an unnatural galactose carrying a less 
hindered azido functionality on C-6, instead of on C-2, was demonstrated. 
Three azido modified IL-6 capturing antibodies were spotted at the same concentration (0.35 
mg/ml) in sodium phosphate buffer (50 mM, pH 7.4) onto poly(DMA-PMA-MAPS) coated slides. The 
reagents for 1,3-dipolar cycloaddition were used in the optimized condition previously determined: 
CuSO4 100 µM, THPTA 400 µM and ascorbic acid 6.25 mM. CuSO4 and THPTA were first mixed for 
10 minutes, and then added to the solution containing the modified antibodies. Finally, just before 
the spotting, ascorbic acid was added to initiate the reaction. 
A slide coated with poly(DMA-NAS-MAPS) was spotted with 0.35 mg/ml of the unmodified IL-6 
capturing antibody in the 50mM sodium acetate, buffer, pH 4, to compare oriented and random 
immobilization via active ester/amine reactivity. 
After the spotting step, the alkyne modified slides were left in the humid chamber for 30 minutes 
and then washed for 10 minutes in PBS, whereas poly(DMA-NAS-MAPS) slides were first blocked 
with ethanol-amine.  
Before starting the incubation, the mass of the immobilized antibody was measured using IRIS, a 
label-free technique briefly described in paragraph 3.1.2.. The mass quantification allows relating 
the efficiency of the Ab-antigen interaction (fluorescence of the bioassay) to the mass (ng/mm2) of 
antibody effectively immobilized. This relation helps to understand the importance of an oriented 
immobilization of the capturing bioprobe. In particular it was demonstrated that a higher amount 
of immobilized probe does not necessary lead a higher amount of antigen captured on the surface 
confirming the importance of an immobilization strategy that favors at most the tail-on antibody 
orientation. 
In the histogram below the amount of the immobilized IL-6 capturing antibody is depicted (Figure 
55).  
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Figure 55: the different amount (ng/mm2) of antibody captured IL-6 (Ab) immobilized onto the 
respective coated surface. The azido modified were all immobilized on poly(DMA-PMA-MAPS) 
coated surface, while the unmodified Ab was immobilized on poly(DMA-NAS-MAPS) surface. 
 
After the incubation with the antigen (IL-6, 2ng/ml), with the biotinylated secondary antibody 
(detection-Ab) and with streptavid-Cy3, a fluorescence signal was obtained and normalized to the 
mass of probe to provide a graphic of normalized fluorescence/(ng/mm2), Figure 56. 
Considering the results obtained (Figure 56), the advantage of an oriented antibody immobilization 
is evident. The dramatic decrease in the efficiency of the antibody when randomly immobilized via 
amine, also compared with the pegylated antibody, is probably due to the higher sensitivity of this 
antibody toward the orientation of its binding-sites. 
 
 
Figure 56: the binding-efficiency of each modified and unmodified antibody for IL-6 capture printed 
on their properly modified surface.  
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The importance of the orientation to achieve good binding efficiency of the target was 
demonstrated by this experiment. Independently from the approach used for the functionalization, 
the side specific azido-modified antibodies show a higher amount of antigent captured per mass 
unit compared to the antibodies randomly immobilized. Even though a higher immobilization yield 
is achieved with the native antibody on poly(DMA-NAS-MAPS), this does not result in a higher 
capture efficiency in this specific bioassay. The PEG modified antibody, Ab-PEG8-N3, thanks to its 
multiple anchoring points was also immobilized with high efficiency: 1.94 ± 0.43 ng/mm2, a value 
close to that of the unmodified one (2.37 ± 0.38 ng/mm2). However the bio-recognition efficiency 
provided by the site-specific azido modified antibodies was higher when compared with the non 
oriented antibodies due to a more efficient antibody-antigen interaction. Furthermore, thanks to 
the azido functionality, the immobilization occurred in only 30 minutes as opposite to several hours 
required by the poly(DMA-NAS-MAPS) surface. 
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7.3. Conclusion. Poly(DMA-PMA-MAPS)-Si/SiO2 platform in antibody microarrays: 
the role of probes orientation 
 
In conclusion, in this work we have developed a simple methodology to increase the performance 
of microarray analysis by combining the superior optical and physical characteristics of a Si/SiO2 
surface with a simple and robust coating procedure using a polymer that allows a click chemistry 
reaction to bind biomolecules to the surface. The polymer forms a thin film which reproduces a 
solution-like environment. The alkyne functionality of the polymer leads to a regiospecific probe 
immobilization by fast copper mediated 1,3-dipolar Huisgen cycloaddition. 
This new functionalization approach was used for the immobilization of an azido site-specific 
modified antibody in a regiospecific manner. The antibody tail-on orientation was found to enhance 
the molecular recognition efficiency toward the antigen in solution. The results shown in this 
chapter confirm the general knowledge that antibody microarrays take advantage from 
orientational control of the immobilized probe. An enzymatic approach based on the use of 
commercially available enzyme, was successfully applied to the site specific protein modification 
with an azido moiety.  
A sandwich assays for interleukin-6 (IL-6) (Figure 54) was developed to demonstrate the advantage 
of an oriented antibody immobilization compared to a random immobilization strategy, exploiting 
both an azido PEG modified antibody (Ab-PEG8-N3) and the amino functionality naturally presents in 
the protein.  
The proposed conjugation approach offers the advantage of insensitivity to pH buffer and side 
reactions of the triazole formed, expanding its application toward every antibody.  
Furthermore, the polymeric coating reproduces a solution-like environment when in contact with a 
buffer solution that results in a swelling of the dimethyalcrylamide back-bone of about 15 nm 
(paragraph 5.1.2). This coating feature coupled with the oriented immobilization mode increases 
the availability of the probes immobilized onto the surface and their accessibility to the target. The 
binding-efficiency of the oriented antibody was found to be higher than that of randomly attached 
antibodies. 
All these advantages, combined with the superior characteristics of the surface (Si/SiO2) pave the 
way for the construction of a high-performing antibody microarray platform. Further studies are 
ongoing, to improve the covalent attachment of the site-specifically modified antibody to 
consolidate the strategy for the oriented covalent immobilization of antibodies. 
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8. Conclusions 
 
In this work we introduce a new polymer obtained from the polymerization of N,N-
dimethylacrylamide (DMA), 3-trimethylsilanyl-prop-2-yn methacrylate (PMA) and 3(trimethoxysilyl)-
propylmethacrylate (MAPS), poly(DMA-PMA-MAPS) and describe its use in the formation of a 
functional coating for glycan and antibody microarray analysis. By combining physisorption and 
chemisorption, an ultra-thin hydrophilic 3D coating covalently grafted onto glassy solid surface 
could be obtained in less than one hour. The dimethylacrylamide (DMA) back-bone interacts with 
the surface by weak non covalent interactions (i.e. H-bond, Van der Waals or hydrophobic forces) 
allowing the whole polymer to get closer to the surface, while the pending hydrolized silanol 
monomers (MAPS) promote condensation of the polymer with surface silanols or between 
contiguous chains providing coating stabilization. 
The backbone of the polymer bears alkyne moieties, which allow binding of azido-modified probes 
by "click" chemistry. This attachment mode offers a number of advantages in the immobilization 
process, such as high grafting efficiency, oriented immobilization and insensitivity to functionalities 
present in natural probes (bio-orthogonality). The high local concentration of probe molecules on 
the polymer and the hydrophilic character of the coating increase the availability of the 
immobilized probes and their ability to interact with the target in solution.  
 
Additionally, this work introduces a new silicon/silicon oxide (Si/SiO2) substrate with superior 
optical properties in order to obtain a high-performing platform for microarray analysis. This 
support allows to enhance the signal fluorescence intensity by a factor of 4, which is vital for 
microarray sensitivity56. This layered substrate is widely available, inexpensive and compatible with 
established glass surface chemistries, it has a low roughness and provides a tuneable wavelength 
enhancement by changing the thickness of the oxide onto the silicon substrate. 
 
The advantages of the technology were demonstrated in glycan and antibody microarray analysis. 
 
In the first application, glycan microarrays, eight different α-mannose derivatives carrying an azido 
functionality on their linker could be covalently immobilized onto poly(DMA-PMA-MAPS) Si/SiO2 
coated surface in a regio-selective manner, and their interaction with the legume lectin 
Concanavalin A was studied. Thanks to the high sensitivity of the solid support (Si/SiO2) and to the 
high binding-capacity of the polymeric coating, carbohydrate-lectin interactions were studied at 
low glycan density. Furthermore, besides the classical qualitative fluorescence analysis, a 
quantitative analysis was carried out to determine surface dissociation constants (KD,surf) of each 
glycomimetic under investigation. A detailed investigation on the influence of multivalency on 
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carbohydrate-lectin affinity could be made by calculating surface dissociation constant (KD,surf) for 
each glycomimetic at decreasing glycan printing concentration.  
 
In the second application, the new polymer coating was used for the regio-specific immobilization 
of azido site-specifically modified antibodies. The antibody tail-on orientation was found to 
enhance the molecular recognition efficiency toward the antigen in solution. The proposed new 
approach was inspired by a work of Zeglis et al.132 that has been reported for the site-specific radio-
labelling of antibody. The results shown confirmed the general knowledge that an orientational 
control of the probes is recommended to provide a high-performing antibody microarray analysis. 
An enzymatic approach based on the use of a commercially available enzyme was successfully 
applied to the site specific modification of an antibody azido moiety.  
A sandwich assays for interleukin-6 (IL-6) was developed to demonstrate the advantage of oriented 
immobilization compared to random immobilization.  
This click conjugation approach offers the advantage of insensitivity to solvent and to buffer pH.  
Furthermore, the hydrophilic character of poly(DMA-PMA-MAPS) coupled with the oriented 
immobilization mode, increases the availability of immobilized probes onto the surface and their 
accessibility to the target in solution.  
 
In conclusion,  a new robust, sensitive, versatile and easy-to-make microarray surface was 
presented, combining the feasibility of poly(DMA-PMA-MAPS) 3D matrix, the versatility of the click 
chemistry and the superior optical characteristics of the Si/SiO2 solid surface used. 
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9. Materials and methods 
 
List of Abbreviations 
 
AIBN Azoisobutyronitrile 
Azido-PEG Polyethylene glycole azide 
BSA Bovine serum albumine 
ConA Concanavalin A 
CuAAc Copper-catalyzed Azide-Alkyne cycloaddition 
Cy-3 Cyanine-3 
DI water Deionized water 
DCM Dichloromethane 
DMA N, N-Dimethylacrylamide 
DMF dimethyl-formamide 
DMSO Dimethylsulfoxide 
EC50 Half maximal effective concentration 
DPI Dual polarization interferometry 
GalNAz Azido galactose 
GalT β(1,4)-galactosyltransferases 
GPC Gel Permeation Chromatography 
KD,surf Surface dissociation costant 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPLC High-permormance liquid chromatography 
IL-6 Interleukin-6 
LBB Lectin binding buffer 
MALLS Multi-Angle Laser Light Scattering 
MAPS 3-(trimethoxysilyl) propyl methacrylate 
MS Mass Spectrometry 
MW Molecular Weight 
Q H2O MilliQ Water 
NAS N-Acryloyloxysuccinimide 
NHS N-hydroxysuccinimide 
NHS-PEG8-N3 N-hydroxysuccinimide-polyethylene glycole-azide 
PBS phosphate buffer saline 
PEG Polyethylene glycole 
Py pyridine 
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PMA 3-trimethylsilyl-prop-2-ynyl methacrylate 
Rf Retardation factor 
SAMs Self-Assembled Monolayers 
Si/SiO2 Silicon/silicon oxide 
TEAB triethylaminetetra 
THF Tetrahydrofuran 
THPTA Tris(3-hydroxypropyltriazolylmethyl)amine 
TLC Thin liquid chromatography 
Tris Trizma Base /2-Amino-2-(hydroxymethyl)-1,3-propanediol 
UDP  Uridine 5'-Diphosphate 
UMP  Uridine 5'-Monophosphate 
  
 
9.1. Materials 
 
Dichloromethane (DCM), methanol (MeOH), and triethylamine (TEA) were dried over calcium 
hydride; THF was distilled over sodium. Reactions requiring anhydrous conditions were performed 
under nitrogen or argon where indicated. 
1,2,3,4-di-O-isopropylidene-D-galactopyranose and 2-Chloro-4H-1,3,2-benzodioxaphosphorin-4-one 
(97%)    were purchased from ABCR (Karlsruhe,  Baden-Württemberg, Germany). Cy-3 azide was 
purchased from Lumiprobe GmbH (Feodor-Lynnen Strasse 23, 30625 Hannover, Germany). The 
SiteClick Antibody Labelling was purchased from LifeTechnologies (part of the Thermo Fisher 
Scientific Inc., Waltham, MA, USA). The Amicon filters were purchased from Millipore (Merk s.p.a., 
Milan, Italy). 
ELISA MAXTM standard set Human IL-6 was purchase from BioLegend (San Diego, CA, USA). 
The bifunctional polyethylene glycol (Azide-PEG8-NHS ester) was purchased from Jena Bioscience 
GMBH (Jena, Germany). 
Tetrazole solution (0.45 M in CH3CN), tert-Butyl hydroperoxide solution (≈5.5 M in decane), Uridine 
5’-monophosphomorpholidate-4-morpholine-N,N’-dicyclohexylcarboxamidine salt and all other 
chemicals, the enzymes (β-(1,4)-galactosidases and β-(1,4)-galactosyltransferases), the 
immunoglobulins (IgG anti-rabbit from porcine serum, IgG anti-pig from rabbit and biotinylated IgG 
anti-rabbit from goat), dry and deuterated solvents (CDCl3, MeOD, D2O), were purchased from 
Sigma Aldrich (St. Louis , MO, USA) and used without further purification. 
Silicon oxide chips with a 100 nm thermal oxide layer were bought from Silicon Valley 
Microelectronics (Santa Clara, CA, USA), IRIS chips with a 500 nm thermal oxide layer were a kind 
gift from Prof. Selim M. Unlu from Boston University, MA (USA) and silicon oxynitride AnaChipTM 
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were brought from Farfield. An Agilent 1200 series liquid chromatography system, (Agilent 
Technologies, Santa Clara, CA, USA) was used to carry out GCP. GPC columns were from Schodex 
(New York, NY, USA); MALLS system was purchased from Wyatt Technology (Santa Barbara, CA, 
USA). The piezoelectric spotter SciFlexArrayer S5 was brought from Scienion (Berlin, Germany) with 
its related software program, the microarray scanner ProScanArray was purchased from Perkin 
Elmer (Boston, MA, USA) along with its ScanArray express software, and the Analight Bio 200 with 
its Analight Explorer software were purchased from Farfield Group (Stockholm, Sweden). IRIS 
instrumentation was a prototype developed in collaboration with the laboratory of Prof. Selim M. 
Unlu at Boston University, MA (USA), and it consists of a CCD camera (Retiga 2000R from 
QImaging), and an ACULED VHL surface-mount LED package (Perkin-Elmer), which has four 
independently driven LEDs with peak emission wavelengths of 455nm, 518, 598nm, and 635nm. 
IRIS images were acquired and ﬁtted with ZoirayAcquire software, then the data were analyzed 
with ZoirayProcess software. For each protein, signals from 35 replicate spots were averaged. 
The HPLC chromatography was carried out using a manual injection (Rheodyne valve) connected to 
a pump JASCO 887-PU, a detector equipped with a preparative cell UVIDEC100-VI that is connect 
with a Data Station LKB 2210 1-channel recorder. The semi-preparative column used is a 
Phenomenex (Jupiter 10u Proteo 90A, size 250x21 10 mm) purchased from Phenomenex (Bologna, 
Italy). 
 1H, 13C and 31P spectra were recorded at 400MHz on a Bruker AVANCE-400 instrument. Chemical 
shifts (δ) for 1H, 13C and 31P spectra are expressed in ppm relative to an internal standard (CDCl3: 
7.26 for 1H and 77.16 for 13C; CD3OD: 3.31 for 
1H and 49.00 for 13C, D2O: 4.79 for 
1H). Signals were 
abbreviated as s, singlet; br s, broad singlet; d, doublet; t, triplet; q, quartet; m, multiplet. Mass 
spectra were obtained with a ThermoFisher LCQapparatus (ESI ionization), or iontrap ESI Esquire 
6000 from Bruker, or a Microflex apparatus (MALDI ionization) from Bruker, or Apex II ICR FTMS 
(ESI ionization—HR-MS). Thin layer chromatography (TLC) was carried out with pre-coated Merck 
F254 silica gel plates. Flash chromatography (FC) was carried out with Macherey-Nagel silica gel 60 
(230–400 mesh). 
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9.2. Experimental section 
 
9.2.1. Poly(DMA-PMA-MAPS) synthesis and characterizations 
 
Synthesis of 3-trimethylsilyl-prop-2-ynyl methacrylate (PMA)  
 
 
 
3-(trimethylsilyl)prop-2-yn-1-ol (2.31 ml, 15.6 mmol) and triethylamine (2.83 ml, 20.27 mmol) were 
dissolved in Et2O (20 ml) and cooled to -20°C. A solution of methacryloyl chloride (2) (1.81 ml, 18.56 
mmol) in Et2O (10 ml) was added drop wise over 1 hour. The mixture was stirred at -20°C for 30 
minutes and then overnight at room temperature. Ammonium salts were removed by filtration and 
the volatiles were removed under reduced pressure.  
 
The yellow oil residue was purified by flash chromatography (EtP:Et2O=50:1, Rf= 0.39) and the 
product (3) was obtained in 81% yield. 
 
1H-NMR (400 MHz, CDCl3): δ = 0.18 (s, 9H, Si(CH3)3); 1.97 (m, 3H, CH3C=CH2); 4.76 (s, 2H, OCH2); 
5.62 (m, 1H, C=CHH); 6.17 (m, 1H, C=CHH). 
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Synthesis of copoly(N,N-dimethylacrylamide (DMA)- 3-trimethylsilyl-prop-2-ynyl methacrylate 
(PMA)- 3-(Trimethoxysilyl)propyl methacrylate (MAPS)), (poly(DMA-PMA-MAPS)). 
 
 
 
The polymer was synthesized via a random radical polymerization in anhydrous tetrahydrofuran 
with a 20% w/v total monomer concentration. The DMA (5) was filtered on aluminium oxide to 
remove the inhibitor. The molar fraction of the monomers DMA (5), PMA (3) and MAPS (4) was 
97:2:1.  
The DMA and PMA monomers were dissolved in dry tetrahydrofuran (THF) in a round-bottom flask 
equipped with condenser, magnetic stirring. The solution was degassed by alternating argon purges 
with a vacuum connection, over a 10-min period. MAPS (4) and α,α’-Azoisobutyronitrile (AIBN) (this 
latter at 2mM final concentration) were added to the solution, which was then warmed to 65 °C 
and maintained at this temperature under a slightly positive pressure of argon for 2 h.  
 
After the polymerization was completed, the solution was first diluted to 10% w/v with dry THF and 
the polymer (6) precipitated by adding petroleum ether (10 times the reaction volume). The 
product, a white powder, was filtered on Buckner funnel and dried under vacuum at room 
temperature.  
 
13C-NMR (400 MHz, CDCl3), δ (ppm): 0.00 (Si(CH3)3); 36.65 (all CH2); 45,62 (OCH2C) 50.94 
(Si(OCH3)3); 53.32 (OCH2CH2) 174.95 (all CO).  
13C-NMR (400 MHz, DMSO), δ (ppm): -0.31 (Si(CH3)3); 36.08 (all CH2); 44.78 (OCH2C) 50.10 
(Si(OCH3)3); 52.76 (OCH2CH2) 173.89 (all CO). 
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The protective trimethylsilyl groups were removed in water under basic condition, using K2CO3 
(9mM) at pH 9. The reaction mixture was stirred at room temperature for 1h, then the polymer (7) 
was dialyzed, lyophilized and the white powder obtained was stored at -20 °C. 
 
13C-NMR (400 MHz, CDCl3), δ (ppm): 36.65 (all CH2); 45,62 (OCH2C); 52.40 (OCH2CH2); 75.92 (CH); 
174.95 (all CO).  
13C-NMR (400 MHz, DMSO), δ (ppm): 36.08 (all CH2); 44.79 (OCH2C); 52.02 (OCH2CH2); 77.63 
(CH); 78.31 (CCH); 174.96 (all CO). 
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 Polymer characterization by Gel Permeation Chromatography 
 
The size of each polymer was characterized using Gel Permeation Chromatography in tandem with 
an UV-detector (λ=214nm). 
A JASCO 880 PU liquid chromatography system, consisting of an isocratic pump to control mobile 
phase flow throughout the system connected to a JASCO UVIDEC-100-III UV detector. ChromNAV 
Chromatography Data System -JASCO was used to analyze the sequence of sample injection and to 
calculate the calibration curve of polyacrylamide standards.  
The GPC setup consists of four Shodex aqueous GPC columns in series: OHpak SB-G (guard column), 
OHpak SB-804M HQ, OHpak SB-803 HQ, and OHpak SB-802.5 HQ. Each column is packed with a 
poly-hydroxymethacrylate gel and connected in series with a decreasing exclusion limit. The 
columns were maintained at 40oC throughout each run using a thermostated column compartment.  
After the polymer sample is fractionated by GPC, the sample flows into a UV-detector. The 
molecular weight of the polymer was obtained by using a calibration curve. 
Copoly(DMA-PMA-MAPS) (7) sample was diluted using the GPC mobile phase (GPC buffer: 100 mM 
NaCl, 50 mM NaH2PO4, pH 3, 10% v/v Acetonitrile) to a concentration of 2.66 mg/ml and the 
sample was run three times through the GPC-UV system to test for reproducibility. Each run 
injected 20 μL of sample to be analyzed and the flow rate through the system was held at a 
constant 0.3 mL/min.  
111 
 
9.2.2. Total synthesis of Uridine 5’-(6-azido-6-deoxy-α-D-galactopyranosyl) 
diphosphate bis-triethylammonium salt (UDP-6-azidogalactose). 
 
13C-NMR, 31P NMR and MS characterizations of the compounds here reported could be found in the 
referential article: M. Bosco, S. Le Gall, C. Rihouey, S. Couve-Bonnaire, M. Bardor, P. Lerouge, X. 
Pannecouke, Tetrahedron Letters, 2008, 49, 2294-2297. 
 
1,2,3,4-di-O-isopropylidene-6-tosyl-6-deoxy-α-D-galactopyranose (9) 
 
 
 
 
 
In a round bottom flask (250ml) the protected galactose (8) was introduced (3.0g, 11.5 mmol). After 
drying under vacuum for 20  minutes the galactose (8) was put under nitrogen atmosphere. Dry 
pyridine (115 ml, 0.1M) was added and the obtained mixture was stirred until a homogeneous 
solution was obtained. The tosyl-chloride (3.4g, 17.25 mmol) was then added and the reaction 
mixture was left 2 h under stirring at room temperature.  
 
The reaction was controlled through TLC (Hex:AcOET=7:3, Ammonium molybdate/Cerium 
sulphate). 
 
Once the reaction was completed the solvent was removed under reduced pressure and re-
dissolved in AcOEt. The crude was washed with HCl 1N, with a saturated NaHCO3 solution and 
brine. The collected organic phases were dried over Na2SO4 anhydrous and the solvent was 
removed under reduced pressure.  
 
The obtained product (9) was used without further purification (quantitative yield). 
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1,2,3,4-di-O-isopropylidene-6-azido-6-deoxy-α-D-galactopyranose (10) 
 
 
 
 
 
The 6-tosyl galactose (9) (2.9 g, 7 mmol) was dried under vacuum and, under nitrogen atmosphere, 
dry DMF (7 ml, 1M) was added. Once the galactose was completly dissolved TBAI (775.8 mg, 2.1 
mmol) and NaN3 (2.73g, 42 mmol) were added.  
The mixture was stirred for 3 days at 100°C under nitrogen atmosphere. 
 
The reaction was monitored trough TLC (Hexane: AcOEt = 7:3). Once the reaction was completed 
the solvent was partially removed under vacuum and the reaction mixture was diluted with AcOEt 
and washed three times with distilled water. The collected organic phases were dried over 
anhydrous Na2SO4 and the solvent was removed under reduced pressure.  
 
The crude was purified through flash chromatography (Hexane: AcOEt = 9:1, Rf = 0.4), and the 6-
azidogalactose (10) was obtain in 69% of yield. 
 
1H-NMR (400MHz, CDCl3) δ: 5.54 (d, 1H, J1-2 = 5 Hz, H-1), 4.62 (dd, 1H, J2-3= 7.8 Hz, H-3), 4.34 
(broad dd, 1H, H-4), 4.19 (dd, 1H, J2-3=7.8 Hz, H-2), 3.90 (ddd, 1H, J5-6= 7.9 Hz, J5-6’= 5.4 Hz, H-5), 
3.50 (dd, 1H, J6-6’ = 12.7 Hz, J6-5=7.9 Hz, H-6), 3.36 (dd, 1H, J6-6’ = 12.7 Hz, J6’-5= 5.4 Hz, H-6’), 
1.55 (s, 3H, C-CH3), 1.46 (s, 3H, C-CH3), 1.34 (s, 6H, C-CH3). 
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6-azido-6-deoxy-α-D-galactopyranose(11) 
 
 
 
 
 
 
The 6-azidogalactose (10) ( 1.72 g , 6.6 mmol) was dissolved in 60 ml of HCl aqueous solution (0.06 
M) and left at 80°C under stirring for 18 hours. The reaction was followed through TLC.  
(Hexane:AcOEt = 8:2 was used to control the presence of the starting material, while a polar eluant, 
DCM:MeOH = 8:2, was used to monitor product (11) formation). 
 
Once the reaction was completed the mixture was frozen, lyophilized and the crude was purified 
with flash chromatography (DCM:MeOH = 8:2). 
 
The purified product (11) was obtained in quantitative yield. 
 
1H-NMR (400 MHz, D2O) δ: 5.26 (d, 1H, J1-2 = 3.8 Hz, H-1α), 4.60 (d, 2H, J1-2 = 7.9 Hz, H-1β), 4.18 (m, 
1H, H-5α), 3.95 (m, 1H, H-4α), 3.89 (m, 2H, H-4β), 3.85-3.76 (m, 4H, H-5β, H-3α, H-2α), 3.67-3.43 
(m, 11H, H-3β, H-6β, H-6β’, H-6α, H-6’α, H-2β). 
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1,2,3,4-tetra-O-acetyl-6-azido-6-deoxy-α-D-galactopyranose(12) 
 
 
 
 
 
The deprotected 6-azido-galactose (11) (1.35 g, 6.6 mmol) was dissolved under nitrogen 
atmosphere in Ac2O (6.3 ml, 60 mmol). The reaction mixture was cooled to 0°C and BF3·Et2O (1.47 
ml, 11.88 mmol) was added. The reaction was stirred for 30 minutes at 0°C and the trend of the 
reaction was controlled through TLC ( Hex:AcOEt = 6:4, Rf = 0.5 ). 
 
Once the reaction was completed the mixture was diluted with 150 ml of DCM. The diluted solution 
was washed three times with NaHCO3 saturated solution and one time with brine. The organic 
phase was dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure. 
 
The crude was purified by flash chromatography (Hex:AcOEt = 7:3, Rf = 0.35). 
 
The product (12) was obtained with 77 % of yield. 
 
1H-NMR (400MHz, CDCl3) δ: 6.40 (d, 1H, H-1α), 5.71 (d, 1H, J1-2=8.4 Hz, H-1β), 5.48 (1H, H-4), 5.40 
(d, 1H, H-3), 5.36-5.32 (dd, 1H, H-2β), 5.10 (dd, 1H, J1-2=3.3 Hz, J2-3= 10.3 Hz, H-2α), 4.22 (broad ddd, 
1H, H-5α), 3.94 (broad ddd, 1H, H-5β), 3.53 (dd, 1H, J6-6’= 12.6 Hz, J6-5=7.3 Hz, H-6β), 3.45 (dd, 1H, J6-
6’=12.8 Hz, J6-5 = 7.6 Hz, H-6α), 3.22 (dd, 2H, J6-6’=12.8 Hz, J6’-5 = 5.3 Hz, H-6α and β), 2.20 (s, 3H, CH3-
COO), 2.15 (s, 3H, CH3-COO), 2.07 (s, 3H, CH3-COO), 2.02 (s, 3H, CH3-COO). 
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2,3,4-tri-O-acetyl-6-azido-6-deoxy-α-D-galactopyranose(13) 
 
  
 
 
 
The acetylated 6-azido-galactose (12) (1.39 g, 3.7 mmol) was dissolved in 14 ml of dry DMF under 
nitrogen atmosphere and the solution was cooled to 0°C. At the same time in a 5 ml round bottom 
flask the monohydrate hydrazine (233.6 μl, 4.81 mmol) was dissolved in 1.6 ml of dry MeOH and 
acetic acid (212.5 μl, 3.7 mmol) was slowly added to obtain hydrazine acetate. After 30 minutes the 
MeOH solution of hydrazine acetate was added drop wise to the DMF solution of the sugar at 0°C. 
The reaction mixture was left 15 minutes at 0°C, then let to warm to room temperature  and stirred 
for 2 hours. 
 
The reaction was control by TLC (Hex:AcOEt = 6:4). 
 
Once the reaction was completed it was first diluted with AcOEt and washed with a solution of 1N 
HCl, a saturated NaHCO3 aqueous solution and final with brine. The organic phase was dried over 
anhydrous Na2SO4 and the solvent was removed under reduced pressure. 
 
The crude was purified with flash chromatography (Hex:AcOEt = 6:4) and a mixture of alpha and 
beta anomer (13) was obtained in 65 % yield. 
  
1H-NMR (400MHz, CDCl3) δ: 5.57 (d, 1H, H-1α), 5.45 (dd, 1H, J4-3= 3.3 Hz, J4-5=1.1 Hz, H-4), 5.43 (dd, 
1H, J3-2= 10.6 Hz, J3-4= 3.3 Hz, H-3), 5.19 (dd, 1H, J2-3 = 10.5 Hz, J3-4= 3.6 Hz, H-2), 4.41 (dd, 1H, J5-6’ = 
4.3 Hz, J5-6 = 8.3 Hz, H-5), 3.46 (dd, 1H, J6-6’ = 12.8 Hz, J6-5 = 8.2 Hz, H-6), 3.23 (dd, 1H, J6’-6 = 12.7 Hz, 
J6’-5 = 4.5 Hz, H-6’), 2.20 (s, 3H, CH3-COO), 2.12 (s, 3H, CH3-COO), 2.02 (s, 3H, CH3-COO). 
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2,3,4-tri-O-acetyl-6-azido-6-deoxy-α-D-galactopyranosyl phosphite Et3N salt (15) 
 
 
 
 
Phosphorous acid (H3PO3, 115 mg, 1.40 mmol) was co-evaporated three times with dry toluene and 
left under vacuum over night. The day after it was dissolved in dry pyridine to obtain a 2 M solution. 
The H3PO3 solution was added drop-wise into a dry pyridine solution of the 6- azido-galactose (13) 
(155 mg, 0.47 mmol), at room temperature under nitrogen atmosphere. The reaction mixture was 
cooled to 0°C, and salycil chloro phosphite (14) (143 mg, 0.71 mmol) was added. The reaction 
mixture was left stirred at room temperature until the starting material has been consumed (4 
hours). 
The reaction was control with TLC (DCM:MeOH=7:3, 1% of TEA). 
 
Work up: 
Once the reaction was completed, a 1 M buffer solution of Et4N
+HCO3
- (TEAB, pH 8.5) was added 
(4ml/mmol of galactose). The mixture was then diluted with DCM and washed three times with a 
0.5 M buffer solution of TEAB (tetraethylammonium bicarbonate, 1M aqueous solution). The 
collected organic phases were dry over Na2SO4 (anhydrous) and the solvent was removed under 
reduced pressure.  
The crude was purified by automated chromatography on silica gel (using a gradient from pure 
CH2Cl2 to 20% of MeOH in X min), in the presence of 1% of TEA), and the product (15) was obtained 
in 84% yield. 
 
1H-NMR (400MHz, CD3OD) δ: 6.92 (d, 1H, JP-H = 635.2 Hz, P-H), 5.80 (dd, 1H, JH-P = 8.8 Hz, J1-2 = 3.6 
Hz, H-1α), 5.48 (d, 1H, J4-3 = 3.0 Hz, H-4), 5.40 (dd, 1H, J3-4 =3.2 Hz, J3-2 = 10.8 Hz, H-3), 5.15 (dd, 1H, 
J2-3 = 10.5 Hz, J2-1 = 3.4 Hz, H-2), 4.43 (m, 1H, H-5), 3.50 (dd, 1H, J6-6’ = 12.9 Hz, J6-5 = 7.7 Hz, H-6), 
3.30 (dd, 1H, J6’-6 = 12.8 Hz, J6’-5 = 5.2 Hz, H-6’), 3.22 (q, 6H, J=7.3 Hz, (CH3CH2)3NH
+), 2.20 (s, 3H, CH3-
COO), 2.10 (s, 3H, CH3-COO), 1.98 (s, 3H, CH3-COO), 1.40 (t, 9H, (CH3CH2)3NH
+). 
 
31P-NMR (121.5 MHz, CD3OD) δ: 1.41 (s, 1P, P-H). 
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2,3,4-tri-O-acetyl-6-azido-6-deoxy-α-D-galactopyranosyl phosphate Et3N salt(17) 
 
A) Counterion exchange 
 
 
 
 
Resin preparation: 
 
DOWEX 50W X80 H+ acidic resin was gently shaken for 2 hours with MeOH, filtered, dried  under 
vacuum over night and regenerated with 5% aqueous solution of HCl for two hours. 
The required volume of HCl solution was determined from this equation, where Y is 4 for a strong 
resin, and the capacity exchange is equal to 1.7 meq/ml: 
 
 
 
Ion exchange column: 
 
The regenerated resin was washed with distilled H2O to remove the HCl excess, and the water was 
removed with several washing cycles with THF. A column (2 cm of diameter) was then prepared (10 
ml of resin in THF) and the H-phosphonate (15) (72 mg, 182 µmol) was dissolved in the smallest 
volume of THF and passed slowly through the exchange column, monitoring by TLC 
(DCM:MeOH=7:3). The product (16) was collected and the solvent was removed under reduced 
pressure and the crude was left under vacuum for several hours. 
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B) Oxidation: 
 
 
 
 
The crude (16) (70.2 mg, 178 µmol) was dissolved in dry THF (2.83 ml) under nitrogen atmosphere. 
t-BuOOH (5.5 M in Undecane, 65 µl, 356 µmol) and I2 (1.78 µmol, 0.5mg), in catalytic amount, were 
subsequently added. The reaction mixture was left stirring in the dark, over night at room 
temperature. The reaction was controlled with TLC (DCM:MeOH=7:3).  
 
Work up: 
 
Once the starting material (16) was consumed, the reaction mixture was neutralized by 
triethylamine ( 356 µmol, 49.6 µl, 2 eq.) and then concentrated under reduced pressure. The crude 
was purified by automated chromatography on a C18 reverse-phase column (water as eluent in the 
presence of 1% of TEA) to give the phosphate (17) in a 30% yield. 
 
1H-NMR (400MHz, CD3OD) δ: 5.78 (dd, 1H, JH-P = 7.7 Hz, J1-2 = 3.4 Hz, H-1α), 5.50 (d, 1H, J4-3 = 3.3 Hz, 
H-4), 5.41 (dd, 1H, J3-4 =3.3 Hz, J3-2 = 10.7 Hz, H-3), 5.31 (dd, 1H, J2-3 = 10.7 Hz, J2-1 = 3.4 Hz, H-2), 
4.43 (m, 1H, H-5), 3.51 (dd, 1H, J6-6’ = 12.5 Hz, J6-5 = 6.2 Hz, H-6), 3.30 (dd, 1H, J6’-6 = 12.5 Hz, J6’-5 = 
5.5 Hz, H-6’), 3.21 (q, 6H, J = 7.3 Hz, (CH3CH2)3NH
+), 2.15 (s, 3H, CH3-COO), 2.09 (s, 3H, CH3-COO), 
1.99 (s, 3H, CH3-COO),1.34 (t, 9H, (CH3CH2)3NH
+). 
 
31P-NMR (121.5 MHz, CD3OD) δ: -0.13 (s, 1P, P-OH). 
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Uridine 5’-(2,3,4-tri-O-acetyl-6-azido-6-deoxy-α-D-galactopyranosyl) diphosphate bis-
triethylammonium salt (19) 
 
 
 
 
Using a rotary evaporator flushed with argon, phosphate (17) (16.9 mg, 27.54 μmol, 1eq.) was dried 
by repeated co-evaporation with distilled pyridine (3 x 1.3 ml) and dried in vacuum (≈ 3 hours). 
UMP-morpholidate (18) (4’-morpholine-N,N’-dicyclohexylcarboxamidinium) (37.8 mg, 55.08 μmol, 
2 eq.) and tetrazole (122.4 µl, 0.45 M in CH3CN, 55.08 μmol, 2 eq.) were then dried by repeated co-
evaporation with distilled pyridine (3 x 1.3 ml) and dried in vacuum (≈1 hour). 
To the dried phosphate (17) was added a solution of the dried UMP-morpholidate (18) in freshly 
distilled pyridine (10 ml). The mixture was dried by co-evaporation with distilled pyridine (2 x 1.5 
ml), dried in vacuum (≈1 hour) and dry pyridine was added (≈ 500 µl). From the reaction mixture 
about 60% of the solvent was removed and was stirred in the dark at room temperature under 
argon atmosphere. After 2 days, toluene was added and the mixture was concentrated in vacuum.  
After lyophilization, product (19) was purified on a semi-preparative HPLC C18-column using the 
eluent and conditions described below to obtain the purified protected UDP-6-azido-galactose (19) 
(12.5 mg, 17.46 μmol) as a white solid, after lyophilization in the presence of NH4HCO3.  
 
Yield= 63.4 % 
 
HPLC semi-preparative column C-18 
Eluent A: NH4HCO3, 50 mM (pH 7.6) 
Eluent B: CH3CN 50% in milliQ H2O 
Velocity= 14 ml/min , Rt (product)= 11 min 
Maximum injectable sample: 30-100 mg. 
120 
 
Using a gradient from pure Eluent A to 50% of EluentB in 40 min. 
 
1H-NMR (400MHz, D2O) δ: 8.02 (d, 1H, Jb-a= 8 Hz, Hb), 6.04-5.98 (m, 2H, Ha, H-1rib), 5.84 (dd, 1H, J1-
2= 3.5 Hz, J1-P = 7.6 Hz, H-1α), 5.56 (d, 1H, J4-3 = 3.0 Hz, H-4), 5.41 (dd, 1H, J3-2= 10.7 Hz, J3-4= 3.2 Hz, 
H-3), 5.18 (m, 1H, H-2), 4.54 (m, 1H, H-5), 4.44-4.19 (5H, H-3rib, H4-rib, H5-rib, H5’-rib), 3.60 (dd, 
1H, J6-6’= 12.8 Hz, J5-6= 6.4 Hz, H-6), 3.47 (dd, 1H, J6’-6= 13 Hz, H-6’), 2.24 (s, 3H, CH3-COO), 2.17 (s, 
3H, CH3-COO), 2.05 (s, 3H, CH3-COO). 
 
MS (ESI-negative mode): calculated for C21H28N5O19P2- [M-] 716.08, found 716.2 
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Uridine 5’-(6-azido-6-deoxy-α-D-galactopyranosyl) diphosphate bis-triethylammonium salt (20) 
 
 
 
 
 
To a methanol solution (681 μl) of the triethylammonium salt of the triacetate (19) (8 mg, 9.8 μmol, 
1 eq.) an aqueous solution of NH4HCO3 (0.1M, 900 µl) and Et3N (34.8 μl, 26 eq.) was added at 0°C. 
After 20 h at 0°C, the solution (kept at 0°C) was diluted with water (4 ml) and the pH was adjusted 
to 7.2 with DOWEX 50W (H+ form) resin. The resin was removed by filtration through a porous filter 
and washed with water (2 ml). After lyophilization, product (20) was purified on a semi-preparative 
HPLC C18-column with the eluent and conditions described below to afford UDP-azidogalactose 
(20) (4 mg, 6.4 μmol) as a white solid after lyophilization with NH4
+ as the counter-ion. 
 
Yield= 65% 
 
HPLC semi-preparative column C-18 
Eluent A: NH4HCO3, 50 mM (pH 7.6) 
Eluent B: CH3CN 50% in milliQ H2O 
Velocity= 14 ml/min , Rt (product)= 3 min 
Maximum injectable sample: 30-100 mg. 
Using a gradient from pure Eluent A to 50% of EluentB in 40 min. 
 
1H-NMR (400MHz, D2O) δ: 7.9 (d, 1H, Jb-a= 8 Hz, Hb), 5.90 (d, 2H, Ha, H-1rib), 5.55 (dd, 1H, J1-2 = 3.6 
Hz, J1-P = 7.2 Hz, H-1), 4.31-4.22 (m, 2H, H-2rib, H-3rib), 4.21-4.14 (m, 4H, H-4rib, H-5, H-5rib, H-
5’rib), 3.91 (d, 1H, J3-4 = 2.8 Hz, H-4), 3.83 (dd, 1H, J3-4 = 3.2 Hz, J3-2= 10.4 Hz, H-3), 3.72 (dt, 1H, H-2), 
3.49 (dd, 1H, J6-6’= 12.8 Hz, J5-6= 7.2 Hz, H-6), 3.38 (dd, 1H, J6’-6= 12.8 Hz, J5-6’= 6.0 Hz, H-6’). 
 
MS (ESI-negative mode): calculated for C15H22N5O16P2
- [M-] 590.05, found 590.7. 
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9.2.3. Microarray surface coating and characterization 
 
Coating of microarray slides with poly(DMA-PMA-MAPS) 
 
The coating solution of poly(DMA-PMA-MAPS) was obtained dissolving the polymer in deionized 
(DI) water to a final concentration of 2 % w/v. The solution was then diluted 1:1 with an aqueous 
(NH4)2SO4 solution at 40% of saturation. The Si/SiO2 slides were immersed into the polymer solution 
for 30 minutes, rinsed in DI water, dried with nitrogen flow and then cured at 80°C under vacuum 
for 15 minutes. Before the immersion, the Si/SiO2 slide was pre-treated with oxygen plasma in a 
Plasma Cleaner from Harrick Plasma (Ithaca, NY, USA). The oxygen pressure was set to 1.2 Bar with 
a power of 29.6 W for 10 min.  
 
Goniometry: Surface coating characterization by Contact Angle measurements  
 
Contact angle measurements were collected via the sessile drop method using a CAM200 
instrument (KSV Ltd), which utilizes video capture and subsequent image analysis. Deionized water 
was used, and its purity was confirmed by correlating the measured surface tension based on the 
pendant drop shape to the literature values for pure water (72 mN/m at 25°C). 
 
Dual Polarization Interferometry (DPI) 
 
Dual polarization interferometry (DPI) measurements were conducted using an Analight Bio 200 
(Farfield Group, Manchester, UK) running Analight Explorer software. A silicon oxynitride 
AnaChipTM surface treated with oxygen plasma was used in this study. To measure the coating 
thickness, the chip was inserted into the fluidic compartment of an Analight Bio 200 and a polymer 
solution (1% w/v in a 20% saturated ammonium sulphate) was slowly introduced into the chip 
channels at a flow rate of 6 μl/min for 15 minutes. The flow was then stopped, and the solution was 
allowed to stay in contact with the surface for 30 minutes before washing the channel with water, 
which was injected into the channel at a flow rate of 50 μl/min. 
Before each experiment, a standard calibration procedure was performed using an 80 % (w/v) 
ethanol and MQ H2O solution. The data were analyzed using Analight Explorer software to calculate 
the mass, density and thickness of the poly(DMA-PMA-MAPS) adsorbed onto the surface. 
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9.2.4. Microarray experiments 
 
9.2.4.1. Qualitative fluorescence analysis 
 
In the study of lectin-glycan interactions, an array was printed of the eight α-mannose derivatives 
(Table 3, paragraph 6.1) carrying an azido linker using a piezoelectric spotter (SciFlexArrayer S5, 
Scienion, Berlin Germany) on the surface of a polymer coated Si/SiO2 slide. Four hundred pL of each 
glycan solution was spotted at 10 µM or 50 µM concentration in aqueous solution in the presence 
of Cu2SO4 · 5H2O (2.5 mM) and ascorbic acid (12.5 mM). An α-mannoside and β-galactoside were 
used as positive and negative controls and were spotted in the same conditions described above. 
The immobilization reaction took place during an overnight incubation in a humid chamber at room 
temperature. The printed slides were sequentially washed with PBS buffer for 10 minutes with 
stirring, rinsed in DI water and dried by a nitrogen stream.  
The arrayed slides were then incubated with biotinylated α-mannose-binding lectin Concanavalin A 
(ConA, 100 ng/ml) in the lectin binding buffer (LBB, 50 mM HEPES, pH 7.4, 5mM MnCl2, 5 mM CaCl2) 
in the presence of 0.2 mg/ml of bovine serum albumin (BSA). After 2 hours of incubation at room 
temperature on a lab shaker, the slides were washed 10 minutes in washing buffer on a lab shaker 
(0.05 M Tris·HCl pH9, 0.25 M NaCl, 0.05% v/v Tween 20), rinsed in DI water and dried with  
nitrogengas. A final incubation for 1 h with 2μg/ml Cy-3-labelled Streptavidin in PBS (Phosphate 
Saline Buffer) in a humid chamber at room temperature under static conditions enabled the 
fluorescence detection of the surface bound ConA  by means of a scanner (ProScanArray scanner 
from Perkin Elmer, Boston, MA, USA) used at 70% laser power and 60% photomultiplier (PMT) gain.  
The fluorescence intensities of 11 spot replicates were confirmed by three experiments that 
provided the same fluorescence intensities for each glycomimetic, with a standard deviation lower 
than 5%. 
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9.2.4.2. Determination of the surface dissociation constant (KD,surf) 
 
Fluorescence microarray experiments 
 
The surface equilibrium constant, KD,surf for the interaction of the eight α-mannose derivatives 
(Table 3, 2-9) with ConA was determined according to a method previously reported by Wong and 
co-workers167. Several silicon/silicon oxide slides coated with poly(DMA-PMA-MAPS) were printed 
with 11 replicates of each glycan at 50 μM concentration to form an array of eight different α-
mannose derivatives (Table 3, paragraph 6.1.). Each slide was incubated for 2 hours with a given 
concentration of biotinylated ConcanavalinA (ConA) (from 47.2 pM to 9.43 nM) dissolved in LBB (50 
mM HEPES, pH 7.4, 5mM MnCl2, 5 mM CaCl2) containing 0.2mg/ml BSA. After 2 hours of incubation 
at room temperature on a lab shaker, the slides were washed 10 minutes in washing Buffer (0.05 M 
Tris·HCl pH9, 0.25 M NaCl, 0.05% v/v Tween 20), rinsed in DI water and dried by a nitrogen stream. 
After 1 hour of incubation with Cy-3 labeled streptavidin (2 μg/ml) in PBS, the slides were scanned 
for fluorescence to evaluate the amount of ConA captured by the immobilized glycans. The 
fluorescence intensities of 11 replicated spots were averaged. 
The experimental conditions used during the incubation were optimized to ensure 
equilibration.The mean fluorescence intensities of the different glycans (spotted in 11 replicates) 
obtained from each single incubation was plotted against ConA concentration. The fluorescence 
values were fitted using OriginPro-8 that enables the calculation of KD,surf as EC50 for each glycan, 
depending on its affinity for ConA. 
For the study of KD,surf at lower glycan density (from 0.5 to 5 µM) the protocol used was the same 
described above for the spotting step, using the glycan at the desired concentration in an aqueous 
solution of Cu2SO4 · 5H2O (2.5 mM) and ascorbic acid (12.5 mM). The concentration range of 
Concanavalin A used during the incubation step was expanded to the micromolar concentration 
(from 0.45 nM up to 13.4 µM). 
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9.2.5. Antibody modification 
 
9.2.5.1. Site-specific enzymatic modification 
 
The site-specific modification consists of two steps: (1) antibody carbohydrates domain 
modification (i.e. removal of the terminal galactose) and (2) the attachment, on the antibody 
domain, of a synthetically modified galactose (Figure 48, section 7.1.2.).  
 
Step (1): Removal of terminal galactose using β-(1,4)-galactosidase: 
 
The first step includes the use of the commercial available enzyme β-(1,4)-galactosidase, from 
Aspergillus oryzae (SIGMA Aldrich), that breaks the covalent binding between glucose and galactose 
presented on the heavy chain of the Fc region of the antibody. The interleukin-6 (IL-6) capturing-
antibody, previously concentrated, was diluted in sodium acetate buffer (10 mM, pH 5) at a final 1 
mg/ml concentration and β-galactosidase (1U) was added. The reaction mixture was left overnight 
at 30°C. 
Once the required time for the antibody carbohydrates domain modification was completed, using 
a centrifugal filter (Amicon Ultra 0.5 ml, Ultracel-30K) the buffer was changed to an alkaline Tris·HCl 
buffer (50 mM, pH 7.4), preparing the condition for the second reaction step. 
 
Step (2): Attachment of a sytnthetically modified galactose using β-(1,4)-galactosyltransferase: 
 
The second step consists of the attachment of a 6-azidogalactose (GalNAz), through the use of the 
commercial available β(1,4)-galactosyltransferase (a mammalian glycosyltransferases from bovin 
milk, from Sigma Aldrich) and the synthetic UDP-6-azidogalactose (synthesis reported in paragraph 
9.2.2.).  
From the 1 mg/ml solution of the modified antibody, 125μl were extracted and put in a 1 ml 
Eppendorf (1 ml vial). Alkaline phosphatase (2 U) , β-(1,4)-GalT (15 mU), unnatural UDP-GalNAz 
(220 μg, 0.37 μmol), MnCl2·4H2O (20 mM) were added to the antibody solution. The reaction 
mixture was brought up to a final volume of 250 μl by adding Tris∙HCl buffer (50 mM, pH 7.4) and 
left to react at 37°C for 24 hours. The reaction is complete when a white precipitate forms (due to 
the hydrolysis of uridine-diphosphate from alkaline phosphatase). Once the reaction was 
terminated, the antibody was purified through centrifugal filters (Amicon Ultra 0.5 ml, Ultracel-30K) 
and the Tris·HCl buffer was changed to sodium phosphate buffer (50 mM, pH 7.4) to facilitate the 
following click-reaction. 
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A similar procedure was adopted for the site-specific modification using the “Site-Click” Antibody 
Labelling Kit from Life Technologies. 
 
9.2.5.2. Random modification 
 
Peg-ylation of the interleukin-6 capturing antibody 
 
To randomly modified 1 mg/ml of IL-6 capturing antibody, a peg-ylation chemistry was adopted. In 
a PBS buffer (50 mM, pH 7.4) antibody solution (5 mg/ml), NHS-PEG8-N3 (0,30 μl, 4 eq) from a 5 
mg/ml stock in DMF was added, and the reaction mixture was left  react at room temperature for 2 
hours. Once the reaction time was completed, using a centrifugal filter (Amicon Ultra 0.5 ml, 
Ultracel-30K), the unreacted PEG was removed and the buffer was changed to  sodium phosphate 
buffer (50 mM, pH 7.4) to facilitate the following click-reaction. 
 
9.2.6. Interleukin-6 sandwich test 
 
In the study of the critical role of antibody orientation during a microarray analysis, the IL-6 test 
was chosen. An array of IL-6 capture antibody, carrying an azido β-galactose on the Fc region(Ab-N3 
(C-6), paragraph 7.1.4.), was printed using a piezoelectric spotter (SciFlexArrayer S5, Scienion, Berlin 
Germany) on the surface of a poly(DMA-PMA-MAPS) coated silicon/silicon oxide IRIS slide. Four 
hundred pL of the capture antibody was spotted at 0.35 mg/ml concentration in buffered solution 
(sodium phosphate 50 mM, pH 7.4) mixed with Cu2SO4 · 5H2O (100 μM), THPTA (400 μM) and 
ascorbic acid (6.25 mM). To validate this alternative protocol for the site-specific antibody 
modification, the same antibody modified through the use of “Site-Click” Antibody Labelling Kit 
from Life Technologies (Ab-N3 (C-2), paragraph 7.1.4.) was printed in the same condition.  
Furthermore, to demonstrate both the advantage of using a bio-orthogonal and regiospecific 
surface chemistry (CuAAc) and the use of an oriented antibody on a 3D-matrix environment, 0.35 
mg/ml of PEG-ylated IL-6 capture antibody (Ab-PEG8-N3, paragraph 7.1.4.) was also spotted on the 
same slide in the same conditions: in sodium phosphate buffer (50 mM, pH 7.4) with Cu2SO4 · 5H2O 
(100 μM), THPTA (400 μM) and ascorbic acid (6.25 mM). 
A slide coated with poly(DMA-NAS-MAPS) was spotted with 0.35 mg/ml of the unmodified IL-6 
capturing antibody (Ab, paragraph 7.1.4.) in the usual spotting buffer (50 mM sodium acetate 
buffer, pH 4), to compare oriented and random antibody immobilization via active ester/amine 
reactivity.  
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The immobilization reaction took place inat least in 30 minutes in a humid chamber at room 
temperature. The printed slides were washed with PBS buffer for 10 minutes, rinsed with DI water 
and dried by with nitrogen gas.  
Before the first incubation step, IRIS images were acquired and fitted with Zoiray Acquire software 
to obtain a mass quantification for each modified printed antibody. For each antibody, signals from 
48 replicate spots were averaged. 
The arrayed slides were then incubated with the antibody IL-6 in incubation buffer (50 mM Tris/HCl, 
015 M NaCl, 0,02% Tween20, pH 7.6) at 2 ng/ml in the presence of BSA (1%). After 2 hours of 
incubation at room temperature on a lab shaker, the slides were washed for 10 minutes in washing 
Buffer (0.05 M Tris/HCl pH9, 0.25 M NaCl, 0.05% v/v Tween 20), rinsed in DI water and dried with 
nitrogen gas. Subsequently the chip was incubated, under static conditions for 1 hour at room 
temperature in a humid chamber, with the biotinylated antibody (or detection antibody), diluted 
1:200 in incubation buffer (50 mM Tris/HCl, 015 M NaCl, 0,02% Tween20, pH 7.6) in the presence of 
1% (w/v) BSA (bovine serum albumin). Once the incubation time was finished, the chip was washed 
in PBS buffer for 10 minutes on a lab shaker, rinsed in DI water and dried with nitrogen gas. 
The final step was the incubation with 2μg/ml Cy-3-labelled Streptavidin in PBS (Phosphate Saline 
Buffer) in a humid chamber at room temperature for 1 hour under static conditions.  
This incubation step enables the fluorescence detection of the surface bound IL-6  by means of a 
confocal scanner laser (ProScanArray scanner from Perkin Elmer, Boston, MA, USA) used at 70%  
laser power and 70% photomultiplier (PMT) gain.  
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